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ABSTRACT 
Energy modulated electron therapy (EMET) is a promising treatment modality that has 
the fundamental capabilities to enhance the treatment planning and delivery of 
superficially located targets. Although it offers advantages over x-ray intensity modulated 
radiation therapy (lMRT), EMET has not been widely implemented to the same level of 
accuracy, automation, and clinical routine as its x-ray counterpart. This lack of 
implementation is attributed to the absence of a remotely automated beam shaping system 
as well as the deficiency in dosimetric accuracy of clinical electron pencil beam 
algorithms in the presence of beam modifiers and tissue heterogeneities. In this study, we 
present a novel technique for treatment planning and delivery of EMET. The delivery is 
achieved using a prototype of an automated "few leaf electron collimator" (FLEC). It 
consists of four copper leaves driven by stepper motors which are synchronized with the 
x-ray jaws in order to form a series of collimated rectangular openings or "fieldlets". 
Based on Monte Carlo studies, the FLEC has been designed to serve as an accessory tool 
to the CUITent accelerator equipment. The FLEC was constructed and its operation was 
fully automated and integrated with the accelerator through an in-house assembled 
control unit. The control unit is a portable computer system accompanied with 
customized software that delivers EMET plans after acquiring them from the 
optimization station. EMET plans are produced based on dose volume constraints that 
employ Monte Carlo pre-generated and patient-specifie kemels which are utilized by an 
in-house developed optimization algorithm. The structure of the optimization software is 
demonstrated. Using Monte Carlo techniques to calculate dose allows for accurate 
modeling of the collimation system as weIl as the patient heterogeneous geometry and 
take into account their impact on optimization. The Monte Carlo calculations were 
validated by comparing them against output measurements with an ionization chamber. 
Comparisons with measurements using nearly energy-independent radiochromic films 
were performed to confirm the Monte Carlo calculation accuracy for I-D and 2-D dose 
11 
distributions. V>.r e investigated the c1inical significance of EMET on cancer sites that are 
inherently difficult to plan with IMRT. Several parameters were used to analyze 
treatment plans where they show that EMET provides significant overall improvements 
over IMRT. 
1ll 
ABRÉGÉ 
La radiothérapie par modulation d'énergie d'électron (RTMEE) est un mode de 
traitement prometteur qui à la capacité fondamentale d'améliorer la planification du 
traitement et son application vers des cibles superficielles. Bien que ce mode de 
traitement présente des avantages par rapport à la radiothérapie par modulation 
d'intensité (RTMI) avec photon, l'expansion de l'implantation de la RTMEE n'a pas 
atteint le même niveau de précision, d'automatisation et de routine clinique que la RTMI. 
Ce retard d'implémentation est attribué à l'absence d'un system automatisé qui contrôle à 
distance la conformité du faisceau ainsi qu'à l'imprécision des algorithmes de calcul de 
dose en milieux hétérogènes pour les faisceaux d'électrons en conformité. Cette étude 
présente une technique innovatrice permettant de faire la planification et le traitement par 
RTMEE. Le traitement est donné en utilisant un prototype de « collimateur d'électron à 
peu de lames» (CEPL) automatisé. Celui-ci possède quatre lames de cuivre, guidées par 
des moteurs pas à pas, qui sont synchronisées avec les mâchoires du mode photon de 
l'accélérateur linéaire afin de former une série d'ouvertures rectangulaires «sous 
champs ». Une modélisation Monte-Carlo du CEPL a été réalisée pour optimiser sa 
conception et sa construction afin de servir d'outil complémentaire aux accélérateurs 
linéaires médicaux actuels. La mise en opération du CEPL est totalement automatisée et 
intégrée à l'accélérateur via une unité de contrôle locale. L'unité de contrôle consiste en 
un ordinateur portable accompagné d'un logiciel fait sur mesure qui contrôle les lames en 
fonction des plans de la RTMEE reçus via la station d'optimisation. La production des 
plans de la R TMEE est basée sur des contraintes de volume de dose et utilise des noyaux 
de calcul pré-calculés et spécifiques au patient traité utilisant un algorithme 
d'optimisation développé localement. La structure des logiciels d'optimisation est 
démontrée. L'utilisation des techniques de calcul de la dose par Monte-Carlo permet une 
modélisation précise à la fois du système de collimateur ainsi que de la géométrie 
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hétérogène du patient afin de prendre en considération leurs impacts sur l'optimisation. 
Les calculs de dose par Monte-Carlo sont validés en les comparant aux mesures obtenues 
avec une chambre d'ionisation. Des comparaisons avec des mesures indépendantes à 
l'énergie ont été obtenues en utilisant des films radiochromiques pour confirmer 
l'exactitude des calculs de Monte-Carlo pour les distributions de dose en I-D et en 2-D. 
Nous avons aussi étudié la signification clinique de la RTMEE sur des sites de cancer qui 
sont par nature difficiles à planifier avec la RTMI avec rayons X. Plusieurs paramètres 
ont été utilisés pour analyser les planifications de traitement et ont démontré que la 
RTMEE offre des améliorations généralement plus significatives que la RTMI avec 
rayons X. 
v 
STATEMENT OF ORIGINALITY 
The complexity of inverse techniques for treatment planning of energy modulated 
electron therapy (EMET) has limited its applications c1inically. The successful 
implementation of EMET requires the utility of an automated beam shaping system that 
allows the manipulation of beam intensities in addition to an accurate dose ca1culation 
engine. Although EMET has been the subject of several other studies, planning accuracy 
and complications during delivery remain central problems. We have attempted to 
overcome these problems by presenting a novel automated few leaf electron collimator 
(FLEC) in conjunction with Monte Carlo-based inverse treatment planning optimization. 
The FLEC was constructed and incorporated within the clinical accelerator so as to be 
easily controlled from the treatment console. The FLEC is integrated with a Monte Carlo-
based inverse planning process. We are the first to construct an electron collimator that 
acquires a sequence of aperture settings from an optimization algorithm and deliver the 
EMET plans automatically. None ofthe previously reported investigations addressed the 
ability to provide an accessory tool for the purpose of EMET that is practical and 
completely automated. Nor there have been Monte Carlo-based, optimized planning tools 
that were connected to any form of delivery units. 
In the process of verifying our Monte Carlo dose ca1culation performance, we present an 
extensive set of measurements. We are the first to use the radiochromic films to show the 
2-D dose distributions of complex intensity maps delivered by different electron beam 
energies where both measurements and ca1culations agree well. We also investigated the 
effects of the partial blocking of electron beams using x-ray collimators for the purpose 
of EMET. We report excellent agreement between Monte Carlo and measurements which 
inc1udes: the effect of the beam output, the isodose lines representing the high dose 
region, and the leakage dose. 
VI 
So far, very Iittle research examined the dosimetric advantages of EMET compared to 
IMR T. AlI the previous research was purely theoretical because means of delivery were 
not established. We present a comprehensive dosimetric evaluation of EMET delivered 
with the FLEe. We show that it provides a valuable addition to the CUITent treatment 
planning techniques when applied to superficialIy located tumors. 
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Chapter 1 
Introduction 
1.1 Radiation Therapy 
Radiation therapy is the treatment of cancer with ionizing radiation where energy 
is transferred to the cells, thereby destroying them by damaging their DNA. The damage 
is caused directly or indirectly by ionizing the atoms that constitute the DNA chain. Most 
of the effects of radiation are caused by free radicals that are formed through ionization. 
Breaking the DNA on both strands of the DNA double helix is the most significant 
cellular perturbations caused by ionizing radiation that leads to diminishing cancer cells. 
Whether used as the main mode of treatment or in conjunction with surgery and/or 
chemotherapy, radiation therapy is considered a very important tool in the fight against 
cancer and is used in the treatment of as many as 50% of all cancer patie~ts [1 J. 
Clinically, radiation delivery is done either in the form of sealed radiation sources that are 
inserted inside the patient (brachytherapy) or using external beams. In the latter, particles 
are accelerated to high energies before being directed at the patient. 
The treatment success rate increases with the increased number of killed tumor 
cells. Hence, the goal of any treatment is to maximize the damage to the cancerous cells 
by radiation [2]. Defined as the amount of energy deposited per unit mass of tissue, 
absorbed dose is directly related to the number of radiation-induced cell deaths [3]. But 
since the principles of radiation killing apply to both the tumor and normal cells, it is 
important for the dose distribution to conform to the shape of the tumor volume while 
minimizing the dose to the normal cells [4]. In order to spare surrounding tissue and 
1 
Chapter 1 Introduction 
maximize the tumor dose, the beam of radiation may be partially blocked, modulated, or 
rotated around the patient's body. This process is referred to as "treatment planning". 
With the advem of 3D imaging, the location of the tumor and the extent of the disease 
can accurately be determined. Hence, treatment plans that match the optimum tumor 
control goals can be achieved. The recent developments in the design of external beams 
have provided us with ideal tools that enable tightened dose shaping through the delivery 
of complex fields. 
1.2 Intensity Modulated Radiation Therapy (IMRT) 
The ability to employ spatially modulated beam intensities in intensity modulated 
radiation therapy (lMR T) is regarded as the outcome of the latest developments in 
radiation therapy [5-11]. In IMRT, each beam is divided into a large number of radiation 
beamlets. Each beamlet is assumed to contribute to the ove raIl dose to the organ by dose 
deposition coefficients (DDCs) that measure the dose deposited to a point per unit weight 
of the beamlet. By assuming that the intensity modulation is linearly mapped onto the 
dose vector by the DDC matrix, inverse treatment optimization algorithms are used to 
manipulate the beamlets in order to escalate the dose to the tumor while providing 
sufficient healthy tissue sparing. The beam portaIs are adjusted by the computer-
controlled multi leaf collimators (MLCs) which offer a delicate control of delivered 
intensities. 
1.3 The Ne{:d for Dosimetric Accuracy 
There are several steps that are involved in the complex process of radiation 
therapy. Each step contributes to an overall uncertainty on the dose distribution which has 
a potential impact on tumor control or healthy tissue complications. These uncertainties 
are introduced through (1) patient setup, (2) accelerator beam output calibration, (3) 
patient data acquisition, and (4) dose calculation algorithms. In order to be consistent 
with the analysis and the outcome of clinical trials, the International Commission on 
Radiation Units and Measurements (lCRU) recommends achieving an accuracy that falls 
within the limits of 5% in dose delivery to the patient [12]. However, since the 
uncertainties in each procedure have independent nature, the required accuracy for each 
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of the four procedures should be limited to 2.5% in order to achieve an overall accuracy 
that matches the ICRU recommendations. The demand for accuracy in ca1culating the 
dose distribution within the treatment volume and normal tissue requires the application 
of a 3-dimensional treatment planning system. Such a system utilizes the information 
pertaining to the treatment machine in addition to the radiation transport properties 
influenced by the geometric patient data. The challenge of performing accurate dose 
calculations is due to: (1) the complicated shape and intensity distribution of the beam, 
and (2) the heterogeneous anatomy of the patient. Both problems have become more 
pronounced over the last years as the beam shaping is attaining more complexity. 
Currently, Monte Carlo simulation is undoubtedly the most accurate method that 
simulates radiation transport and predicts doses in complex heterogeneous media 
representing the human body [13-21]. Arguably, its main disadvantage, however, are the 
extremely long computing times that are required in order to obtain a dose distribution 
with a good statistical accuracy. Although this is still true to sorne extent, the use of 
modem computing power that is available nowadays along with the aid of valid 
approximations have considerably reduced the required computation times for Monte 
Carlo simulations. In recent years, manufacturers have developed commercial Monte 
Carlo-based clinical treatment planning systems [21-25]. 
1.4 Modulalted Electron Therapy, Why Not? 
High energy electron beams are used frequently in radiation therapy. They have 
unique characteristics that are not provided by x-rays or other forms of accelerated 
particles. Namely, a high surface dose followed by a rapid faH-off until the dose is 
reduced to a few percent of the maximum dose. Such advantages over x-ray therapy 
make electron therapy well-suited for superficial targets. Moreover, most clinical linear 
accelerators can produce electrons with a wide range of energies. With these 
characteristics, electron beams have the potential of being modulated with the same level 
of automation, accuracy and clinical routine as their x-ray counterpart [26-29]. 
Theoretically, aH the advances in IMRT could be implemented so as to achieve electron 
beam modulation. Another advantage of electrons is that in addition to their intensity, 
their nominal energy is also a function of modulation. However, despite its potential 
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capabilities, energy modulated electron therapy (EMET) lagged behind IMRT. Two 
major reasons contributed to this lag: (1) the dosimetric complexity of electron beam 
planning and (2) the absence of a practical and automated collimation device. 
The accuracy of the dose calculation algorithm is critical to the success of the 
inverse treatment optimization. It is the dose calculation algorithm that is responsible for 
producing the dose kernel data, i.e., DDCs, which are used by the optimizer algorithm to 
produce an optimal distribution. If the DDCs are poorly modeled, the optimization 
procedure will produce a "theoretical" plan that significantly differs from the 
"deliverable" one. Therefore, realistic dose kernel data are essential for a meaningful 
optimization outcome. ln x-ray IMRT, analytical dose calculation algorithms are the most 
widely used. Despite recent indications that more accurate dose algorithms reduce the 
discrepancies between planned and delivered dose distributions [30-33], analytical 
algorithms generally show decent dosimetric accuracy for the task of optimization. 
However, for electron beams, they suffer from severe limitations that restrict their use in 
optimization algorithms. For example, the pencil beam algorithm, which is considered the 
best available analytical dose calculation algorithm, could yield an error of up to 20% in 
the case of oblique incidence on heterogeneous medium [13,19,20,34,35]. ln addition, it 
fails to predict the beam output under beam collimation devices to within reasonable 
accuracy. If the dose per unit weight of the beamlet is not known precisely, the basic 
requirement of the optimization procedure is violated. Hence, analytical dose calculation 
algorithms, despite their current relative success in photon beams, are not suitable for 
EMET. Monte Carlo algorithms, on the other hand, have the ability to account for the 
fundamentals of electron transport through collimation devices and inside the 
heterogeneous patient. It is therefore proposed that Monte Carlo techniques can be the 
essence of a successful application of EMET [28]. 
The other major reason behind the limited applications of EMET is the absence of 
a remotely automated collimation system that is fully integrated into the optimization and 
the dose calculation algorithms. Although attempts were made to incorporate different 
collimation tools as upgrades to the existing technology [28,36-39], a full delivery system 
has not yet found its clinical implementation. These attempts tried to solve pieces of the 
puzzle without a comprehensive approach to de al with the problems of EMET. For 
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example, several authors discussed the possibility of employing an electron MLC 
(eMLC) for the purpose of EMET. But these approaches dealt only with the collimation 
problem isolated from the possibility of automated delivery and, more importantly, 
isolated from the impact of the presence of such collimator on the optimization 
procedure. There is no doubt that these studies shed sorne light on the problems 
encountered wh en dealing with EMET and proposed a number of solutions. However, 
EMET treatment planning and delivery remained only a research topic. 
1.5 Hypoth{~sis and Objectives 
In this work, we present a novel technique of delivering EMET usmg an 
automated "few leaf electron collimator" (FLEC) prototype. The FLEC serves as an 
accessory tool to cUITent-day accelerator equipments. It allows for an optimization 
technique that uses a limited number of Monte Carlo-generated and patient-specifie 
kemels in order to perform inverse planning. 
We hypothesize that the integration of Monte Carlo calculated dose distributions 
with an optimization algorithm that communicates with the FLEC leads to the clinical 
implementation of EMET. We consider the clinical implementation to be demonstrated 
when the FLEe collimation system is comprehensively automated to acquire the plans 
from the optimization algorithm and deliver them in a clinical setting. We also 
hypothesize that the Monte Carlo-calculated plans are accurate compared to the plan 
delivery verified experimentally. In addition, we hypothesize that the EMET technique 
will be superior to CUITent treatment modalities for superficially located lesions. 
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In order to resolve the stated hypotheses, the work has the following objectives: 
• Design, construction, and automation of the FLEC that fits on a frame 
that fits in the electron applicator. 
• Incorporation of Monte Carlo-based inverse treatment planning software. 
• Dosimetric evaluation of the significance of EMET compared to IMRT 
and three dimensional conformaI therapy (3D-CRT). 
• Dosimetric validation of the Monte Carlo ca1culations used to deliver the 
optimal plans. 
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1.6 Thesis Outline 
This thesis consists of three manuscripts, two of which were published and the 
third one is still under review. Chapter 2 presents a brief introduction to electron beam 
therapy. It describes the fundamentals of electron beam characteristics, dosimetry, and 
treatment planning. It includes a comparison between the algorithms used for electron 
transport in treatment planning systems. In the third chapter, a comprehensive review of 
the literature discussing alternative approaches for EMET delivery is presented. Chapter 
4 consists of a paper pub li shed in Physics in Medicine and Biology. It introduces the idea 
of the FLEC in conjunction with a Monte Carlo dose calculation engine. An in-house 
optimization algorithm that has been modified to perform EMET planning is presented. 
EMET treatment plans for a simple phantom and a realistic patient have been produced 
and compared to 3D-CRT. In chapter 5 we present a paper published in Medical Physics 
where we show the expected clinical advantages that would be obtained by using EMET 
delivered with the FLEe. A detailed dosimetric evaluation is presented for EMET, and is 
compared further to both 3D-CRT and IMRT. The construction and validation of the 
FLEC is discussed in chapter 6 which presents the results of a recently submitted paper to 
Medical Physics. It demonstrates the structure of a control unit that was built and 
integrated to deliver EMET plans. This study validates the Monte Carlo-ca1culated I-D 
and 2-D dose d:lstributions of energy modulated electron beams. Chapter 7 summarizes 
the main contributions of this work and proposes sorne future work. Finally, an appendix 
is included to briefly introduce the McGill Monte Carlo Treatment Planning (MMCTP). 
This appendix was not included in the manuscripts due to the required concise nature of 
the published papers. Finally, it is worth mentioning that slight modifications were made 
to the notations and abbreviations used in the original published manuscripts. These 
minor modifications, such as the use of italics and addition of spaces, were required to 
maintain consistency of formatting throughout the thesis. Reprints of the publications are 
included in a dedicated appendix. 
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Chapter 2 
Introduction to Electron Bearn Therapy 
Since the early 1950s, electron beam therapy has been considered a comerstone 
modality for radiation therapy applications. The use of electron beams is continuously 
being enhanced with the remarkable developments in electron treatment machines, dose 
measurements, electron transport algorithms, and new advancements in energy 
modulated electron beam delivery. This chapter presents a general overview of the 
fundamentals and applications of high energy electron beams in radiation therapy. A 
basic introduction is provided to describe electron beam characteristics, dosimetry, and 
treatment planning. 
2.1 Electron Interactions 
Electrons may interact with matter in three basic ways: (1) soft collisions, (2) hard 
collisions, and (3) nuclear scattering. In the classical approach, these modes of 
interactions can be characterized depending on the relation between the classical impact 
parameter b and the classical atomic radius a, as shown in Fig. 2-1. The impact parameter 
is defined as the perpendicular distance between the incoming electron and the nucleus. It 
is dependant on the energy of the incoming electron and the atomic number. 
Soft collisions occur when the impact parameter is much larger than the atomic 
radius causing a Coulomb interaction between the electron and the atom as a whole. Hard 
collisions occur when the impact parameter is of the same order of magnitude as the 
radius of the atom. Here, the incident electron interacts with an orbital electron resulting 
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undisturbed electron trajectory e 
------------------~A----~----~------~)· 
electron cloud 
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b 
~--+-------- nucleus 
Figure 2-1: Representation of an electron traversing the field of an atom; Ha" is the 
classical atomic radius, "b" is the classical impact parameter. 
III the ejection of the orbital electron with considerable kinetic energy. The ejected 
electron, called a delta ray, is able to produce its own track that can potentially cause 
further series of ionizations and excitations in the absorber. If the impact parameter is 
much smaller than the atomic radius, the electron interacts with the electric field of the 
nucleus. In most of these interactions, the charged particle is scattered elastically without 
losing any energy. In the case of inelasic electron-nucleus interactions, the electron loses 
energy through the emission of radiation in a process referred to as bremsstrahlung 
production. The production of bremsstrahlung photons becomes more important for 
higher atomic number Z materials. As electrons travel through the absorbing medium, 
their energy is continuously degraded until they completely stop. 
2.1.1 Stopping power 
The average rate of energy loss dT of an electron per unit of path length dx is 
called the linear stopping power. From this definition, the stopping power Scan be 
. S dT 
wntten as = --. 
dx 
Since thicknesses of the materials are often expressed in mass units, the stopping 
properties of the absorbing media are often defined in terms of the mass stopping power 
(%). The mass stopping power can be subdivided into two components: the "mass 
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collision stopping power" (SI) which accounts for the energy loss through hard and 1 P col 
soft collisions, and the "mass radiative stopping power" ( SI) ,which takes into 1 Prad 
account the energy loss due to radiative interactions. 
According to Bethe and Heitler [1], with the aid of M011er' s [2] and Bhabha' s [3] 
work, the mass collision stopping power for electrons and positrons is defined as: 
(§...J = 21rre2m(2NA ~ [ln(T / I)+ln(1+~)+F±(T)-5], (2-1) 
P col fJ 
where rc is the classical electron radius, 1 is the mean ionization/excitation potential, NA is 
the Avogadro's number, me is the electron mass, P is the incident particle velocity 
normalized to the speed of light, r is the kinetic energy of the incident particle in units of 
moc
2
, T is the kinetic energy of the incident particle, (j is the density correction, and F± is 
a function that depends on wh ether the incident particle is electron or positron. Equation 
2-1 shows the dependence of the collision stopping power on the charge and energy of 
the incident particle. 
The radiative stopping power can be expressed as 
(SJ - 1 2 NAZ2 (T 2)B-- -r -- +mc 137 e A e r' P rad (2-2) 
where Br is a slowly varying function that is dependent on Z and T [4]. The radiative 
stopping power has a quadratic dependence on Z. In addition, the radiative energy loss 
increases linearly with the particle energy. Therefore, bremsstrahlung production 
becomes the predominant mechanism of energy loss for high energy electrons impinging 
on high Z materials. 
2.1.2 Absorb(~d dose 
The absorbed dose D is defined at a point inside a volume as the expectation 
value of the energy imparted to matter per unit mass and is represented by 
D=dE. 
dm 
(2-3) 
The energy imparted (or absorbed) E is found by taking the sum of aU energies entering 
the volume and subtracting aIl the energies leaving the volume while accounting for any 
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mass energy conversion within the volume. The SI unit for the absorbed dose is Gray 
(Gy) which is equivalent to 1 joule per kilogram. 
When absorbed dose is calculated, two parameters are required: (1) electron 
fluence and (2) the "restricted" stopping power (!:.-J that refers to the rate of energy 
P col,'" 
loss in collisions per unit path length in which the energy is absorbed "locally". Hence, 
any electron with an energy that is higher than ~ is assumed to deposit its energy outside 
the unit mass where the dose is calculated. Hence, the absorbed dose can be calculated 
from the differential electron fluence spectrum dCl> as 
dT 
D = ru dCl> (T) . (!:.-J dT + TE,.. 
dT P col,'" 
(2-4) 
where TE,.. is the track-end term which can be approximated by 
(2-5) 
2.2 Treatment Units 
The use of high energy electrons in radiation therapy started with the development 
of the Van de Graaff and betatron accelerators. Despite being cumbersome, the Van de 
Graaff generator provided one of the earliest sources for producing electron beams in 
radiation therapy, as reported by Trump [5]. It is an electrostatic accelerator in which the 
particles cannot be accelerated to energies higher than the potential energy of the 
maximum voltage available in the machine. Because of its limited maximum energy, the 
Van de Graaff generator was only used for treating surface lesions. 
Betatrons, based on the technology of cyclic accelerators, were able to accelerate 
electrons to much higher energies. In cyclic accelerators, particles are accelerated 
gradually by repeatedly following a closed path of variable electric and magnetic fields 
until a maximum kinetic energy is obtained. Cyclic acceleration was implemented in 
betatrons where electrons are accelerated using the electromagnetic induction by allowing 
them to circulate in a vacuum chamber that is placed between two magnet poles. 
Changing the flux of the magnetic field by using an altemating CUITent applied to the 
magnets induces an electric field inside the vacuum chamber. The induced electric field 
14 
Chapter 2 Introduction to Electron Bearn Therapy 
accelerates the electrons which are kept in circular orbits by the magnetic field. Because 
of their ability to produce high energy electron beams, betatrons provided an environment 
for early clinical research. The studies that discussed the design of scattering foils and 
collimators were initially investigated using betatrons. AIso, with betatrons, the early 
calibration procedures and dose measurements were performed [6]. However, betatrons 
were bulky and noisy machines. They gradually lost their appeal with the development of 
medical linear accelerators (linacs) that were able to provide much higher dose rates and 
larger field sizes using quieter machines with more compact design allowing isocentric 
mounting. 
2.2.1 Medicalilinear accelerator (linac) 
Linacs are cyclic accelerators that use the microwave radiofrequency to accelerate 
electrons. After being initially produced thermionically from a filament and accelerated 
in an electrostatic accelerator, called an electron gun, electrons enter a loaded metallic 
accelerating waveguide. In the waveguide, high power radiofrequency waves produced 
by a microwave generator are propagated according to Maxwell' s equations. The electron 
acceleration is gained by the transfer of energy from the radiofrequency fields to the 
electrons with the help of the specially designed loaded waveguide that allows the 
electrons to continuously "see" a positive potential ahead and a negative potential behind. 
Once the desired energy has been achieved, the electron beam is directed through a beam 
transport system to the linac head. 
The design of the linac exhibits differences because of the variety of 
manufacturers. These differences include standing vs. traveling wave accelerating 
structures, magnetron vs. klystron microwave generators, and various bending magnet 
systems. However, all designs share common features of the treatment he ad in which 
they incorporate systems for (l) broadening and flattening, (2) dose monitoring, and (3) 
collimation of the beam. 
The broadening and the flattening of the electron beam is achieved in modem 
linacs using a dual-foil scattering systems [7]. In this system, a primary thin foil made of 
a high Z material is separated by a few centimetres from a secondary foil made of a low Z 
material. Such a system minimizes the increase in energy spread [8,9] and the 
bremsstrahlung production while maximizing the flattened field size. 
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The use of monitor chambers is of critical importance because of the need to 
evaluate the beam output stability and measure the integrated dose of the flattened 
electron beam. The monitor chambers quantity the delivery of electron beams using a 
quantity called monitor unit (MU) which is adjusted to deliver a certain dose in Gy inside 
a water phantom. To avoid overdose delivery to the patient, linacs are equipped with 
safety interlocks that terminate the beam irradiation in case of any failure. 
Collimators are considered a major component of the treatment head. They are 
designed to col1imate the beam to different sizes in order to conform the irradiation to a 
localized volume. Because electrons suffer from significant in-air scattering, two sets of 
collimators are required. Hence, the collimation system in clinicallinacs usually consists 
of a primary coUimator that is close to the source and a secondary collimator that is close 
to the patient. The former is defined by the x-ray jaws and the latter can be in the form of 
inserts or trimmer bars. The movable x-ray collimators, consisting of two perpendicular 
pairs (jaws) of tungsten, define the primary collimation and are located approximately 60 
cm from the isocenter of the beam. The lower collimators are auxiliary collimators that 
are provided in fixed attachable cones. 
In addition to the basic components of the linac, an auxiliary system is also 
required to provide vacuum pumping, water cooling, microwave transmission, and 
shielding from radiation leakage. The advancements in modem electronics and computer 
control resulted in linacs that are easily operated and remotely controlled. 
The type of the accelerator is usually defined by its frequency range (L-band for 
~103 MHz, X-band for ~104 MHz, and S-band for 2856 MHz). S-band accelerators are 
the most commonly used waveguide structures in conventional linacs because of design 
practicality. X-band linacs are used in applications that require compactness ( e.g., in 
robotic and CT-type gantry mounting) because of their short waveguide length. The 
design of medical linacs has been extensively reviewed [10-12] and a good basic 
introduction was provided by Podgorsak et al. [13]. 
In addition to linacs used in routine radiotherapy, special machines have been 
built to serve for intraoperative radiation therapy (lORT) purposes. Mobile X-band 
machines that ean be moved into the operating room were designed to deliver single 
radiation fractions to the patient on a surgi cal bed [14-16]. 
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2.2.2 Microtron 
The microtron IS another form of electron accelerator that accelerates the 
electrons by the osciIlating electromagnetic field of a single microwave cavity. There are 
two available types of microtrons: circular and racetrack. For the former, a single magnet 
is used to accelerate electrons by aIlowing them to circulate multiple times through a 
microwave resonant cavity. The particle is kept in phase with the microwave power and 
the electron energy is gained in increments until a desired energy is obtained. As for the 
latter, it uses a multicavity structure similar to the one used in the linac through which the 
beam passes repeatedly and is bent by two D-shaped pole pieces. Although microtrons 
offer sorne advantages over linacs, such as smaIler beam divergence and less energy 
spread in the spectrum, they are not widely implemented in radiation therapy clinics. 
2.3 Characlteristics of Clinical Electron Beams 
2.3.1 Central axis depth dose 
Electron beam depth dose curves exhibit features that are clinicaIly advantageous 
in treatment of lesions at shaIlow depths. As shown in Fig. 2-2, when incident on water, a 
single electron beam with an energy ranging from 6 Me V to 22 Me V could deliver a high 
surface dose foIlowed by a broad region of nearly maximum dose (plateau) and then a 
steep faIl-off lateraIly and distaIly. These properties make electron beams weIl suited for 
treating superficial targets with minimized dose to the underlying organs at risk providing 
them with remarkable clinical advantages over the conventional photon beams. Electron 
beams with energies that are higher th an approximately 22 Me V lose their rapid dose faIl-
off at depths beyond the depth of the maximum dose and behave simi1arly to photon 
beams due to bremsstrahlung energy loss. 
Figure 2-3 shows a typical percentage depth-dose (PDD) curve. PDD is a 
dosimetric function that relates the dose delivered to a point along the central axis of the 
beam to the dose at the point of the maximum dose. According to the recommendations 
of ICRU 35 [17], the PDD is characterized by several parameters: 
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PDDs: The relative surface dose at 0.5 mm depth. 
PDDx: The relative dose due to the x-ray component. 
Zmax: The depth of the maximum dose in water. 
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Figure 2-2: PDD curves for electron and photon beams of 10xlO cm2 field size at 
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Figure 2-3: Specifications of parameters that are used to characterize electron beam 
central axis depth dose curve. 
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The therapeutic range which varies between 90% and 80% of the 
maximum dose. 
Rso: The depth of the 50% dose level. 
Rp: The practical range. lt corresponds to the point of intersection 
between the tangent at the inflection point of the faU-off portion of 
the PDD and the bremssstrahlung background extrapolated toward 
Zmax. 
Go: The normalized dose gradient that measures the steepness of the 
descending part of the PDD. 
Of these parameters, Rso and Rp are the most important because of their role in 
determining the energy specifications of the electron beams. The energy of the pencil 
electron beam exiting the linac window is degraded because the electron beam passes 
through multiple components before hitting the surface. This results in the clinical beam 
consisting of a spectrum of energies. According to TG-25 [18], the energy parameters of 
the electron beam are characterized by (1) the most probable energy at the surface ( Ep.o), 
(2) the mean energy on the surface ( Eo) , and (3) the energy at depth Z (Ez). 
( E p,o) is defined as: 
(2-6) 
where Cl = 0.22 MeV, C2 = 1.98 MeV cm-l, and C3 =0.0025 MeV cm-2• (Eo) is obtained 
from: 
(2-7) 
where C4 = 2.33 MeV cm-l. FinallY(Ez) is expressed, according to Harder's relationship 
[19], as: 
(2-8) 
where Z is the depth in phantom. These energy parameters are easily obtained from PDD 
measurements. 
lt should be noted that the PDD parameters are sensitive to smaU differences in 
energy, scattering foils, collimations and source surface distance (SSD). The surface dose 
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increases with increase in energy of the electron beams. Expressed in cm, the range 
parameters, Rp, R80, and R90, can be approximated as (~) Ep,o' (~) Ep,o' and (y;) Ep,o , 
respectively, when Ep.o is expressed in MeV. Although Zmax does not have an apparent 
dependence on the energy of the beam, it is dependent, however, on the size and shape of 
the field. Finally, the bremsstrahlung contamination is exhibited as a tail beyond Rp 
which increases with higher energies. 
Because of its importance in clinical applications of electron beams, PDD data 
must be measured for aIl electron energies and possible applicators. The report AAPM 
TG-25 recommends a comprehensive procedure to de termine the PDD data for a given 
linac [18]. 
2.3.2 Output factors 
Output factors are defined as the ratio of dose per MU at Zmax for a given field size 
to the dose per MU at Zmax for a reference field size. Since the increase in field size as 
defined by the photon collimator leads to increased scatter from the collimator, the 
collimator setting has a significant influence on the electron dose. The output dependence 
on the x-ray jaw opening variations is large, especially at low electron energies [20]. 
Therefore, most linacs provide a fixed primary collimation and vary the secondary 
collimation. This keeps the variation in output measurements relatively small. Moreover, 
output factors are affected by a change in SSD. Hence, they should be measured properly 
for SSDs that differ from the reference SSD, i.e. SSD f. 100 cm. 
Various approaches were introduced for modeling the output of an arbitrary field 
size [6] after acquiring a significant amount of measurement data. In the model reviewed 
by Khan [21], output factors at a standard SSD are obtained using an equivalent square 
field size [20]. For extended SSD, the output is assumed to follow an inverse square 
relationship [22]. Hogstrom [23] reviewed an analytical model for predicting output 
based on the physics of electron transport. 
Recently,. Monte Carlo methods were used to perform output calculations [24-26]. 
Monte Carlo-based software that calculates output factors for Varian CL2300 accelerator 
was commissioned at the Medical Physics Unit, McGill University [27]. 
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2.3.3 Virtual electron source 
A virtual electron source is the point at which the pencil electron beam spreads 
into a broad beam. Unlike an x-ray beam that has a we11 defined point source at the target 
position, the electron beam point source needs to be obtained from measurements. 
Various methods were introduced to obtain the virtual electron source [22,28]. Reporting 
the virtual source values for a11 clinical situations is important for treatment planning and 
for analytical dose calculation algorithms. 
2.3.4 Effects of oblique incidence and tissue heterogeneities 
The dose distributions of electron beams are significantly affected by oblique 
incidence, Surfil ce curvatures, and tissue heterogeneities. Ekstrand and Dixon [29] 
discussed the impact of using oblique beams. Hogstrom [30] showed that the dependence 
of electron beam interactions on tissue heterogeneities may lead to unpredicted dose 
distribution results if the transport of electrons is not carefu11y studied. 
2.4 Dose M.easurements 
2.4.1 Phantom materials 
When used in radiation therapy, the term "phantom" refers to the material and 
geometry that can serve as a model for radiation transport in the patient. Since water is 
the main constiluent of many body tissues, most dosimetric procedures are performed in 
water phantoms. The "water tank" is one of the most important tools that are available in 
every radiation therapy department. It is a computerized phantom used mainly for 
acceptance testing and commissioning of treatment units. Being automated, the water 
tank allows for dose measurement at any point in the phantom and performs scans along 
the three-dimensional axes. Smaller tanks that are manually controlled are also available. 
Despite its usefulness, the use of water in performing dose measurements is not always 
practical. Solid phantoms with radiological properties that are similar to those of water 
were developed to offer an alternative medium for routine measurements. Commercial 
Solid Water® is available and it is replacing the use of the conventional solid phantoms 
such as polystyrene and Lucite. Solid Water has a physical density of 1, an electron 
density of 1.02, an effective atomic number of 7.54, and a CT number of 15 (compared to 
the water properties of 1, 1, 7.4, and 0, respectively). 
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2.4.2 Absolut,e and relative dosimetry 
Dose measurement for electron beams IS divided into absolute and relative 
dosimetry. The aim of absolute dosimetry is to determine absorbed dose (in Gy) under 
standard irradiation conditions. It relates the relative amount of charge collected by the 
monitor chamber in the linac, referred to as a monitor unit (MU), to the absolute dose at a 
reference point. Such a relation is referred to as "calibration". Relative dosimetry, 
however, describes the dosimetric functions that relate the dose at a point irradiated under 
certain conditions to the reference point at which the dose has been measured accurately. 
Examples of relative dosimetry are PDD, off-axis profiles, isodose distributions, and 
output factors. 
Absolute dosimetry for electron beams can be performed using calorimetry [31-
33] or chemical dosimetry [34,35]; however, because of technical difficulties, these 
dosimeters are Ilot widely used. The routine absorbed dose calibration for electron beams 
in standard clinical departments is usually performed using ionization chambers. Relative 
dosimetry is carried out using thermoluminescent dosimeters (TLD), silicon diodes, and 
film. 
2.4.3 Dose m(~asurement methods 
2.4.3.a Ionization chambers 
Ionization chambers refer to dosimeters that measure the dose deposited by 
ionizing radiation through collecting the created charges inside an active volume of air 
sandwiched bet'ween two electrodes with an applied voltage operated between them. For 
electron beams, measurements that are performed with ionization chambers are assumed 
to follow Bragg-Gray cavity theory. Assuming that the chamber is small enough to 
prevent significant perturbations to the electron fluence, a direct proportionality is 
established betvveen the number of collected charges in si de the chamber volume and the 
dose at the same point without the chamber. However, applying the Bragg-Gray cavity 
theory in determining the absorbed dose for electrons requires accounting for mass 
collision stopping power ratios, mass of the gas inside the chamber, the perturbations 
caused by introducing the chamber into the phantom, and the effective point of 
measurement. The dependence of the mass stopping power ratios and perturbation factors 
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on the depth in the phan tom is considered a disadvantage of using ionization chambers 
for electron beam dosimetry [18]. 
Determination of absorbed dose 
Except for those at the National Physical Laboratory in the United Kingdom [36], 
there are no available international standards for absorbed dose in water for electron 
beams. The calibration of ionization chambers carried out by most standards laboratories 
is only provided for high energy photon beams but not for high energy electron beams. 
The use of photon beam-calibrated ionization chambers is therefore extended to electron 
beams by following national/international protocols. Depending on the quantity used for 
calibration (exposure, air kerma, absorbed dose) of an ionization chamber in a given 
photon beam, codes of practice were developed to use these photon-calibrated ionization 
chambers to de termine absorbed dose in water for electrons of megavoltage energies. 
Protocols were developed, revised, and rewritten to accommodate the change in 
calibrating options [36-38] and they provide detailed discussions of the problems 
encountered with the use of ionization chambers for calibrating electron beams. 
Corrections are implemented for various effects, su ch as polarity effects, perturbation 
effects, and ion collection efficiency. 
Types of clinical ionization chamber 
Cylindrical chamber 
Counted as the most frequently used dosimeter in medical physics, the cylindrical 
ionization chamber provides a reliable secondary standard for absolute absorbed dose 
calibrations. It was initially designed by Farmer with a relatively thin wall to reduce the 
electron fluence perturbation. The Farmer chamber contains an inner electrode made of 
aluminium which has an atomic number of 13 in order to compensate for the carbon wall 
that is made of graphite with an atomic number of 6. The materials were purposely 
chosen to provide a flat energy response. Originally, the farmer chamber had a nominal 
collecting volume of 0.6 cm3. Smaller ionization chambers were developed later with 
miniature dimensions. The Exradin AI2 chamber, for exampIe, has a collecting volume 
of 0.01 cm3. The use of a small chamber is advantageous in locations where steep dose 
gradients are suspected. The advantage of being symmetric simplifies the use of 
cylindrical chambers in profile measurements. 
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ParaUel plate ionization chamber 
Parallel plate ionization chambers were developed primarily for measurements of 
electron beams that inherently have steep depth dose gradients. These types of chamber 
have a thin wall and a small fixed electrode spacing (within 2 mm) that minimizes the 
cavity perturbations. Compared to the cylindrical chambers, parallel plate chambers can 
avoid the significant perturbations in the electron fields that result from the relatively 
large cavity sizt:: especially at low energies. Protocols usually de scribe a method to locally 
cross-calibrate paraUel plate chambers with cylindrical chambers that are calibrated at 
standard laboratories. 
2.4.3.b Thermoluminescent dosimeter (TLD) 
TLDs are considered to be relative solid state dosimeters. They consist of crystals 
with imperfections in the form of impurities which, upon irradiation, may trap electrons 
and holes traveling through the conducting band and valence band, respectively, 
following irradiation of the crystal. The trapped charged carriers remain at a metastable 
energy state that is in the order of a few eV from the valence band. Heating the crystal 
increases the probability of the trapped charge carriers gaining enough energy to escape 
the trap. The electron rises to the conducting band and then faIls to recombine with a 
positive hole trapped in a storage trap. Or conversely, a free hole moving through the 
valence band may recombine with an electron trapped in a storage trap. The 
recombination energy is released in the form of visible or ultraviolet light. Therefore, 
TLDs require a readout procedure that employs photomultiplier tubes to detect the 
emitted light. 
The most noteworthy TLD material is lithium fluoride (LiF) doped with 
magnesmm (Mg) which has an effective atomic number of 8.2 (comparable to the 
effective atomic number of soft tissue of 7.4). lt has a useful dose range from 10-5 to 10 
Gy and its response is essentiaIly independent of the dose-rate. 
Being highly sensitive, TLDs can be constructed in small dosimeters that are 
suitable for measurements in regions of steep dose gradient. Boone et al. [39] used TLDs 
to show the effects of tissue heterogeneity that simulates complex patient geometry on 
the dose distribution. TLDs, on the other hand, have difficulty providing measurements 
of the entire dose distributions in phantoms. When requiring 2D dose distributions, TLDs 
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are cumbersome and time consummg to use. AIso, the readout of TLDs erases the 
dosimetric data making it impossible to be stored for archivaI purposes. 
2.4.3.c Silicon diodes 
Silicon diodes are another form of solid state detectors. By irradiating a doped 
layer of a semiconductor, the charged particles are set free allowing a signal current to 
flow. The diode: has a sensitivity that is nearly 3 orders of magnitude higher than that of 
an ionization chamber for the same sensitive volume. 
Because of their high sensitivity combined with their spontaneous dose read-out, 
diodes are well-suited for scanning devices. Silicon diodes offer the advantage of 
providing a constant ratio of stopping power (silicon-to-water) for a wide range of 
clinical electron energies. When scanned along the central axis, the measured ionization 
curve can be directly converted into dose. However, diodes suffer from directional 
dependence, temperature dependence, and radiation-induced damage in the sensitive 
layer. These shortcomings lead Khan et al. [18] to advise strongly that before accepting 
diode measurements, they should be compared with fully corrected ionization chamber 
measurements for central axis depth dose curves. 
2.4.3.d Films 
In electron therapy, films are used extensively because of their convenience and 
effective means of measuring 2D dose distributions. Since their review of film dosimetry 
of high energy electrons in 1969, the recommendations of Dutreix and Dutreix [40] are 
still implemented as the basis for film dosimetry [6,18]. After being irradiated and 
processed, films are analyzed using a densitometer to obtain a map of optical densities. 
The net optical density of an exposed film (after deducting the background fog) is related 
to the dose based on the sensitometrie eurve (also known as an H-D eurve) whieh is a 
plot of optical density as a funetion of dose to the medium. An equation that fits the 
sensitometrie eurve establishes the relationship for determining the dose to the film based 
on various irradiations. It is reeommended to obtain the equation for eaeh batch of film 
without relying on previously reported equations beeause of the known variation of 
manufaeturing charaeteristies of films [18,41]. 
Films h.ave a high spatial resolution and ean provide a lasting record of dose 
distributions that allows for multiple readouts. In addition, they are favoured for the 
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dosimetry of sc:anning electron beams smce ionization chambers and diodes reqmre 
significantly longer exposure time for data accumulation. Films can be positioned either 
perpendicularly to the beam' s axis or parallel to it (in order to obtain spatial dose 
distributions). The perpendicular placement of films requires adequate compression of 
the phantom to avoid the presence of air gaps that may compromise the results [18,40]. 
Shiu et al. [42] showed a good agreement between results obtained using ionization 
chambers and radiographic films. 
Types of films 
Two types of film are used for dosimetry in radiation therapy: 
Radiographic film 
Radiographic film consists of a transparent film base that is coated from one or 
both sides with a radiosensitive emulsion containing crystals of silver bromide. After 
exposing the film to radiation, chemical reactions occur within the exposed crystals. After 
developing the :fi1m, these crystals darken with the extent of darkening being dependent 
on the radiation energy absorbed. The need for a light-tight packing and film 
development are considered the main disadvantages of radiographic films. The use of 
radiographic films in electron beams was discussed in AAPM Task Group report No. 25 
[18]. 
Radiochromic film 
Radiochromic film is considered a recent dosimetric tool developed to produce 
immediate pennanent colored images of a radiation exposure pattern. Upon irradiation, a 
solid state polymerization of colorless molecules is initiated which changes the color of 
the film from transparent to varying shades of blue. The dose is determined based on the 
absorption spectrum. AAPM Task Group report No. 55 provides guidelines for dosimetry 
using radiochromic films [41]. 
Being self-developing, nearly tissue equivalent, and nearly energy independent 
are considered the main advantages offered by radiochromic film over radiographic film. 
The relative small change in response to change in energy makes the radiochromic films 
useful for modulated electron beams. Radiochromic films are used extensively for 
brachytherapy dose measurements where the high spatial dose resolution and tissue 
equivalence are required. 
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It was mentioned by many authors that the use of film should be restricted to 
relative dosimetry because of different sources that affect the optical density readout such 
as changes in processing conditions and emulsions [18]. However, in avoiding the special 
developmental procedures needed for radiographic films, as stated by TG-55 [41], the use 
of radiochromic film to obtain absorbed dose with an acceptable precision is feasible. 
2.4.4 Comparison of different dose measuring tools 
Results of relative dose distributions that are obtained with different dosimeters 
should be comparable with reasonable accuracy. Ten Haken et al. [43] compared depth 
dose curves in water/polystyrene for multiple electron energies using films, diodes, two 
different cylindrical chambers, two parallel plate chambers, TLDs and radiographic films. 
With careful implementation of the recommendations of TG-25, excellent agreement 
with an average difference ofless than 1 % or 1 mm could be achieved [43]. 
2.5 Treatm(~nt Planning 
The electron treatment is planned such that a uniform prescribed dose is delivered 
to the planning target volume (PTV) with minimal dose given to normal tissues and 
critical structures. The planning starts with delineation of the PTV on images obtained by 
a computed tomography (CT) scanner. This is followed by the selection of appropriate 
beam energies élInd field sizes. ln certain situations, extra photon beams may be required 
to enhance the uniformity of dose distributions inside the PTV. ln addition, accessory 
tools are commonly used to achieve the treatment objectives. One of the standard tools 
often used is a field shaping cutout that is inserted at the end of the treatment cone to 
provide irregular field shapes that match the PTV. Skin collimation and internaI 
collimation are two forms of field shaping that are implemented for certain types of 
treatments. Placement of bolus (near-water-equivalent material) on the skin surface to 
provide extra scattering and/or energy degradation of the electron beam is also a common 
practice. Bolus is used also to serve as a missing tissue compensator that flattens out 
irregular surfaces. The thickness of bolus is determined as part of the treatment planning 
procedure. 
ln addition to its contribution to localizing and specifying tumors, CT provides 
significant patient information about the patient geometry that is critical for dose 
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calculation. A 3D model of the patient is reconstructed based on its variable tissue types 
and densities. The correlation between CT numbers and electron densities plays an 
important role in computerized calculation algorithms. 
Computerized treatment planning systems have been developed and are 
commercially available to facilitate patient data acquisition and calculate dose 
distributions. Each treatment planning system is characterized by the way it models the 
electron transport in its dose calculation algorithm. It is the dose calculation algorithm 
that is considered the most important and unique feature of any treatment planning 
system. 
2.6 Electron Transport Calculation 
2.6.1 Analytical radiation transport-pencH beam algorithm 
Analytical radiation transport is a formalism that characterizes and calculates the 
c1inical beam parameters based on scattering models. This formalism requires performing 
a set of measurements using the treatment machines to obtain beam data that are fed into 
an algorithm. Derived from the input data, the algorithm processes the transport 
parameters based on the scattering model to evaluate dose distributions for any selected 
geometry. 
The scattering model derived from the Fermi-Eyges theory was the first model to 
be used for electron beam transport. Eyges [44] inc1uded the energy loss as an extension 
to the cosmic ray theory of multiple Coulomb scatter for thick targets developed by 
Fermi. Brahme [45] applied the Fermi-Eyges theory to characterize electron beams [45] 
and their transport through air leading to a momentous contribution in designing beams 
and patient dose calculations. 
2.6.1.a Early d~velopments of pencH beam algorithm 
By mid seventies, Lillicrap et al. [46] had shown that a measured broad incident 
beam could be divided into a grid of smaller narrow constituents called "pencil beams". 
The dose at any point of interest is computed from the sum of aIl contributing individual 
pencils. But the presence of tissue heterogeneities limited the proposed approach due to 
the impracticality of measuring aIl the pencils in different media. However, the 
introduction of the Fermi-Eyges theory in electron beams stimulated several researchers 
28 
Chapter 2 Introduction to Electron Beam Therapy 
/r~--' 1 t-
, , 
- - ~-- - ! - - -- - SfC!' lT:;;ajon.rç eut. 
c::. S.'W~'I 
(ili1,~Ç' 
Figure 2-4: Schematic diagram of the original Hogstrom 's pencil beam algorithm 
representation. Reprinted with permission from IOP Publishing ([rom Hogstrom et al., 
Physics in Medicine and Biology; 1982). 
to investigate independently its application in dose ca1culations [47-49]. The most 
significant mode! was Hogstrom's pencil beam algorithm (HPBA) that received a wide 
acceptance in the commercial and research treatment planning systems (Fig. 2-4). With 
the limited computer power that was available at the time of its development, the HPBA 
offered a sufficiently fast dose ca1culation algorithm that provided a de cent accuracy in 
dose ca1culation and could be easily implemented to aHow for beam and patient 
modeling. The power of the HPBA lies in its ability to account for irregularly-shaped 
electron fields, variable air gaps, and surface curvatures while using CT data to correct 
for internaI heterogeneities. The detailed history of evolution of the electron pencil beam 
algorithm was discussed in depth by Jette [50]. 
2.6.1.b PencH beam definition 
A pencill beam is a pixel that identifies the most elementary type of a broad 
electron beam. It is defined as aH electrons that pass through a pixel of a divided broad 
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beam and is characterized by its energy, the root mean square spread of the electron 
distribution function about its mean direction, and the planar fluence of electrons. The 
electrons passing through a point within the pixel are not differentiated from electrons 
passing through the center since they are aIl assumed to be uniformly distributed with 
equivalent angu:lar distributions. The algorithm assumes "perfect" collimators and ignores 
the scattering from them. A pencil beam impinging perpendicularly on a semi-infinite 
slab creates an energy deposition kemel. The basic task of a pencil beam algorithm is to 
generate the kemel distribution based on the geometry of the bearn/patient configuration. 
ln the HPBA, the complex angular distribution of a pencil beam at any point in the 
patient geometry is approximated by a Gaussian distribution. Another model was 
developed to use the sum of three Gaussian distributions to represent the dose profile of a 
pencil beam at each depth [51-53]. lt is referred to as the generalized Gaussian pencil 
beam algorithm (GGPBA). 
2.6.1.c General formalism 
For a broad beam, the dose to a point (x,y,z) is calculated at a given depth by 
convolving the relative primary fluence distribution with the profile of the pencil beam 
distribution as D)llows: 
De (x,y,z) = J J <1>(x",y")d( x" - x,y" - y,z )dx"dy" , (2-9) 
where De (x,y,z) is the dose delivered by the electron component which includes the 
effects of beam modifiers, heterogeneities, and surface curvature and <1>( x", y") represents 
the relative weight along the fan line at the point (x",y"). The convolution kemel, 
d(x"-x,y"-y,z), is the dose contribution at (x,y,z)from the pencil beam at(x",y"). 
The dose distribution of a pencil beam is separated into a central-axis term, derived from 
the measured depth dose distribution in water and corrected for heterogeneities based on 
CT numbers, and an off-axis term, equivalent to the laterai distribution derived from the 
Fermi-Eyges theory. 
The formalism implemented by Hogstrom et al. [48,54] expressed the dose to a 
point as an integrai of the doses delivered by Gaussian pencil beams according to 
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DJx,y,z} = (( dx"dy"<l>(x", y") 
{
JI 1 [( x' - X")2 + (y' _ y")2 ]} 
X ? dxdyexp 7 2Jrcr HU!I(z) 20"-
aIr aIr 
[ 
SSD + d (" " )]2 Dmeas [0 ° d .. (" " )] efJ X ,y ,z Xe "effx,y,z S:S'D 
.. +z 
(2-10) 
J [ (x - X")2 + (y _ y")2] 
X 2 "" exp 2" " 2JraMCS (x ,y ,z) 2aMCS (x ,y ,z) 
where deff(x,y,z) is the effective depth at the point (x,y,z) corrected from the actual 
depth in water based on CT numbers. It is ca1culated by integrating the ratio of linear 
collision stopping power (tissue to water) along the ray from the source to the 
point (x,y,z). The central-axis depth dose curve at the effective depth, represented 
by D;eas [O,O,deff(X",y",z)], is a quantity derived from measured central-axis depth dose 
curve in water. The inner integrals in the second term are taken over the are a defined by 
the projection of the irregular shape of the collimator at depth z. a~cs and 0"2 air are two 
moments of the linear angular scattering power (a) that characterizes the beam spread as 
explained by Hogstrom [48], where: 
(2-11 ) 
The first beam spread term, 0"2 air, is the transformation of the root mean square of the 
projected angular distribution at the plane of final calculation to the plane at the depth of 
ca1culation. The second term, a~cs' is the integrated linear angular scattering power over 
a fan line from the patient surface to the plane of calculation. 
The common feature in the pencil beam formalism is that aIl integrals over 
Gaussians are evaluated in terms of the difference between two error functions as 
indicated in the equation: 
[ x
2
} l [Jrg(X)]}:;{ [xi+~hl [xi-~l}J fi(x)exp ---( ) x= Li Xi 1 erf ~ -erf ~ .(2-12) 
g X i 2 g ( Xi ) g ( Xi ) 
Precalculated and tabulated, the error function tables provide accessible fast solutions to 
solve for dose distributions. 
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In addition to the CT data tables that are needed to perform the dose calculations 
in correlated heterogeneous media [48], Hogstrom described the specifications of the 
input beam data required for HBRA [54]. These specifications include: 
(l) Most probable electron energy (Ep,o) calculated from the practical range that IS 
obtained from the measured depth dose curve. 
(2) Depth dose data and off-axis ratios for each nominal electron energy for a set of 
square fields. 
(3) Initial angular divergence determined by measunng the penumbral width as a 
function of distance from the collimator. 
(4) Source-to-surface distance (SSD) and Source-to-Collirnator distance (SCD) which 
represents the distance from the virtual source position (as defined by Khan et al.[18]) to 
the standard treatment plane and to the location of the final collimation, respectively. 
The clinical implementation of HPBA in 3D treatment planning system was described by 
Starkschall et al. [55]. lncorporating reconstructed equations with precalculated error 
functions along with different optimization procedures has lead to significant 
improvement in computational efficiency. Consequently, it established the basis for 
electron dose calculations for commercial 3D systems such as Pinnacle and FOCUS. 
2.6.1.d Limitations of pencil beam algorithm 
Despite their usefulness for broad beam electron dose calculations in radiation 
therapy, pencil beam models encounter significant limitations as discussed in depth by 
Hogstrom [56]. The most significant properties that primarily lead to considerable 
inaccuracies in dose calculations are: 
(1) The assumption of slab geometry: 
The original pencil beam mode! was formulated with the assumption of semi-
infinite slab approximation. Therefore, when evaluating dose contributions, it is the 
anatomy along the axis of the central ray of each pencil that defines the slab 
heterogeneity characteristics and, therefore, is used to calculate the dose. Since the 
anatomy along the central axis could be different from that along the mean path of the 
electrons, a considerable error could occur. The errors are more pronounced when 
differences in scattering properties between adjacent tissues are significant. Lax [57] 
showed that the presence of bone heterogeneities at deep depths (beyond half of the 
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electron range) leads to an overestimation of the dose calculation within the tissue. He 
showed that the slab geometry assumption is behind that overestimation. AIso, due to that 
assumption, the dose in the air cavities is also underestimated. 
(2) The Gaussian scatter distribution function 
The pencil beam model was developed based on Fermi-Eyges small angle 
scattering the ory . The model predicts that the root mean square spread of the Gaussian 
increases with depth. However, the "pure" Gaussian model does not represent a true 
distribution as electrons scatter through large angles in the tail region. Electrons that 
scatter with larger angles have shorter ranges. The GGPBA model that calculates the 
radial dose distribution as the sum of three Gaussians, takes better account of large angle 
scattering events. This leads to an overall improvement in the accuracy of the calculation 
especially at the penumbra region where the electrons exhibit a larger angular scattering. 
(3) The inability to account for secondary electrons 
The effect of electron-electron scattering is neglected in the original HPBA. This 
implies inaccurate prediction of the dose for small fields, causing the maximum dose 
build-up to occur at depths deeper than those calculated, with a steeper faH-off beyond 
the therapeutic depth [58]. 
2.6.1.e PencH beam algorithm in commercial electron treatment planning systems 
Following the reported results of evaluating pencil beam algorithm [48,54,59-62], 
the algorithm \Vas implemented in 3D commercial treatment planning systems. Different 
studies were performed to evaluate the accuracy of the clinically-used dose calculation 
algorithms in tn~atment planning systems. 
FOCUS 
Muller-Runkel and Cho [58] tested the accuracy of HPBA in the FOCUS 
treatment planning system (Computerized Medical Systems Inc., St. Louis, MO) for 
different data sets that represent clinical applications for electron beam therapy. They 
showed that FOCUS is well implemented within the limitations of HPBA. Good 
agreement between measurements and algorithm was found for straight-on beams in 
homogeneous water phantoms except for the lower isodoses. They also showed that the 
small field sizt~s are poorly modeled and that the oblique beam models show severe 
discrepancies due to the violation of the inherent assumption of slab geometry. 
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CADPLAN 
The dose calculation algorithm in CADPLAN (Varian Medical Systems, Palo 
Alto, CA) was investigated by Samuelsson et al.[63]. CADPLAN uses a model of 
GGPBA. The standard setup of perpendicular incidence in water phantom showed a more 
accurate calculation than was reported by Muller-Runkel where the error in the penumbra 
was eliminated. For complicated situations that involve tissue heterogeneities, the 
deviations were up to 10%. The profiles for geometries with a gantry angle of 30 degrees 
also showed large deviations. Ding et al.[64] performed another study to evaluate the 
accuracy of CADPLAN for various energies and field sizes in different phantoms. 
CADPLAN fails to calculate the magnitude of dose changes in complex heterogeneous 
geometries. 
Helax-TAfS 
Both HPBA and GGPBA are implemented in the dose calculation algorithm in 
Helax-TMS commercial treatment planning system. Blomquist et al.[65] used a 
comprehensive data set to evaluate the system. HELAX-TMS retrieves precalculated 
pencil beam kernels that were computed based on the GGPBA model that accounts for 
small and large angle scattering. Prior to entering the patient, the pencil beams are 
modeled accorditng to HPBA to handle the initial angular spread and air transport. The 
results showed that small heterogeneities and obliquity are problematic and cause errors 
outside the acceptable limits. 
2.6.1.f Summary 
During the past two decades, significant modifications have been introduced to 
improve the accuracy of the originally proposed pencil beam algorithm. This includes the 
phase-space evolution algorithm [66,67] and pencil beam redefinition algorithm (PRBA) 
[68]. Although these modifications have now reached a satisfactory degree of 
development, they still exhibit what Hogstrom and Almond [6] described as a "failure" of 
practice for radiation therapy because oftheir inability to model actual treatments [6]. 
2.6.2 Monte Carlo transport 
Monte Carlo transport calculations have been continuously gammg a more 
important role in the field of medical physics. In his review paper, Rogers [69] stated that 
the number of published papers on Monte Carlo has doubled every five years during the 
34 
Chapter 2 Introduction to Electron Bearn Therapy 
period from 1967 to 2000 in the journal of Physics in Medicine and Biology. Because of 
its wide acceptance as a powerful tool for modeling radiation transport, Monte Carlo 
techniques were used in a wide range of implementations in order to derive physical 
quantities that are relevant to radiation therapy. Monte Carlo was used in optimizing the 
design of linacs [70], deriving dose deposition kernels for treatment planning systems 
[71,72], obtaining source spectra [70,73-75], calculating stopping power ratios [76-78], 
analyzing detector response [79-81], studying and optimizing portal imaging [82-84], and 
it is still continuing to be a lively field of research [85]. In addition to its ability to 
provide a wide range of data, Monte Carlo techniques offer solutions that are able to go 
beyond measurement capabilities. For example, Monte Carlo techniques have the 
aptitude to extract the fractions of either primary or scattered dose and proceed with only 
one of them. It is also possible when performing calculations to know the contribution 
from each component in the treatment head to the total dose. 
2.6.2.a Overview 
In the context of radiation therapy, Monte Carlo transport calculations usually 
refer to algorithms that allow the determination of the dose deposited in a certain volume 
by following the path of representative partic1es as they travel inside a medium. After 
generating a partic1e (following a distribution that describes the source of radiation), the 
partic1e is tracked through the medium for a certain distance before it scatters into another 
direction and/or energy. The transport of the partic1e is governed by probability 
distributions and cross sectional data that are obtained from well-known fundamental 
laws of radiation physics. While a partic1e is traveling in a geometry, it gives birth to a 
shower of secondary partic1es until it is totally absorbed by the scoring volume or departs 
to another volume of interest. In a Cartesian coordinate system, the sub-volume in which 
the particle is scored is referred to as a voxel. The transport of a primary incident particle, 
including its progeny, until its complete absorption or escape from the voxel geometry is 
referred to as "history". 
Theoretically, a patient that is treated with a radiation dose of 40 Gy is bombarded 
with the order of 1012 partic1es. This translates to more than 1016 partic1es that are 
transported through the system inc1uding the treatment head and the patient. Even with 
the aid of the fast computers currently available, processors are still unable to follow the 
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track of each individual particle and perforrn the consequent calculations within a 
reasonable time. Therefore, to accelerate this process, the tracks of randomly selected 
particles are followed as a sample representing the average behaviour of aIl particles. 
These representative particles are sampled using a computer based pseudo-random 
number generator. This introduces a statistical uncertainty in the quantities calculated by 
Monte Carlo which is dependent on the number of simulated histories. 
The inclusion of electron transport adds a new dimension to Monte Carlo 
simulation. In principle, direct simulation that includes aIl kinds of possible interactions 
could be used for electrons in a similar fashion as that used for photon transport. 
However, due to the fact that a high energy electron undergoes on the order of 105 
interactions in its slowing down process, processors cannot handle the tracking of each 
individual particle on an event-by-event basis. Berger [86] proposed the use of condensed 
history techniques for calculating electron transport where interactions are grouped into 
steps and the angular deflection and the energy loss are evaluated on a step by step basis. 
The transition from one step to the next step accounts for many interactions where 
multiple collision models, such as multiple scattering or restricted stopping power, are 
considered. Since its introduction, the condensed history technique has become the basis 
for aIl current codes that handle electron transport for energies above 10 ke V. 
Variance reduction techniques were developed to improve the simulation 
efficiency by reducing the statistical uncertainties for a fixed computational time. In su ch 
techniques, the "natural" physics as weIl as the scoring procedures are "manipulated" in a 
number of different ways so as to increase the relative occurrence of certain events. 
F orced interactions, Russian roulette, particle splitting, range rejection, geometrical 
symmetry, and PRESTA are commonly used techniques in Monte Carlo codes. In his 
review chapter, Sheikh-Bagheri et al. [87] offered excellent explanations for variance 
reduction techniques and their impact on the improvement of Monte Carlo calculations. 
Because of its intensive computing time, there had been a traditional belief that 
Monte Carlo is impractical for routine clinical treatment planning despite its ability to 
accurately predict dose distributions in highly complex geometries. However, this belief 
started to fade away with the ever continuing increase in computer power and parallel 
processing along with the variance reduction techniques that improve the computational 
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Figure 2-5: A 3D image of a Monte Carlo model of Varian CL-2300 (18 MeV) using 
EGSnrc/BEAM 
efficiency. Although not yet published at the time of the writing of this thesis, the AAPM 
is preparing to approve a Task Group report on application of Monte Carlo techniques to 
clinical treatment planning [69]. 
2.6.2.b Monte Carlo codes for radiation therapy 
There are wide varieties of Monte Carlo codes that are used in radiation therapy. 
ETRAN/ITS [88,89], Electron Gamma Shower EGS4/EGSnrc [90,91], MCNP4/MCNP5 
[92-94], PENELOPE [95], and GEANT3/GEANT4 [96,97] are aIl available Monte Carlo 
packages that significantly contributed to the impact of Monte Carlo applications. The 
BEAM/EGS4 user interface [98], which was later upgraded to EGSnrc/BEAM [99], 
facilitated easy modeling of radiation therapy accelerators leading to significant grow in 
the research of photon and electron beams (Fig. 2-5) . Many studies have been performed 
to compare the results of different codes for clinical electron beams [100,101]. 
As the trend to use Monte Carlo calculation in treatment planning grew, the 
demand for simplified Monte Carlo algorithms increased. Monte Carlo packages were 
originaIly designed to provide solutions for a wide range of radiation transport problems 
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that were beyond the interest of radiation therapy. Customized codes were introduced to 
avoid time-consuming complications caused by built-in options that are integrated within 
Monte Carlo packages. 
Macro lv/ante Carlo (MMC) 
Macro Monte Carlo (MMC) was first proposed by Mackie and Battista [102] to 
apply precalculated kernels for treatment planning. The kernels are stored in large look-
up tables that include the electron transport characteristics. Neuenschwander et al. [103] 
implemented th{~ MMC algorithm in spherical volume elements called kugels. The code 
tabulates the probability of electrons exiting the kugel as a function of the exit location, 
energy, and direction. Wh en it was introduced, MMC offered a faster calculation 
algorithm than EGS4. However, it suffered from a lack of accuracy in comparison with 
EGS due to the lack of modeling of the transport of secondary electrons and 
bremsstrahlung photons [103]. 
Super Monte Carlo (SMC) 
Keall and Hoban [104] introduced Super Monte Carlo (SMC) that incorporates 
the precalculated kernels to construct probability distributions for electron transport. 
SMC differentiates itself from MMC by performing rigorous step-by-step calculation for 
each electron step. Compared to EGS, SMC provided dose accuracy within 1.5% but 
without substantial gain in the calculation time. 
Voxel Monte Carlo (VMC/XVMC) 
Voxel Monte Carlo (VMC) [105,106] is a fast Monte Carlo code designed to 
simulate electron transport un der certain restrictions specifically designed for 
radiotherapy purposes. Unlike EGS, which is designed for a wide range of energies and 
materials, the VMC code is applicable only within an energy range of 1-30 MeV and for 
low Z materials that have physical densities between 0 to 3 g/cm3. With the aid of 
multiple uses of each simulated history, VMC was able to perform calculations faster 
than EGS by a factor of 30, although it still uses an advanced transport algorithm. After 
benchmarking the VMC code for electron transport, a new code (XVMC) [107] was 
introduced for coupled photon and electron transport. Doucet et al. [108] showed that 
XVMC calculations performed for electron beams in heterogeneous phantoms provide 
excellent agreement with both measurements and EGSnrc. 
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2.6.2.c Monte Carlo in commercial electron treatment planning systems 
Until recently, Monte Carlo-based treatment planning systems remained 
predominantly research tools [10 1,109, Il 0]. However, introducing Monte Carlo 
algorithms in commercial treatment planning systems designed for electron beams is 
becoming a trend for new treatment planning systems. Two commercial systems have 
been reviewed in scientific literature: 
Eclipse 
Eclipse (Varian Medical Systems) is a commercial electron dose calculation 
software that implements the MMC algorithm. Within one month, two independent 
studies evaluating Eclipse were published. Popple et al. [Ill] evaluated the accuracy of 
Eclipse by comparing the calculations with a set of measurements. ResuIts similar to that 
previously reported in validation of MMC were shown. Expected deviations for small 
fields with low energy beams were also demonstrated. Ding et al. [112] investigated 
more geometries and different setups including extended SSDs and oblique beams. 
Concerns arising from using Monte Carlo in commercial treatment planning systems 
were discussed in depth by Ding et al. [112]. This includes a comparison between 
reporting the dose-to-medium versus dose-to-water. The effect of statistical uncertainties 
on point dose prescription was also discussed. Eclipse is configured for Varian electron 
beams only. 
Theraplan Plus 
Cygler et al. [113] tested the accuracy of VMC algorithm implemented in the 
dose calculation engine of a commercial treatment planning system software developed 
within Theraplan Plus (MDS Nordion, Ottawa, ON, Canada). The software consists of a 
linac he ad model and a VMC++ code (VMC code rewritten in C++) for electron and 
photon transport through the patient anatomy. It was shown that the software could be 
faster than EGS by two orders of magnitude with the same level of accuracy. Excellent 
agreements (within 2.5%) were obtained between calculations and measurements 
performed in he:terogeneous phantoms. ResuIts showed that discrepancies are sensitive to 
size of the voxels. Errors as high as 5% at material interfaces were found wh en voxel 
sizes were poorly selected. However, based on their resuIts, it was concluded that Monte 
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Carlo-based treatment planning offers the best approach for modern clinical treatment 
planning [113]. 
2.6.3 Pen cil beam algorithm vs. Monte Carlo techniques 
Scientific literature is accumulating evidence that Monte Carlo techniques are 
superior to pencil beam algorithms [113,114]. In a study by Ding et al. [115], 
comparisons of dose calculations in equivalent phan toms were performed between pencil 
beam-based and Monte Carlo-based commercial treatment planning systems. Wh en 
compared to the Monte Carlo-based algorithm, the pencil beam-based algorithm results in 
large errors in phantoms containing three-dimensional heterogeneities. Coleman et al. 
[116], however, claimed that pencil beam-based algorithms offer mode st accuracy and 
can be used as an alternative in the case of unavailability of Monte Carlo-based treatment 
planning systems. Antolak et al. [117] demanded a higher standard of agreements 
between Monte Carlo calculations and measurements where the criteria of acceptance 
was raised to be within 2% of Zmax or 1 mm over the entire range of clinical parameters. 
Such requirements continue the challenge to improve the applications of Monte Carlo in 
radiation therapy. 
2.7. Clinical Use of Electron Therapy 
The unique characteristics of the electron beam made it a preferred therapeutic 
modality for treating malignant lesions located at superficial depths. Most of the 
applications of the electron beam revolve around its distinct advantage of delivering a 
total dose to tumors while maintaining minimum irradiation to the normal tissues. 
Electron beams are used in many applications including: total skin irradiation [118], total 
scalp irradiation [119,120], craniospinal irradiation [121], and electron arc therapy [122-
125]. However, these techniques are often implemented as special procedures in regional 
centers. Still, the main role of electron beams in radiation therapy will continue to be in 
the management of superficially located disease. Newer modalities that benefit from the 
advantages ofjèred by electron beams are being developed. Discussion of these 
modalities is the topic of the next chapter. 
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Chapter 3 
Energy Modulated Electron Therapy 
The innovations in computer-controlled medicallinear accelerators heightened the 
interest in x-ray intensity modulated radiation therapy (IMRT) [1-6]. Most importantly 
was the advent of multileaf collimators (MLCs) which provided a tool to employ non-
uniform fluence distributions that is able to design optimum intensity modulated beams. 
By manipulating the intensities of individual subdivisions ofbeams (beamlets), a desired 
optimum pattern of dose can be achieved. Being an inverse treatment planning problem, 
an optimization algorithm is required to satisfy certain constraints which can be defined 
based on clinical relevant parameters. Examples of these constraints are: uniformity of 
the dose, conformity to the planning target volume (PTV), and sparing of the organs at 
risk (OARs). IMRT has become a weIl established treatment modality and a major 
research specialty that is served by several commercial systems. 
Although IMRT has been widely used for treating deep-seated tumors [7-11], it 
has been less effective for superficially located tumors. This is mainly because of the low 
surface dose exhibited by the x-ray beams. Furthermore, the slow attenuation of x-ray 
beams results in a high exit dose and a large integral dose in the patient. It has been 
reported that a large volume that receives low radiation doses may introduce a long term 
risk of developing radiation-induced cancers [12]. 
To overcome these shortcomings and because of the nature of the electron beams, 
sorne studies have investigated the possibility of adding single electron beams, which 
offer high surface doses, to photon IMR T in order to improve treatment planning for 
shallow targets [13-15]. However, energy modulated electron therapy (EMET) has 
garnered increasing interest for delivering high conformaI dose to targets near the surface 
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[16-20). For a successful EMET delivery, three main ingredients are required; namely: 
(1) an accurate dose ca1culation algorithm to model the electron transport and dose 
deposition, (2) an optimization algorithm that solves the inverse problem, and (3) a 
delivery unit. This chapter explores the state-of-the-art methods of delivering EMET. 
3.1 Bolus ConformaI Therapy 
The electron bolus is a tissue equivalent material that is customarily placed on the 
skin surface in order to provide extra scattering and energy degradation of the electron 
beam. Because of the irregular surface of the patient, the use of a spatially uniform 
electron beam is not always optimal. The irregular surfaces often lead to non uniform 
dose distributions within the target. Such non-uniformity is represented as hot spots 
(over-dosing) and cold spots (under-dosing). In addition, the variable depth of the distal 
surface of the planning target volume (PTV) causes overdosing of normal tissues that are 
adjacent to the PTV. These potential deficiencies can be eliminated with the use of bolus 
which offers useful advantages to the treatment planning due to its ability to compensate 
for the missing tissues. Bolus is often used to flatten out the irregular surfaces and to 
reduce the penetration of the electrons. 
Since the variation in the bolus thickness corresponds to a variation In the 
practical electron range, a spatially dependent energy modulation can be achieved by the 
modulation of the bolus thickness. For example: energy modulation with a step as low as 
0.2 MeV can be achieved because of its equivalence to a 1 mm bolus thickness. Hence, 
the custom-shaped bolus represents a me ans of EMET despite its frequent use in 
conventional three dimensional conformaI therapy (3D-CRT) for forward treatment 
planning. 
The methodology for computer aided design of electron bolus was initiated at M. 
D. Anderson Cancer Center (Houston, TX) by Low et al. [21). Low et al. [21,22] 
designed bolus based on ray tracing from the electron source to the patient surface that 
tracks the distal surface of the PTV. The goal of the design is to have a total radiological 
thickness of (bolus+PTV) that is equivalent to the therapeutic range in water (R90). The 
radiological thickness refers to the effective thickness accounting for the differences in 
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Figure 3-1: (a) Custom made bolus electron bolus for postmastectomy chest wall case. 
(b) Isodose distribution using bolus for 16 MeV electron beam. Reprinted with 
permission from Elsevier ([rom Perkins et al., International Journal of Radiation 
Oncology Physics; 2001). 
tissue densities. Once the initial grid of bolus thicknesses is determined, it undergoes 
sorne design modifications in order to homogenize the dose distribution based on 
ca1culations that are performed using the pencil beam algorithm. The grid is then adjusted 
so that it smoothes the bolus thickness. Different operators were introduced to assist the 
optimal design of bolus. They have been implemented in a local treatment planning 
system at the M. D. Anderson Center [22,23]. 
The fabrication of the bolus to a high level accuracy is labour intensive and 
requires large milling machines that are not likely to be available in radiation therapy 
clinics. Therefore, in the case of M. D. Anderson Center, the final design is provided 
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electronically to a third party company that performs the milling and ship the custom-
made bolus back to the institution. 
After receiving the fabricated bolus, the patient undergoes another CT procedure 
with the bolus placed on himlher. It is important to verify the accuracy of the milling by 
verifying the positioning of the bolus and ensuring that minimum air gaps are present in 
order to avoid any perturbation to the planned dose distribution [23]. The dose 
distribution is then computed using the treatment planning system. Although the effects 
of the presence of bolus are measurable and consequently quantifiable, the quality 
assurance procedure does not require measurements that validate the 2-D dose 
distribution nor point dose measurements [23]. Rather, it assumes that the dose 
distribution calculated by the treatment planning system is accurate without further 
verification. 
Results have been demonstrated for the applications of custom-made bolus at M. 
D. Anderson Cancer Center. Comparisons between conventional treatment planning and 
bolus technique were presented for different clinical sites including paraspinal muscles 
[22], post-mastectomy irradiation [24], and head and neck [23]. In these studies, the use 
of bolus technique showed modest improvements on the coverage of the PTV and 
reduced dose to the organs at risk (Fig. 3-1). 
Although this technique was imp1emented for treatment of many patients [25], 
there are still sorne concems regarding sorne of its disadvantages. Most notably, its 
dependence on the accuracy of the pencil beam algorithm which cannot calculate dose 
within 4% accuracy in conditions of tissue heterogeneities and surface irregularities. 
Because of this, Kudchadker et al. [26] reported that the dose spread in the PTV was 
found to be as much as 20% which violates the goal of maintaining the uniformity to 
within 10% limits [26]. It was suggested that further electron beam modulation is 
required to restore the dose uniformity [26]. However, although not available presently, 
beam modulation requires a considerable amount of resources that are similar to those 
required by IMR T. 
Another disadvantage of the bolus technique is that it is labour-intensive and time 
consuming. It requires the procedure of outlining volumes from CT scans to be 
performed twice. Planning is a1so performed in two stages: prep1anning and post-
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planning. ln addition, the quality assurance procedure requires extensive verification of 
treatment positioning to ensure the best possible fit which might cause the need for 
another round of refabrication of bolus. 
lt has been reported, also, that the use of the bolus technique raises a risk of 
developing complications due to the increase in the skin dose. Therefore, long-term 
follow up were suggested to assess the potential risk for skin fibrosis complications [24]. 
Finally, the use ofbolus design technology is stilllimited and has not been widely 
implemented. Despite being available for more than a decade, none of the commercial 
treatment planning systems has adopted the automated bolus designing procedure. The 
technology remained localized in one region without feasible efforts to transfer it to 
widespread use. 
3.2 Collimator-based Modulated Electron Therapy 
3.2.1 Inverse treatment planning 
ln inverse planning, the beam parameters are optimized to match the prescribed 
dose distributions defined by an objective function that ranks the treatment plan merits. 
The objective function is formulated su ch that it reflects the treatment quality through 
clinically relevant criteria. These objectives could be either physical (which depend on 
measurable physical quantities) or biological (which depend on radiation response 
models). lt is assumed that the objective function is dependent on the vector representing 
the beam modulation weights. This section presents a brief introduction to the 
optimization algorithms used for radiation therapy applications. 
3.2.1.a Optimization algorithms 
ln radiation therapy, an optimization algorithm refers to a mathematical method 
that searches through successive iterations for the lowest objective function. The 
optimization usually starts with an initial guess of beam weights. lt is then followed by 
modifying these weights to produce new dose data that is used to evaluate the objective 
function and its convergence. This procedure is repeated until the goals are met. 
Searching for the optimum solution can be deterministic or stochastic. ln the 
deterministic method, the algorithm modifies and approves different solutions based on 
predefined mathematical formulae. The stochastic method, on the other hand, approves 
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different iterates in a probabilistic manner. The deterministic method is by far faster than 
the stochastic one. However, the final solution obtained by the deterministic method is 
critically dependent on the initial values of the parameters which might lead to 
entrapment of the objective function in local minima. Such dependence is avoided by 
extensive searches throughout the solution space exhibited by the stochastic method 
which cornes at the expense of the speed. 
(1) Deterministic method: steepest gradient optimization 
The steepest gradient method minimizes the objective function, F(w) , with 
respect to the weight vector w, following these general steps: 
(1) Starting with an initial weight Wn, a decent direction dn is computed by 
taking the gradient of the objective function at the CUITent weight. 
(2) A feasible step À is then calculated such that it satisfies the condition 
F(w" +ÀxdJ < F(w,J. 
(3) The weight is updated as w 11+1 = w" + À x d n • 
(4) The process is continued until the maximum number of iterations is 
achieved or until the relative change in the objective function is smaller 
than a cut-off value. 
(2) Stochastic method: simulated annealing optimization 
Simulated annealing is a process that is analogous to the physical annealing where 
a heated system is slowly cooled so that it reaches its lowest energy state. If the annealing 
concept is applied to the optimization, the global minimum is reached in the same way as 
a heated system reaches its final state. The optimization follows the anal ogy by 
cOITesponding the objective function to the free energy system while linking the 
optimization parameters to the physical system components. The COITect functioning of 
the optimization requires concise representations of the objective function and the state 
space. In addition, the properly designed simulated annealing process should consist of 
three major components: 
(1) Generating function that keeps generating new solutions within a feasible 
range. 
(2) Acceptance function that determines whether the newly generated iterate 
is acceptable. This function applies the so-called Metropolis criterion 
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where it does not reject the inferior state immediately. Rather, ev en if the 
new objective function does not satisfy the convergence conditions, it 
might be accepted based on the Boltzmann probability (PB): 
-t',F -[F(wn,",.)-F("~,'d)l 
PB=e kT =e kT 
where l1F is the difference in the objective function between the new and 
the old solutions, k is the Boltzmann constant, and T is the system 
temperature. 
(3) An annealing function that updates the system temperature which is 
crucial since it affects the probability of the acceptance of new solutions. 
The annealing scheme requires properly selected initial temperature, 
optimal cooling rate, and sampling sizes of iterations at each temperature 
step. 
3.2.1.b Aperture vs. beamlet-based optimization 
In IMR T, the inverse problem is solved based on the assumption that a broad 
beam could be divided into a number of small radiation beamlets (defined by MLC) 
which are modulated in an iterative process until the objectives are met. By varying the 
weights of the beamlets, the ide al dose distribution could be constructed after adding the 
contribution of each individual beamlet. The weights of the beamlets are converted into a 
2-D intensity map that is deliverable using MLC. It is crucial to assume that the beamlet-
by-beamlet addition is equal to the dose that is delivered by the leaf sequence. Although 
such assumption has been successful in IMRT, the scattering behavior of electrons makes 
this approach nearly impossible in the beam delivery for EMET. The effects of scattering 
and leakage severely distort the fluence profiles especially when small beamlets are used. 
The problem is even magnified when a certain beamlet is assigned a low weight while 
sUITounded by high weight beamlets. To circumvent this problem, Lee et al. [27] 
proposed the use of a second optimization to account for the bremsstrahlung leakage 
electron scattering. However, the second optimization was reported to be computation 
intensive and time inefficient [28]. 
"Aperture-based" optimization was introduced as an alternative approach instead 
of the beamlet-based optimization [29,30). In this approach, the use of intensity maps is 
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avoided by using a sequence of deliverable apertures that could be divided virtually into 
beamlet grid. A typical initial aperture as large as 7x7 cm2, compared to 1 x 1 cm2 
beamlets, were reported suitable for EMET purposes [29]. Since the beamlet-based 
optimization has much more free parameters, the dose distribution that results from the 
beamlet-based optimization is expected to be better. However, wh en such a plan is 
undeliverable, aperture-based optimization offers an adequate alternative. 
The use of pencil beam algorithm in the planning for EMET, delivered with any 
form of electron collimators, encounter a number of difficulties. The algorithm suffers 
from inherent limitations that reduce its accuracy in oblique incidence, extended air gaps, 
mixing of energies, and heterogeneous phantoms. Because of the dependence of the 
optimization process on accurate modeling of the beamlet ( or aperture) calculation inside 
the patient geometry, Ma et al. [31] showed that the use of Monte Carlo algorithm as a 
calculation engine is more suit able for EMET. 
3.2.2 Treatment delivery 
3.2.2.a Using xMLC 
Introducing x-ray multileaf collimators (xMLC) revolutionized the practice of 
radiation therapy. The xMLC allows the delivery of complex field shapes in rapid 
succession. Since it is computer controlled with the ability to deliver automatic leaf 
sequence, it offered an attractive approach to be used for electron beam collimation. 
Different studies have investigated the possibility of utilizing the xMLC for 
isocentric delivery of electron beams. But because of the large air gap between the xMLC 
and the patient in addition to the presence of the scattering foil systems, the penumbra of 
the collimated electron beams was found too high. Klein et al. [32] concluded that the use 
of xMLC for electron beams in conventional linear accelerators is only acceptable for 
short source-surface distances (SSDs) that are less than 70 cm. Du Plessis et al. [33] 
favoured the use of ev en shorter SSD (60 cm) to provide a collimation suitable for 
electron planning. Therefore, isocentric treatments with the available xMLC are 
impossible. 
However, the MM50 racetrack microtron, designed by Brahme [34], was reported 
to be a treatment machine that can produce highly collimated electron beams using 
xMLC with relatively sharp penumbra [35]. It uses a scanning beam technique that 
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avoids the need for the scattering foils. Having a treatment head that is filled with helium 
gas and a doubly focused xMLC that is only 35 cm ab ove the isocenter, electron 
penumbra could be kept sufficiently small. Karlsson and Zackrisson [18,36,37] showed 
improvements in dose distribution in the patient for several applications by matching 
multileaf collimated of mixed electron and x-ray beams. Hence, the use of scanned 
electron beam has the potential capability for intensity and/or energy modulation of 
electron beams [16,20]. Nevertheless, the width of the dose kernels was reported to be 
excessively large at lower energies which limit their applications for electron modulation 
[25]. AIso, scanned beam technology is not commonly used in clinical accelerators and 
this type of machine is only available at a handful centers around the world. 
In order to use the xMLC as a means of electron modulation, significant changes 
are required to modify the commercially available treatment heads. Karlsson et al. [38] 
suggested replacing air atmosphere in the treatment head with helium, changing the 
position of the scattering foils, and lowering the xMLC plane so that the electron beam 
characteristics are clinically acceptable. The implementation of such modifications 
requires an unfeasible redesign of the complete treatment he ad and cannot be a simple 
upgradeable solution. 
3.2.2.b Using eMLC 
Similar to the adaptation of the xMLC, electron multileaf collimator (eMLC) was 
introduced to replace the need for labor intensive fabrication of custom blocking and to 
allow EMET delivery. The implementation of eMLC was initiated after the reported 
difficulties encountered with the possibility of using the existing xMLC for modulated 
e1ectron therapy. Therefore, an alternative approach was introduced that emp10ys the use 
of an electron specific MLC that is located approximate1y 40 cm closer to the patient than 
xMLC. Different prototypes of eMLC were constructed. 
Ravindran et al. [39] designed a manual eMLC that cou1d be added as an 
accessory to the Siemens Mevatron 15 x 15 cm2 app1icator. lt consists of 30 pairs of low 
melting point alloy (LMA) with a 1eaf thickness of 1.6 cm, a 1eaf width of 0.48 cm, and a 
1ength of 12 cm. Aimed for the simp1est application of eliminating the use of electron 
cutouts, the basic dosimetric properties of the eMLC were compared to those of the 
cutouts. That included depth dose curves, beam profiles, and output factors. However, the 
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Figure 3-2: (a) Retractable eMLC designed at MD. Andersson Cancer Center. 
Reprinted with permission from Medical Physics Publishing ([rom Hogstrom et al., 
Medical Physics; 2004). (b) eMLC prototype buitt at Stanford University. It is mounted 
on 25x25 cm2 applicator of Varian CL21 00. Reprinted with permission from IOP 
publishing ([rom Ma et al., Physics in Medicine and Biology; 2000). 
reported long time that is required to manually shape the irregular fields, along with an 
approximately 8 kg weight of the device, were considered major disadvantages of the 
eMLC. It did not show more appealing convenience over the use of cutouts. 
Ma et al. [31] developed another prototype of manual eMLC (Fig. 3-2(b)) 
intended for the application of EMET (it was called in their study as modulated electron 
radiation therapy (MERT)). In their prototype, 30 steelleafpairs were mounted on a steel 
frame attachable to the 25x25 cm2 applicator of Varian Clinac 2IOOC. Each leaf has 
straight ends with the dimensions of 0.48 cm width, 2.54 cm thickness, and 20 cm length. 
The eMLC, weighing more than 12 kg, gives an air-gap clearance of 10 cm above the 
surface of SSD=100 cm and is able to form a field size of 15.7x15.7 cm2. The 
characteristics of individual beamlets were investigated, especially for the purpose of 
forming large fields. When comparing a square field defined by the eMLC to the square 
field that is formed by the addition of multiple beamlets, results show fluctuations in the 
dose distributions under the field and an increased leakage dose outside the area projected 
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Figure 3-3: Monte Carlo calculated dose profiles in a water phantom for 20 MeV 
electron beams collimated by an eMLC of 1.5 cm thick tungsten leaves for a single 4 cm 
x 4 cm electron field (dotted) and a 4 cm x 4 cm field formed by four 1 cm x 4 cm 
electron fields (solid fine) (a) at surface; and (b) at 3 cm depth. Reprinted with 
permission of lOP publishing ([rom Ma et al., Physics in Medicine and Biology; 2000) 
by the field (Fig. 3-3). Part of their investigations included a comparison of the beamlet 
dose distributions in a heterogeneous medium between Monte Carlo calculations and 
pencil beam algorithm. They recommended the use of Monte Carlo calculations as dose 
calculation algorithm for EMET. Lee et al. [40] performed further investigations of the 
prototype where new specifications for eMLC were recommended. That included the use 
of 1.5 cm thick tungsten leaf, instead of the 2.54 cm thick steel, in order to reduce the 
leakage effects. The implementation of these recommendations have not yet been made 
nor clinically studied nor was there a discussion about automating the new collimator. 
A different manual eMLC was constructed by Hogstrom et al. [41] with a 
retractable feature that, theoretically, allows for isocentric treatments and arc therapy in 
addition to the standard SSD treatments (Fig. 3-2(a)). Built to be compatible with a 
Siemens Primus linac, the eMLC consists of 21 pairs of rounded brass alloy leaves to 
project up to 20x21 cm2 if it is at the standard position. The leaf has a thickness of 3 cm, 
a length of 26 cm, and a width of 0.9 cm. This eMLC, unlike the ones previously 
menti one d, was not designed as an addition to the existing applicator. Rather it fits in a 
specially constructed treatment applicator. Comparisons between this model of eMLC 
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and the model designed by Ravindran et al. were shown for the basic dosimetric 
properties. Although su ch eMLC has the potential to work on an isocentric setup, the 
results were shown only for a normal beam incident with a gantry angle at 0° due to the 
weight of the eMLC that causes sagging of the gantry and/or the leaves. This represents a 
major concem for the potential use of this prototype. Also, the excessive length of the 
leaf in the direction of the leaf travel raises another concem when the eMLC is close to 
the patient for certain clinical situations such as parotid-neck treatments. In their 
conclusion, they planned to fabricate a final version with 2.0 cm thick and 0.5 wide 
tungsten leaves. ln addition, there was a brief mention of the incorporation of motors that 
will be added to each individual leaf. As far as known, the final version is still under 
development. 
FinaIly, plans for an automated eMLC were announced recently by Gauer et al. 
[42] who designed and studied a manual eMLC in Germany. The study focused on the 
characteristics of the leaf design and provided minimal discussions on the dosimetric 
properties of the beamlets defined by their model of eMLC. For example, variations of 
the x-ray jaws were mentioned as a me an of providing enhanced profile distribution but 
there was no mention of their impact on the beam output. AIso, the proposed automated 
design will include trimmer bars between the x-ray jaws and the eMLC to reduce electron 
scattering ab ove eMLC. However, the effects that result from these trimmer bars were 
neither measured nor simulated. The manual eMLC weighed approximately 20 kg with 
more weight that is expected due to the addition of motors and the extra electronics. The 
automated eMLC is being assembled by 3D Line Medical Systems (Schwarzenbruck, 
Germany). 
3.2.3.c Summary 
Using eMLC, EMET treatment plans were designed and showed superiority over 
3D-CRT and IMRT treatments for sorne clinical cases [27,43]. However, these plans 
remained only as research topics without attempts of delivering them. Despite the 
numerous reports showing the potential use of eMLCs for EMET purposes, there is, yet, 
no available delivery unit that is able to perform sophisticated treatments obtained from 
an inverse treatment planning system. Moreover, the quality assurance of implementing 
this technique has not been discussed. 
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Figure 3-4: Prototype of electron arc therapy-specific eMLC. The leaf resolution 
projects to 4 cm at isocenter. Reprinted with permission from Elsevier ([rom Leavitt et 
al., International Journal of Radiation Oncology Physics; 1989). 
3.3 Modulated Electron Arc Therapy (MEAT) 
Modulated electron arc therapy (MEAT) refers to an irradiation technique that 
confonns the prescribed dose to a large superficial curved volume by utilizing multiple 
arced beams of differing energies and intensities. In this technique, the electron 
energy/intensity is partitioned in angular segments based on the depth of the PTV. 
In the early proposed applications, MEAT was planned using cutout inserts with 
fixed shapes that are chosen to account for the variation in the patient radius of curvatures 
between transverse planes [44]. This approach assumes that the radius curvature within a 
single transverse plane is constant. Since this assumption neglects the considerable 
variations in the radius of curvatures, another approach was proposed. Leavitt et al. [45] 
demonstrated that in order to achieve a homogeneous dose distribution, the shape of the 
secondary collimator should be variable as a function of the angle of the arc. The shaping 
of variable fields was accomplished by a prototype computer-controlled eMLC (Fig. 3-4) 
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[45,46]. The advantages benefited by superposition of multiple electron energies showed 
an improved radial depth dose uniformity [47]. 
The treatment planning of MEAT requires each arc to have special specifications 
that include the angle of rotation, monitor unit prescriptions, collimator width, and 
nominal energy. Commercial treatment planning systems still lack adequate 3D dose 
calculation algorithms designed for that purpose. The eMLC designed for MEAT has a 
resolution of 4 cm which is considered coarse for electron planning. It was designed 
exclusively for MEAT and was not shown to be practical for other EMET applications. 
Also, rigorous quality assurance procedures have not been developed [25]. Despite these 
disadvantages, inversely optimized MEAT has the potential to be beneficial if accurate 
dose calculation algorithms are employed. 
3.5 Conclusion 
In this chapter, different methods of delivering EMET were presented. Although 
clinical utilities were demonstrated, these methods are unable to offer full solutions that 
can provide adequate tools for plan optimization, dose ca1culation, treatment delivery and 
quality assurance. In aIl the mentioned approaches, only partial solutions are proposed 
where they either propose a delivery tool without investigating the effects of the dose 
calculation algorithm or discuss the optimization without addressing the means of 
delivery. Until becoming commercially available, the proposed systems are not likely to 
achieve widespread applications. 
The plan optimization in EMET is much more complex than in IMRT because of 
the significant effects of beam collimation on the dose distribtuions. Such dependence 
requires faithful ca1culation of the dose kemels that are fed in the optimization 
algorithms. In addition, having a simple accessible treatment delivery device that is fully 
automated is essential to demonstrate clinical significance. To achieve an optimal 
application of EMET, the effects of the delivery unit should be integrated in the 
optimization algorithm. Hence, the fundamentals of electron transport through the 
collimators and inside the heterogeneous patient should be used in post-hoc optimization 
step. This must be followed by verifying that the planned dose distribution is truly 
delivered through the development of careful quality assurance procedures. 
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Chapter4 
Monte Carlo-based Inverse Treatment Planning for Energy 
Modulated Electron Therapy 
In order to implement energy modulated electron therapy (EMET) clinically, we 
propose a simplified collimation system that is easily automated and integrated with a 
Monte Carlo-based inverse treatment planning. To achieve this goal, a planning process 
was built which involves developing (1) a Monte Carlo treatment planning system [see 
Appendix A] and (2) an optimization algorithm. We chose to improve the existing in-
house developed optimization algorithm that was initially programmed in our department 
to study x-ray intensity modulated radiation therapy (IMRT) planning [1]. This research 
tool has been modified in order to communicate with the Monte Carlo treatment planning 
system. Different routines have been introduced to ob tain the dose deposition coefficients 
(DDCs) for each organ, required to perform the optimization, from the Monte Carlo 
ca1culated dose distributions. 
In addition to the treatment planning requirement, a delivery method was also 
investigated. The few leaf electron collimator (FLEC), fitted on a standard electron 
applicator and backed up by the x-ray collimator, was introduced to facilitate the delivery 
of a flexible combination of different energies and intensities. Its light-weight design 
accompanied by the proposed automation, gives the FLEC the potential to overcome the 
limitations of other proposed electron collimation systems. AIso, the rectangular fields 
(fieldlets) that are delivered by FLEe can be fully simulated through the beam 
configuration and the patient geometry. Using the detailed information of realistic 
deliverable beam ports, the optimization process determines the weights in the form of 
the prescribed number of monitor units given to each fieldlet. This "aperture-based" 
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optimization was recommended, as discussed III the prevlOus chapter, as a realistic 
approach for optimizing EMET plans. 
In this chapter, we present a paper published in Physics in Medicine and Biology. 
It discusses the feasibility of using the FLEC for EMET purposes. It describes the general 
vision of the FLEC and shows the structure of our approach for obtaining EMET plans. 
The ability to perform EMET treatment planning is demonstrated. Comparisons with 
conventional treatment planning are shown for a theoretical target in a homogeneous 
water phantom. AIso, the advantages of using EMET for a head & neck treatment case 
are shown. 
Title: Monte Carlo-based modulated electron beam treatment planning using a few leaf 
electron collimator - feasibility study 
Authors: Khalid AI-Yahya, Dimitre Hristov, Frank Verhaegen, and Jan Seuntjens 
Published in Physics in Medicine and Biology vol. 50 p. 847-857 (2005). 
Submitted: 6 July 2004; revised: 14 October 2004; published: 17 February 2005. 
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Abstract 
Energy modulated electron beam therapy with conventional clinical accelerators 
has lagged behind photon lMRT despite its potential to achieve highly conformaI dose 
distributions in superficial targets. One of the reasons for this is the absence of an 
automated collimating device that allows for the flexible delivery of a series of variable 
field openings. Electron-specific multileaf collimators attached to the bottom of the 
applicator require the use of a large number of motors and suffer from being relatively 
bulky and impractical for head and neck sites. ln this work we investigate the treatment 
planning aspects of a proposed "few-Ieaf' electron collimator (FLEC) that consists of 
four motor-driven trimmer bars at the end of the applicator. The device is designed to 
serve as an accessory to standard equipment and allows for the shaping of any irregular 
field by combination of rectangular fieldlets. Using a Monte Carlo model of the FLEC, 
dose distributions are optimized using a simulated annealing inverse planning algorithm 
based on a limited number of Monte Carlo pre-generated, realistic phantom-specific dose 
kemels and user-specified dose-volume constraints. Using a phantom setup with an 
artificial target enclosed by organs at risk (OAR) as weIl as using a realistic patient case 
we demonstrate that highly conformaI distributions can be generated. Estimates of 
delivery times are made and show that a full treatment fraction can be kept to 15 minutes 
or less. 
4.1 Introduction 
Energy Modulated Electron Therapy (EMET) has the ability to provide conformaI 
dose distributions to superficial tumors for which it could be competitive to the intensity 
modulated radiation therapy (lMRT). The high surface dose followed by a steep fall-off 
make the electron beams well suited for treating shallow targets. However, EMET has 
not yet been clinically used to its full potential in contrast to photon lMRT. The main 
reasons for this lag in clinical implementation are: (1) the lack of dosimetric accuracy of 
electron pencil beam algorithms in the presence of heterogeneities and beam modifiers 
and (2) the absence of a practical automated collimation device that allows the delivery of 
series of different field openings (fieldlets) during one treatment. Although a high degree 
of accuracy of the dose calculation could be achieved if Monte Carlo techniques are used 
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[2-4], the development of a beam shaping device that is able to preserve the electron 
beam characteristics and yet allow for flexible use of multiple fieldlets remains 
challenging. 
In recent years, significant efforts have addressed the feasibility, implementation 
and clinical utility of EMET which employs a thin-Ieaf multileaf collimator attached onto 
a frame at the bottom of an existing electron applicator [5-10]. To automate such 
collimator in a clinical setting, this approach requires the presence of a large number of 
motors at the bottom of the e1ectron applicator and suffers from being relative1y bulky 
and impractical to handle. 
The use of inverse techniques for treatment planning of EMET is more complex 
than in photon beam IMR T since collimation has a profound effect on electron scattering 
and the dose gradients in a specific sub-field. In addition, accurate dose calculations in 
and near patient heterogeneities are essential for a successful application of EMET. 
Having detailed information about the effect of both the collimation devices and the 
complex patient geometry on the dose provided to the optimization algorithm wou1d lead 
to a truly optimal treatment plan. Hence, the output and the dose distribution realized 
through the combination of multiple sub-fields requires the electron transport to be 
faithfully modeled through the collimating system and inside the patient. Any 
optimization algorithm that does not make use of realistic dose deposition kemel data 
will inevitably produce segment weights that lead to suboptimal and/or undeliverable 
dose distributions. 
In this work we introduce an approach to deliver EMET plans using a simplified 
model for an automated collimation device. This feasibility study is based on Monte 
Carlo calculations where the fundamentals of electron transport and scattering through 
collimating devices and in the heterogeneous patient are aIl taken into account. 
4.2 Materials and Method 
4.2.1 Design of few leaf electron collimator 
To facilitate the formation of irregular electron fields and to allow the flexible 
combination of different energies and intensities, a few leaf electron collimator (FLEC) is 
proposed as an add-on accessory that could fit on a light-weight frame at the bottom of an 
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Figure 4-1: (a) Position of few-Ieaf collimator (FLEC) relative to other components in 
the accelerator (not to scale). (b) Schematic drawing ofbeam 's eye view of FLEe. 
electron applicator. In its most basic appearance (as shown in Fig. 4-1), this collimator 
consists of four blades (or trimmer bars) driven by mot ors so as to form arbitrary square 
or rectangular fields with an area between zero and nominally 9x9cm2 (for the 15x 15 cm2 
electron applicator) and between zero and 14x14 cm2 (for the 20x20 cm2 electron 
applicator). Any irregular irradiation field can be made up by a combination of 
rectangular and square fields which possibly could involve the use of collimator rotation 
in a more evolved stage. The function of the FLEC is an automated final re-collimation of 
electron fields, previously collimated by jaws and/or the photon MLC that will be used as 
backup collimation devices. Hence, the blades, made of copper, can be relatively thin. In 
our study, their thickness was 1.5 cm and their width was 3 cm. To first order, the 
delivery of complex dynamic electron fields will be performed in a step-and-shoot 
approach, whereby every sub-field is formed by simultaneous collimation of the electron 
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beam by the jaws and the FLEe. We verified the ability of our clinical accelerators to 
dynamically control jaws wh en ron in electron mode. 
4.2.2 Monte Carlo calculations 
In this study, the BEAMIEGSnrc [11] Monte Carlo code was used to simu1ate a 
CL2300 CD linear accelerator for the electron energies 6, 9, 12, 15, 18 and 22 MeV as 
weIl as for the photon energies of 6 and 18 MV. The transport parameters used in EGS 
accelerator simulations were ECUT= AE= 700 keV cutoff for electron transport, PCUT= 
AP= 10 ke V for photon transport, and the electron step is 1 % (i.e. ESTEPE= 0.01). After 
validation of the simulated beams against standard dosimetric data that includes the 
validation of the model in the presence of the beam modifiers, the Monte Carlo model 
was used to generate a master phase space file above the jaws for aIl energies. The 
procedure for the selection and ca1cu1ation of fie1d1et arrangement is conducted as 
follows: 
1) A user-specified number of field1ets is geometrically selected and positioned to 
conform the shape of the projected target. The fieldlets are chosen such that they are 
matched at the edges of the projected 3D volume of the PTV. An algorithm for 
optimizing the best fie1dlet configuration based on the 3D PTV contour is being 
deve10ped. For the purpose ofthis feasibility study, the fie1d1ets were selected manuaIly. 
2) Using the mas ter phase space file, we proceeded with the simulation of the fieldlet-
specific jaw openings as weIl as with the lower part of the accelerator including the 
FLEe. For each fieldlet setting of FLEC, the secondary jaws are set so as to project an 
opening equal to the one projected by the FLEC plus a margin of 0.5 cm on aIl sides. The 
phase space file of a fully simulated fie1dlet, for all energies, is scored at a source-surface 
distance (SSD) of 95 cm. 
3) The final phase space file of the fieldlet is then transported through the patient 
geometry using the XVMC code [12,13]. The patient is modeled by converting the CT-
data into a density matrix with a size of 128x128x (number ofs1ices) with the dimensions 
of the voxel size varying from 0.25 to 0.35 cm. 
4) Once the dose distribution of each fieldlet IS generated, a Monte Carlo dose 
distribution given in absorbed dose to tissue per particle is converted to absorbed dose to 
tissue per monitor unit. This is obtained using energy-dependent calibration factors 
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obtained from simulations that are performed under accelerator calibration conditions 
(1 Ox 10 cm2, zmax). The Monte Carlo calculated dose distribution provided by each fieldlet 
-after it is "properly" normalized- represents the dose deposition kemel whose weight is 
modulated by the optimization algorithm. The number of simulated partic1e histories was 
chosen to achieve a statistical uncertainty on the dose calculation of 1 % or less per 
fieldlet. 
4.2.3 Treatment plan optimization 
Figure 4-2 shows a schematic diagram of the inverse treatment planning system. 
The optimization is performed using the simulated annealing (SA) algorithm proposed by 
Sait and Youssef [14]. The optimizer selects the fieldlets, their energies, and their 
associated intensities that correspond to the optimal plan while the rejected fieldlets 
receive the weight of zero. 
The dose-volume objective function, FDV (w), is represented by 
FDV (w ) = Ff: (w ) + F[)AR (w ) (4-1) 
where w stands for the array of fieldlet weights, Ff: (w) represents the (dose-based) 
target objective term and F~R (w) represents the (volume-based) organs at risk (OAR) 
objective term. The objective functions are calculated as follows: 
[ ]
2 D w Dmax FD(w)=trmax'"'e(D (w)_Dmax) TV,P()- TV + 
TV TV ~ TV,p TV Dmax 
pETV TV 
[ . ( )]2 D
mm 
-D w trmin '"' e(Dmin _ D (W)) TV TV,p 
TV ~ TV TV,p D mm 
pETV TV 
, and (4-2) 
(4-3) 
where tr;; and tr;:n refer to the penalty parameters of the target maximum and minimum 
dose constraints respectively, e defines the Heaviside or step function, and DTV (w) is 
,p 
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Figure 4-2: A schematic diagram of the current EMET procedure. 
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the dose deposited to point p of the target (denoted by TV) which contains a total of N TV 
dose points. The dose to the target volume is constrained by the user-specified maximum 
and minimum dose D;'(:' and D;:" and relevant dose-volume relations for critical organs 
are specified by the dose-volume constraints of(D;;; ,Vo~"; ) , where 1 labels aIl the organ 
1 1 
constraints. Each constraint in the OAR is assigned a penalty value ffOAR that weighs the 
individual penalty contribution to the overall objective function. 
The optimization algorithm was developed in an in-house buiIt inverse treatment 
planning system that is developed within a visual software environment (AVS 5.4, 
Advanced Visual Systems, MA), running under SUSE LINUX. Software has been 
developed to interface the optimizer with the Monte Carlo calculated kemels so that the 
dosimetric data as weIl as the contour data required for the optimization algorithm could 
be extracted. The software also extracts the dose deposition coefficients (DDCs) which 
define the relative dose contribution from each fieldlet to each voxel contained in a 
specific contour. Moreover, the optimal fluence data obtained by the optimization 
algorithm are interfaced again with the kemels and then fed back to the clinical planning 
system (CadPlan 6.2.7) to display the final dose distribution. Another optimization 
algorithm, based on the deterrninistic steep dose volume histogram (DVH) minimization 
[15], has been developed within the same environment and objective function. It will be 
used for future studies for comparison with the simulated annealing algorithm to check 
the ability of both of the two algorithms to achieve the optimum optimization goals. That 
would include the study of the effect of the dependence of the generated fieldlet weights 
on the initial condition that might result in entrapment in a local minimum of the 
objective function if the deterrninistic approach is used. 
Note that, since we work a priori with realistic and deliverable beam port dose 
distributions, there are no additional steps involved (analogous to an MLC leaf sequence 
calculator in IMR T) in deterrnining the delivery of the distribution. The combined dose 
distribution is also truly optimized since the effects of both the presence of the 
heterogeneities as weIl as the bremsstrahlung produced by the collimation device are 
taken into account without the need to correct the final dose distribution for the leakage 
and transmission. As shown in Fig. 4-2, in the event that no convergence can be achieved 
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Structure Dose (Gy) Volume (%) Penalty Value 
Target 50 100 
Target 60 0 
Organ 1 40 2 0.3 
Organ 1 30 10 0.3 
Organ 2 40 2 0.3 
Organ 2 30 10 0.3 
Table 4-1: Target dose and organ dose-volume levels in EMET optimization for the 
phantom case. 
in the optimization process with the existing fieldlets new beams have to be added and 
the optimization process repeated. An example of such a case could be the need to reduce 
skin dose through the use of one or more conventionally shaped photon beams. As only a 
limited number of additional fieldlets would be required, the incremental time needed for 
this process is limited. 
4.2.4 Treatment planning details 
4.2.4.a Simple water phantom 
We have planned for EMET on a three dimensional homogeneous sol id water 
phantom geometry as weIl as for a realistic head and neck case. For the homogeneous 
phantom case, contours and CT data were acquired from the CART files, the file format 
used by CadPlan treatment planning system. We used a phantom scanned through CT to 
emulate the planning procedure where our calculations will be performed. The target was 
drawn to be sUITounded by critical structures shown in Fig. 4-3. The lateral extent of the 
target was 8 cm and the inferior-superior extent was 6 cm while the depth varies laterally. 
The isocenter was placed at the surface so that the phantom is at an SSD 100 cm. With 
each electron energy, five fieldlets were simulated: two of them were adjacent to cover 
the PTV laterally (along x-axis) with a size of 4.5x7 cm2 each; two were chosen to cover 
the PTV widely (along z-axis) with a size of 9x3.5 cm2, and one fieldlet that was of the 
size of 9x7 cm2 to properIy cover the PTV. Table 4-1 summarizes the dose and dose-
volume constraints prescribed for this case. 
4.2.4.b Head and neck case 
For the he ad and neck case, we generated two plans: (1) the conventional 
tangential wedged photon beams with cutout-shaped electron boost and (2) EMET with 
four electron fields in addition to the wedged photon beams. In plan 1, the dose 
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Figure 4-3: Dose distribution of an optimized EMET plan and DVHs for a hypothetical 
target and two organs at risk surrounding the PTV in a homogenous soUd water phan tom 
scanned by CT (PTV is outUned in yellow). 
distribution was calculated after the simulation of the MLC-shaped wedged beams using 
our in-house Monte Carlo-based treatment planning system. We acquired the beam 
modifiers as well as the monitor unit settings to perform the simulation for each beam 
and add the individual normalized dose distributions to be displayed in the clinical 
treatment planning system. In plan 2, the four electron fields were 9, 12, 15, 18 MeV with 
6 fieldlets each such that the PTV is fully covered. In addition, we considered each 
photon field as a fieldlet and allowed the optimization algorithm to decide whether or not 
to use its contribution in the final plan. 
4.3 Results and Discussion 
4.3.1 Homogeneous phantom 
Using our automated EMET system, we calculated the dose distribution for an 
imaginary PTV outlined in a homogeneous solid water phantom that has been scanned by 
CT. Fig 4-3(a) shows the conformity of the isodose distribution obtained by EMET at the 
isocenter slice based on a 50 Gy prescription. The corresponding DVHs are shown in Fig. 
4-3(b) for the PTV and the OARs. The DVH confirms the coverage of the PTV with the 
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Figure 4-4: Comparison of (a) isodose distributions and (b) DVH for an outlined target 
using conventional two AP-PA wedged, MLC-shaped 6 MV beams mixed with one lateral 
12 Me V electron beam and EMET technique usingfour fields of9, 12, 15, and 18 Me V. 
Figure 4-5: Dose distribution obtained by EMET shows that the algorithm takes the 
effect of the heterogeneity into account at the cost of the conformity. 
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Fieldiet 9 MeV 12 MeV 15 MeV 18 MeV 6MV 
1 2310 450 3000 0 ANT 0 
2 7425 0 400 76 POS 1240 
3 315 1408 1590 1372 
4 360 736 60 1892 
5 4750 36 0 0 
6 855 1536 120 252 
7 1980 0 270 1036 
8 495 0 0 0 
Table 4-2: The totai number of the prescribed monitor units obtained by the optimizer 
over the whole treatment. The beam-on time required ta deliver one fraction remains 
within 5 minutes interval. 
prescribed dose but it shows also the presence of hot spots due to the use of limited 
number of fieldlets where the bulging effect that occurs at the edge of the fieldlets causes 
the appearance of dose heterogeneity wherever the fieldlets are junctioned. For this 
particular case, the effect could be reduced by the use of a photon field that covers the 
PTV to create more uniformity within the target. The hot spots could be eliminated by 
feathering the field edges using dynamic delivery of the fieldlets. Although it has not 
been implemented yet, it is a potential topic of future study. 
4.3.2 Head and neck case 
To demonstrate the ability of EMET to deal with more realistic scenarios, a plan 
was generated for a head and neck case and compared with the conventional treatment 
technique. Figure 4-4(a) shows the comparison between the Monte Carlo ca1culated 
isodose distribution for a conventional plan using two wedged and MLC-shaped photon 
beams boosted by a lateral 12 MeV electron beam with an optimized plan provided by 
EMET. It is shown that the EMET plan provides better conformity of the prescribed 50 
Gy to the PTV as opposed to the conventional plan where the 50 Gy isodose line extends 
to coyer more volume of the healthy tissues. It is also shown that the low-dose isodose 
line (20 Gy), obtained by EMET, covers a small volume compared to the conventional 
plan. If we consider any tissue outside the PTV as an OAR, then EMET would show 
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Figure 4-6: XY scatter-plot for the weighted fluence obtained by the optimizer for each 
energy, 
superior behavior in saving such OAR. The DVHs, shown in Fig. 4-4(b), of both plans 
show that they both converge to the same maximum dose with more uniformity within 
the PTV if the conventional plan is used. Hot spots were observed to be spread along the 
PTV for the EMET plan due to the junctioning effect, while in the conventional plan the 
hotspots are localized in the soft tissue. Figure 4-5 shows the dose distribution obtained 
by EMET for a slice that contains part of the target located in bone tissues. It shows that 
the PTV is fully covered with the prescription dose of 50 Gy ev en though the slice shows 
a high level of heterogeneity. With the use of realistic Monte Carlo simulated fieldlets 
kemels a priori, where the patient heterogeneities have been accounted for in the 
optimization algorithm, the EMET plan is truly optimized with its initial requirements. 
However, due to the competing goals in the objective function between covering the PTV 
adequately and conforming the prescribed dose to it, the final outcome depends on which 
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goal has higher priority. In this case, the coverage of the heterogeneous tissue came at the 
cost of the conformity. 
The intensity maps for each energy field, obtained by weighing the Monte Carlo 
simulated fieldlets to their contribution provided by the optimizer, are shown in Fig. 4-6. 
The map shows the dominance of the 9 Me V electron field. Su ch dominance is due to the 
shallow depth of the tumor. There is also a significant fraction of the high energy electron 
fieldlets at the positions which is attributed to the presence of bone tumor heterogeneity 
along the path of that specific fieldlets. Table 4-2 shows the final output provided by the 
optimizer converted to monitor unit settings. Note that these numbers represent the 
setting of the complete delivery and need to be fractionated based on the number of 
fractions prescribed by the physician. The minimum output to be given by the optimizer 
was set to be one monitor unit, yet several fieldlets were given a zero weight inc1uding 
the anterior photon beam. The posterior photon beam, however, was given a relatively 
high weight which improved the homogeneity of the distribution as specified by the 
constraints. 
The calculation time required to obtain phase files of 24 fieldlets used in this 
EMET plan was a total of 24 hours with a 10 Pentium III CPUs c1uster. Calculating aB 
dose distributions based on the generated phase space files is estimated to be 30 minutes 
in the same cluster. The optimization process produces its results within 2 hours. Most of 
the time consumed in the process is due to the production of the phase space files that 
could be significantly reduced by the use of the beam models or by building up a library 
of selected phase space files. 
4.4 Conclusions 
In this work, we studied the feasibility of a simplified collimation device to 
deliver conformaI electron beam dose distributions. Our results show that EMET offers 
advantages over the conventional treatments and leads to a significant reduction of the 
dose delivered to the healthy tissues. In the case studied, the bearn-on time for one 
fraction would be within 5 minutes if the accelerator was set to run 500 MU per minute. 
The transition time for the 6 fieldlets for each of the four energies used is estimated to be 
around 8 minutes based on the basic characteristics of standard motofs and the pitch of 
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typical driving screws. Given the fact that we used a limited number of fieldlets, the 
optimization algorithm could provide weights that conform to the target within 
reasonable delivery time. More work is needed in the selection of fieldlets and in 
investigating the use of beam models. A prototype of FLEC is under construction in our 
department. Comparisons between EMET and IMRT is being investigated and the 
feasibility of using a practical combined plan is underway 
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Chapter 5 
Clinical Significance of Energy Modulated Electron Therapy 
Using Few Leaf Electron Collimator 
Energy modulated electron therapy (EMET) is capable of delivering high 
conformaI dose tailored to superficially located targets which are inherently difficult to 
plan with x-ray intensity modulated radiation therapy (lMRT). This chapter presents a 
paper published in Medical Physics showing the advantages gained from introducing 
EMET. Following the preliminary results of the previous chapter, we extend our 
comparison of dosimetric studies to include IMR T. We introduce multiple plan 
evaluation parameters to examine the significance of EMET compared to the available 
treatment modalities; namely, conventional three-dimensional conformaI radiation 
therapy (3D-CRT) and IMRT. 
Title: Energy modulated electron therapy usmg a few leaf electron collimator in 
combination with IMRT and 3D-CRT: Monte Carlo-based planning and dosimetric 
evaluation 
Authors: Khalid AI-Yahya, Matthew Schwartz, George Shenouda, Frank Verhaegen, 
Carolyn Freeman, and Jan Seuntjens 
Published in Medical Physics vol. 32 p. 847-857 (2005). 
Submitted: 3 May 2005; revised: 17 June 2005; accepted: 7 July 2005; published: 30 
August 2005 
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Abstract 
Energy modulated electron therapy (EMET) based on Monte Carlo dose 
ca1culation is a promising technique that enhances the treatment planning and delivery of 
superficially located tumors. This study investigated the application of EMET using a 
novel few-Ieaf electron collimator (FLEC) in head & neck and breast sites in comparison 
with three dimensional conventional radiation therapy (3D-CRT) and intensity modulated 
radiation therapy (IMRT) techniques. Treatment planning was performed for two parotid 
cases and one breast case. Four plans were compared for each case: 3D-CRT, IMRT, 3D-
CRT in conjunction with EMET (EMET-CRT), and IMRT in conjunction with EMET 
(EMET -IMR T), aIl of which were performed and ca1culated with Monte Carlo 
techniques. For aIl patients, dose volume histograms (DVHs) were obtained for aIl organs 
of interest and the DVHs were used as a means of comparing the plans. Homogeneity and 
conformity of dose distributions were ca1culated, as weIl as a sparing index that compares 
the effect of the low isodose lines. In addition, the who le-body dose equivalent (WBDE) 
was estimated for each plan. Adding EMET delivered with the FLEC to 3D-CRT 
improves sparing of normal tissues. For the two he ad & neck cases the mean dose to the 
contralateral parotid and brain stem was reduced relative to IMRT by 43% and 84%, and 
by 57% and 71%, respectively. Improved normal tissue sparing was quantified as an 
increase in sparing index of 47% and 30% for the head & neck and the breast cases, 
respectively. Adding EMET to either 3D-CRT or IMRT, results in preservation of target 
conformity and dose homogeneity. When adding EMET to the treatment plan, the WBDE 
was reduced by between 6% and 19% for 3D-CRT and by between 21% and 33% for 
IMRT, while WBDE for EMET-CRT was reduced by up to 72% when compared with 
IMRT. FLEC offers a practical means of delivering modulated electron therapy. 
Although adding EMET delivered using the FLEC results in perturbation of target 
conformity when compared to IMRT, it significantly improves normal tissue sparing 
while offering enhanced target conformity to the 3D-CRT planning. The addition of 
EMET systematically leads to a reduction in WBDE especially when compared with 
IMRT. 
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5.1 Introduction 
Electron beams offer significant advantages over megavoltage photon beams in terms of 
delivery of high dose at shallow depths, rapid fall off of the dose distribution beyond the 
treatment volume, and low exit dose. Nevertheless, the use of modulated electron beams 
stiIllags behind that of photon intensity modulated radiation therapy (IMRT). Compared 
with IMRT, energy modulated electron therapy (EMET) has not been widely 
implemented due to problems inherent to electron beams su ch as dosimetric accuracy and 
verification as weIl as a lack of systems for automatic delivery. Studies have shown the 
fundamental capability of modulated electron beams for the delivery of tailored dose 
distribution and different delivery approaches have been proposed [1]. An automated 
system of bolus modulation was proposed to design and produce patient specific bolus 
[2-5]. But such system is expensive and planning and treatment with bolus-modulated 
electron beams remain time consuming and cumbersome. 
Electron multileaf collimators (eMLC) [6-8] have been designed for use in their 
own support frame and have the potential to serve for modulated electron radiation 
therapy applications [8]. Aside from being relatively bulky, due to the presence of a large 
number of motors in close proximity to the patient, automation of such a complex system 
has not been satisfactorily addressed. 
We have recently proposed and studied the feasibility of a simplified "few-leaf 
electron collimator" (FLEC) for delivering EMET [9]. The FLEC is designed as an added 
accessory tool able to automatically form a sequence ofrectangular openings (fieldlets) to 
compose any irregular electron field. It consists of four copper bars driven by stepper 
motors that are electronically coupled to the motors controlling the photon jaws so that 
both of them simultaneously project the same opening at SSD= 1 00 cm. Being backed up 
by the jaws, the e-collimator blades have a thickness of only 1.1 cm and a width of 3 cm. 
These limited lateral dimensions ensure that the collimator fits within a regular clinical 
electron applicator. 
The use of inverse planning techniques for EMET is more complex than for 
photon beam IMR T since collimation has a profound effect on electron scattering and the 
dose gradients in a specifie fieldlet. In addition, accurate dose calculations in and near 
patient heterogeneities are essential to ensure that the optimizer has the dose information 
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required for calculation of fieldlet weights that lead to an optimal treatment plan. Hence, 
the output and the dose distribution realized through the combination of multiple sub-
fields requires faithful modeling of electron transport through the collimation system and 
inside the patient. 
The total body dose resulting, mainly, from scatter and leakage in photon beams 
is considered to be a significant disadvantage to IMRT [JO-12]. To deliver an equivalent 
target dose, IMR T techniques require a considerable increase in bearn-on time compared 
to conventional techniques (between 2 - 5 times longer) [13,14]. The increased number of 
monitor units (MUs) leads to a greater whole-body dose to the patient due to the leakage 
and scattering of x-rays, thereby increasing the risk of radiation induced malignancies 
[15]. In contrast, electron beams are not associated with the hazard of the increased total 
body dose due to the absence of the target and the flattening filter that produce and flatten 
photon beams and cause leaking and scattering away from the beam direction. 
In this work, we investigated the clinical significance of a "few-Ieaf' collimator 
with an associated inverse Monte Carlo-based planning algorithm for electron beams. As 
the use of a limited number of electron fieldlets may result in undesirable dose 
heterogeneity within the target when applied as a sole treatment modality, the 
combination of EMET with either traditional photon beams or IMRT beams is of greater 
interest because it achieves the conformity and target uniformity desired in an optimal 
plan with better sparing of normal tissues. EMET planning was thus performed either in 
conjunction with photon beams used in three dimensional conformaI therapy (EMET-
CRT) or in conjunction with IMRT (EMET-IMRT). We studied three clinical cases: two 
parotid gland cases and a breast case. We estimated the whole body dose-equivalent 
(WB DE) of the conventional 3D-CRT, IMRT, EMET-CRT, and EMET-IMRT plans 
using measured dose data at various distances from the isocenter. This work represents 
the results of a feasibility study and the full application of the technique awaits the 
implementation and validation of a QA pro gram that verifies the accuracy of the delivery 
using similar techniques as those used in IMR T. 
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Parotid Cases 
Goal (Gy) 
Target 60 
Limit (Gy) 
Tissue 50 
Eye(L) 40 
Eye(R) 40 
Lens(L) 8 
Lens(R) 8 
Spinal Cord 40 
Brain 50 
Brain Stem 50 
Larynx 50 
Breast Case 
Target 
Tissue 
Heart 
Lung 
Goal (Gy) 
50 
Limit (Gy) 
50 
20 
20 
Clinical Significance ofthe FLEC 
Vol Below Goal (%) Min (Gy) Max (Gy) 
2 57.5 68 
Vol Above Limit(%) Max (Gy) 
20 68 
2 45 
2 45 
1 8 
1 8 
4 45 
33 53 
33 53 
50 50 
Vol Below Goal (%) Min (Gy) Max (Gy) 
3 48 55 
Vol Above Limit(%) Max (Gy) 
1 50 
10 45 
10 50 
Table 5-1: Objectivefunction parameters used in treatment planning and optimization. 
5.2 Methods and Materials 
5.2.1 Patient selection, volume definition, dose prescription 
Two parotid cancer patients post-surgical resection previously treated with 
adjuvant radiation were selected. Each patient had been immobilized with a thennoplastic 
mask, and had had a planning computed tomography (CT) scan of the he ad and neck with 
5 mm slices. The clinical target volume (CTV), planning target volume (PTV), and 
organs at risk (OARs) (brain, brain stem, spinal cord, eyes, lenses, larynx, and 
contralateral parotid) had been contoured for each patient. The CTV included the post-
surgie al bed and areas at risk for microscopie disease. The PTV included the CTV and a 
3 mm margin. The dose prescribed to the PTV was 60 Gy, at 2 Gy per fraction. For 
inverse planning, dose constraints to the OARs are seen in Table 5-1. 
One patient with left sided breast cancer post mastectomy previously treated with 
adjuvant radiation was selected. The patient had been immobilized with a breast board, 
and had had a planning CT scan of the thoracic cavity with 5 mm slices. The clinical 
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target volume (CTV) and organs at risk (lungs, heart, contralateral breast, skin, and ribs) 
had been contoured. The skin was outlined for a depth of 2-3 mm. The CTV included the 
left chest-waIl as defined on the planning CT scan. The dose prescribed to the CTV was 
50 Gy, at 2 Gy per fraction. For inverse planning, dose constraints to the OARs are seen 
in Table 5-1. The IMRT plan dose constraints did not include the skin or ribs as we did 
not want to compromise the target coverage. For aIl cases, the normal tissues excluding 
the OARs and target volumes were defined. 
5.2.2 Treatment planning 
5.2.2.a Treatment planning system 
To ensure consistency of the companson between different plans, aIl plans 
computed in this work were Monte Carlo recalculated using the dose engine embedded in 
the MMCTP (Mc Gill Monte Carlo Treatment Planning) system. This planning interface 
was developed with the capability of importing treatment plans from different planning 
systems from which it reads the CT data, beam arrangements and the MU prescription. 
After acquiring the plan information, the patient-specific beam arrangements are 
simulated using the Monte Carlo EGS/BEAMnrc package [16] to obtain the phase space 
data (PSD) representing the beam energy and particle properties. For each energy, the 
MU calibration of the system is obtained based on a dose calculation in reference 
calibration conditions. The PSD of each beam is stored in a file from which each particle 
is transported through the patient density matrix (256 x 256 x (number of slices)) derived 
from CT data (voxel size varying from 0.15 to 0.2 cm) using the fast Monte Carlo code 
XVMC [17]. The beams are added based on their MU weights to obtain a final dose 
distribution displayed in MMCTP. 
Simulation of the photon beams of aIl plans included importing the MLC file 
from the clinical treatment planning system (CadPlan ®) and converting them to an input 
file readable by the DYNVMLC module [18] in BEAMIEGSnrc. The DYNVMLC has 
the ability to fully model the details of the leaves used in the Millennium 120 leaf 
collimator including the difference on the thickness of the inner and the outer leaves, leaf 
holes, tips, air gaps. For dynamic delivery in IMR T plans, the leaf sequence files were 
extracted from the IMRT system station and converted to a format suitable for the 
BEAMnrc DYNVMLC component module in which the physical openings at the MLC 
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plane are calculated and the MLC segments are sampled based on the MU settings. 
MMCTP is equipped to process the IMRT plan and provide a Monte Carlo-recalculated 
dose distribution for each approved plan. The wedges were simulated using the WEDGE 
module developed by van der Zee and Welleweerd [19] and modified to work within the 
BEAMnrc environment. While the validation of the simulations of DYNVMLC has been 
reported in another study [18], the simulations of the WEDGE module have been 
extensively studied over a wide set of experimental setups and the differences between 
measurements and calculations were less than 3%. 
S.2.2.b Energy modulated electron therapy planning 
EMET was planned and the delivery was calculated as described in a previous 
study [9]. Briefly, it involves the use of the automated FLEC in conjunction with Monte 
Carlo-calculation of patient-specific dose deposition coefficients (DDC). Keeping the 
outer dimensions of the FLEC not larger than the currently existing standard electron 
applicators has the consequence that geometrical restrictions associated with the electron 
treatment of he ad & neck patients can be overcome. The weight of the FLEe is estimated 
to be around 3-4 kg in addition to the weight of a clinical electron treatment applicator. In 
the first order, the delivery of complex dynamic electron fields will be performed in a 
step-and-shoot approach, whereby every sub-field is formed by simultaneous collimation 
of the electron beam by the jaws and FLEC. A complete fraction from a typical treatment 
plan consisting of a combination of 25 subfields of 4 energies can be delivered within a 
15 minute timeframe [9]. The DDCs are obtained by manual selection of suitable fieldlets 
that geometrically conform to the target followed by full Monte Carlo simulation of each 
fieldlet for all energies using the BEAMnrc code to obtain a phase space representation of 
the fieldlets. Particles from this phase space are then transported through the patient 
model using the XVMC code. The dose distribution of each simulated fieldlet is 
considered a kemel that is fed into an optimization algorithm. Each fieldlet's phase space 
file contains 2-6 million particles depending on its dimensions which results to a 
negligible latent uncertainty. In a previous study, the accuracy of the Monte Carlo engine 
for clinical electron beams has been commissioned and compared to measurements in 
heterogeneous phantoms and the overall accuracy was less than 3% near maximum dose 
[20]. The number of simulated histories was selected so as to achieve a statistical 
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Case 1 (Parotid) 
3D-CRT EMET-CRT IMRT EMET-IMRT 
Energy Angle MU _ Ene~ Angle MU E~ergy Angle MU Energy Angle MU 
6 MV 345 142 6 MV 345 86 6 MV 240 259 6 MV 240 297 
6 MV 200 141 6 MV 200 199 6 MV 280 199 6 MV 280 89 
6 MV 270 97 6 MV 270 39 6 MV 310 226 6 MV 310 67 
6 MeV 270 48 6 MV 350 160 6 MV 350 131 
9 MeV 270 53 6 MV 30 216 6 MV 030 219 
12 MeV 270 251 6 MeV 270 50 
9 MeV 270 60 
12 MeV 270 279 
Case 2 (Parotid) 
3D-CRT EMET-CRT IMRT EMET-IMRT 
Energy Angle MU Energy Angle MU Energy Angle MU Energy Angle MU 
6 MV 10 165 6 MV 10 211 6 MV 330 209 6 MV 330 158 
6 MV 190 155 6 MV 190 76 6 MV 100 209 6 MV 100 102 
6 MV 90 134 6 MV 90 11 6 MV 130 207 6 MV 130 171 
9 MeV 90 159 6MV 170 212 6MV 170 111 
12 MeV 90 135 6 MV 30 198 6 MV 30 146 
15 MeV 90 320 6 MV 60 247 6 MV 60 206 
9 MeV 90 43 
12 MeV 90 74 
15 MeV 90 219 
Case 3 (Breasl) 
3D-CRT EMET-CRT IMRT EMET-IMRT 
Ener~ Angle MU _ Ener~n Angle MU Energy Angle MU Energy Angle MU 
6 MV 302 205 6 MV 302 156 6 MV 302 207 6 MV 302 137 
6 MV 127 205 6 MV 127 156 6 MV 312 184 6 MV 312 120 
6 MeV 46 370 6 MV 322 196 6 MV 322 101 
9 MeV 46 414 6 MV 127 185 6 MV 127 130 
6 MV 117 228 6 MV 117 144 
6 MV 107 243 6 MV 107 150 
6 MeV 46 570 
9 MeV 46 805 
Table 5-2: The total MUs to deliver the plans of the conventional 3D-CRT*, EMET-CRTt, IMRTtt, and EMET-IMRTt. The addition 
of EMET reduces the photon beam contributions of the 3D-CRT and IMRT plans by transferring some weight to the electron beams. 
The electron MUs and the photon MUs are not additive since they contribute differently to the whole body dose. (* The number of 
MUs is prescribed by the CadPlan treatment planning system. t The number of MUs is prescribed by the EMET optimizer. tt The 
number of MUs is prescribed by the COR VUS treatment planning system.) 
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uncertainty within 2% or Iess per fieldlet in the voxels recelvmg 10% or more of 
maximum dose. Ma et al. illustrated that su ch small statistical uncertainties in modulated 
electron beams will not affect the final results represented in DVHs [21]. 
The in-house developed optimization software operates under a graphical 
programming system (Application Visualization System, A VS Inc.) and uses the 
deterministic steep dose volume histogram (DVH) minimization algorithm [22] as an 
optimization technique. The software manages the extraction of the dosimetric 
information from the Monte Carlo ca1culated kemels which includes the contour data and 
the DDCs that characterize the relative dose contribution from each kemel to each point 
confined in an individual contour. Obtaining both contour data and DDCs for the PTV 
and OARs is followed by assigning the prescription, the dose-volume constraints, and 
their related penalties. The EMET optimizer evaluates the role of each fieldlet in the 
overall dose distribution and assigns a relative weight to il. After an optimum plan is 
achieved, the EMET optimizer retums the energies of the contributing fieldlets along 
with their associated relative intensities in the form of number of MUs. Fieldlets that 
receive a weight of zero by the optimizer are considered rejected. In this work, the Monte 
Carlo simulated photon beams are considered as fieldlets in both EMET -CR T and 
EMET-IMRT plans. The EMET optimizer determines the weight of the entire field in the 
same fashion it deals with an electron fieldlet. Thus, the optimizer reweighs the overall 
delivered IMRT treatment but does not change the leaf sequence of each ofthe individual 
IMR T fields. 
5.2.2.c Treatment techniques 
For each patient, we have used four planning techniques that are summarized in 
Table 5-2 
Technique 1: 3D conformaI radiotherapy C3D-CRT) technique 
For each of the two parotid cases, three wedged 6 MV photon beams from a Varian 
Clinac 2100EX accelerator (Varian Medical Systems, Palo Alto, CA) were used. The 
perpendicular beams (the 270° beam for the first case and the 90° beam for the second 
case) were given a reduced weight to obtain a more homogeneous dose distribution. The 
fields were shaped by means of the beam's eye view (BEV) feature in ACQSIM (Philips, 
Andover, MA) and a 120 multileaf collimator (MLC) was used with a 6-mm consistent 
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margm around the PTV to reduce the dose to the OARs. For the breast case, two 
tangential rectangular 6 MV photon fields were chosen based on the BEV feature to 
entirely coyer the CTV. A wedge angle of 30 degrees was selected to provide a uniform 
dose distribution within the CTV. 
Technique 2: IMRT 
The commercial inverse planning system (CORVUS 5.0, NOMOS Inc., Cranberry 
Township, PA) was used to generate the IMRT plans. The IMRT technique used five 
step-and-shoot 6 MV beam orientations for the first parotid case and six gantry angles for 
the second parotid case and the breast case. The optimization procedure was performed 
without considering the effect of tissue inhomogeneities. Although the CORVUS 
treatment planning system allows one to use heterogeneity corrections in the optimization 
procedure, Yang et al. showed that this leads to only a negligible difference when 
compared to the CORVUS plan obtained without the heterogeneity correction for 
coplanar plans [23]. The effect of this approximation is manifested as discrepancies 
between the predicted DVH by the optimization algorithm and the "actual" DVH 
obtained after calculating the dose distribution with Monte Carlo simulations which 
rigorously accounts for the effect of tissue inhomogeneities. 
Once the IMRT plans are approved, leaf sequence files were produced for each beam 
orientation derived from the intensity maps required to achieve the fluence proposed by 
the optimization algorithm and the dose distribution is then recalculated by Monte Carlo 
methods. 
Techniques 3 and 4: EMET-CRT and EMET-IMRT 
For case 1, 10 fieldlets of 6, 9, and 12 MeV in addition to the newly-weighted three 
beams of the conventional plan were selected for the EMET -CRT and the same electron 
fieldlets (with different intensities) were also selected in conjunction with the 5 IMRT 
fieldlets for the EMET-IMRT. Case 2 employed 12 fieldlets with energies of 9, 12, and 
15 MeV. The intensity maps of the 9 and 12 MeV electron fields are shown in Fig. 5-1. 
The breast case used 8 fieldlets of 6 and 9 MeV. Table 5-2 shows the MU settings for the 
four techniques where the settings of the EMET plans were provided by the EMET 
optimizer. 
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-~ -, ., 
Figure 5-1: The intensity map aftwa energy fields based an the relative weights assigned 
by the EMET aptimizer. The intensity map is narmalized ta the fieldlet with the highest 
MUs. 
5.2.3 Plan evaluation parameters 
For each case studied, the mean dose, minimum dose, and maximum dose to the 
target were calculated for each of the four plans. As per Nutting et al. [24], the minimum 
dose is defined as the dose received by 2: 99% of the target volume and the maximum 
dose is defined as the dose received by :s 1 % of the target. DVHs were obtained for each 
of the four treatment plans for the target and OARs delineated. Only the mean dose and 
the maximum dose were reported for the OARs. 
Conformity was compared by ca1culating the conformity index (COIN95) defined by 
Baltas et al. [25] for each plan. COIN95 is defined as the product of the fraction of the 
target covered by higher than 95% (PT~5) of the prescribed dose and the ratio of the 
PTV 
volume of the target receiving at least 95% of the prescribed dose to the total volume of 
tissue receiving at least 95% of the prescribed dose(PT~5): 
V95 
COIN95 = PT~5 PT~5 . 
PTV ~5 
(5-1) 
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Figure 5-2: Schematic diagram of two plans that have the same coverage of the 95% 
isodose line to the PTV volume but with difJerent conformity of the low isodose lines. The 
conformity index (COIN95) will be equivalent for both plans despite their difJerences. 
The sparing index (SPIN50/JO) could be used to difJerentiate between them. 
However, although COIN95 provides reasonable evaluation of the conforrnity 
surrounding the target for the high dose values, it does not consider the volume that lies 
in the low dose region. As shown in Fig. 5-2, having two plans delivering the same 95% 
coverage will not be differentiated by the COIN95 factor if one plan extends the 30% line 
to cover larger volume which is undesirable if it could be avoided. We therefore propose 
the use of a new terrn, the sparing index (SPIN50/10), to quantify the volume that 
receives between 50% and 10% of the prescribed dose. We have defined this as: 
SPIN50110 = 1- ~~o , (5-2) 
where V;~o is the ratio of the volume of tissue that receives between 10% and 50% of the 
prescribed dose to the irradiated volume. The irradiated volume was defined as the 
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volume of tissue that receives 0.5% of the prescribed dose. SPIN50110 can not stand 
alone without being evaluated in conjunction with COIN95 where both values, ideaUy, 
should approach 1. 
We also used the homogeneity index HI901l1O to compare plans in terms of the 
ability to deliver homogeneous dose distribution to the target. HI901l1 0 is defined as the 
percentage of the target volume with a dose higher than 90% and lower than 110% of the 
prescribed dose. These parameters assist in comparing plans that have the same volume 
of the PTV and irradiated volume since there is a central dependence of these parameters 
on the planning volume in relation to normal tissue. 
5.2.4 Assessment of whole body dose-equivalent (WBDE) 
The dose was measured using a cylindrical Farmer ionization chamber placed at a 
depth of 2 cm in a solid water phantom and positioned at 35, 55, 75 and 95 cm away from 
the edge of the field. To resemble the patient geometry, a semi-spherical solid water 
phantom that mimics a he ad was placed at the isocenter while the other parts of the body 
were mimicked using bolus bags to account for the effect of the internaI scatter. Dose per 
MU was obtained for a 7x7 cm2 field (a typical field collimated with jaws and FLEC 
used in EMET) at aU energies (6,9, 12, 15 MeV), as weU as the dose per MU for 10xlO 
cm
2 
of the 6 MV photon field which agreed with the results obtained by other authors 
[26]. Using the total number of MUs acquired from the CadPlan treatment planning 
system for the conventional plan, from the CORVUS treatment planning system for the 
IMR T plan, and from the EMET system for both the EMET -CR T and EMET -IMR T plan, 
WBDE was estimated by multiplying the total MUs of each field by the dose value per 
MU measured at 40 cm from the isocenter. This value was used as a reasonable 
approximation to determine WBDE resulting from the 60 Gy prescribed dose for he ad & 
neck cases and the 50 Gy prescribed dose for the breast case. Figure 5-3 illustrates the 
comparison of the behavior of the peripheral dose caused by the four techniques based on 
the total MUs prescribed for the breast case. It is important to note that this estimate of 
the total body dose assessment serves only as a first order approximation due to the vital 
dependence of the WBDE on the treatment technique of each plan. In this work, we have 
used WB DE only to relatively compare different planning techniques. 
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Figure 5-3: Off axis dose at depth of 2 cm in soUd water phantom based on the number 
of MUs given by four techniques. 
5.3 Results 
5.3.1 Parotid cancer cases 
The isodose distributions of the four different plans with the DVHs of the outlined 
organs for the two cases are shown in Figures 5-4(a) and (b). Table 5-3 shows the 
summary of the DVH analysis of the four treatment plans for each case where the 
minimum, maximum, and me an doses to the target are reported. COIN95, SPIN501l0, 
H190/110, and the estimate for the WBDE are shown in Table 5-4. 
The target was weIl covered by aIl four plans. However, the IMRT plan gave the 
highest conformity to the target, followed by the EMET-IMRT plan. The use of IMRT 
and EMET -CR T produced hot spots, but these were within the target volume and were 
considered acceptable. For case 2, the hot spots with the EMET-CRT plan were within 
lOI 
Plan PTV Brain Brain Stem Cord Contralateral 
Parotid 
mean min max mean max mean max mean max mean max 
Case 1 (Parotid) 
3D-CRI 59.1 49.6 62.2 3.60 24.5 16.0 19.9 7.5 3l.6 12.7 14.7 
IMRI 59.7 55.9 64.7 4.82 29.2 17.2 25.1 9.9 32.2 9.9 16.3 
EMET-CRT 59.5 50.7 63.6 2.79 23.9 7.4 Il.3 3.8 18.2 5.7 6.7 
EMET-IMRT 59.9 54.7 65.4 2.9 23.5 9.1 14.5 7.2 24.2 7.5 14.3 
Case 2 (Parotid) 
3D-CRI 59.9 56.9 63.1 9.01 59.3 18.4 29.3 8.1 43.2 13.7 15.7 
IMRT 60.3 55.1 68.9 6.64 52.2 17.8 38.4 8.6 39.9 9.5 15.1 
EMET-CRT 59.6 52.2 65.9 5.94 55.4 5.3 18.7 4.6 40.7 2.5 3.1 
EMET-IMRT 59.3 53.2 66.1 6.15 51.8 14.0 34.5 7.8 37.3 6.5 1l.l 
Plan Breast Lung Heart Skin Ribs 
mean min max mean max mean max mean max mean max 
Case 1 (Breast) 
3D-CRI 52.4 47.3 55.5 14.3 48.7 2.1 6.2 4l.7 5l.9 12.2 52.2 
IMRT 5l.7 48.1 56.3 11.2 42.8 4.3 17.2 40.7 55.6 9.5 49.4 
EMET-CRT 52.5 48.5 55.4 12.4 45.1 2.3 10.1 42.6 51.4 1l.8 49.9 
EMEI-IMRT 52.4 48.7 56.2 10.1 41.3 3.8 17.3 41.7 53.7 10.3 49.5 
Table 5-3: Comparison of dose for PTV and OARs using four planning techniques. min= minimum dose; max= maximum dose; 
mean= mean dose. 
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Figure 5-4: A comparison of the Monte Carlo calculated dose distributions and DVHs 
for ail outlined organs produced by four plans: (1) 3D-CRT, (II) EMET-CRT, (III) IMRT, 
and (IV) EMET-IMRT (a) and (b) are for the two parotid cases and (c) is for the breast 
case. The target is outlined in yellow. 
the air-filled cavities of the temporal bone in the mastoid air cells. Since the dose 
distribution was calculated by Monte Carlo, the dose that is reported is the actual dose 
that is deposited in the air cavities. The hot spots with the IMRT plan were in the soft 
tissues due to the heterogeneities that were not taken into account in the optimization. As 
expected, the high isodose curves were very conformaI with both the IMRT and EMET-
CRT plans, but the low isodose curves for the IMRT plan contained a much larger 
volume of normal tissue compared with the EMET-CRT plan as seen in Fig. 5-4. This 
corresponds to the EMET-CRT plan having a much higher SPIN50/10 value than the 
IMRT plan (Table 5-4). If the SPIN 50110 is accepted as a measure of the ability of a 
given plan to spare the normal tissues in the low dose regions, then the EMET -CRT plan 
had a 47% higher sparing on average compared to the IMRT plan. 
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Plan COIN95 * SPIN50/lOT HI901110TT WBDE!i(mSv~ 
Case 1 
(Parotid) 3D-CRT 0.56 0.49 0.957 9.4 
IMRT 0.68 0.52 0.997 26.3 
EMET-CRT 0.59 0.77 0.956 8.9 
EMET-IMRT 0.62 0.59 0.985 20.8 
Case 2 
(Parotid) 3D-CRT 0.54 0.69 0.987 11.3 
IMRT 0.69 0.61 0.935 31.8 
EMET-CRT 0.62 0.88 0.957 9.4 
EMET-IMRT 0.64 0.60 0.973 23.4 
Case 3 
(Breast) 3D-CRT 0.30 0.93 0.949 8.5 
IMRT 0.54 0.67 0.956 25.7 
EMET-CRT 0.43 0.88 0.980 7.2 
EMET-IMRT 0.57 0.71 0.960 17.4 
Table 5-4: Comparison of treatment planning evaluation parameters of the four planning 
techniques. *COIN95= Conformity Index. tSPIN50/10= Sparing Index. ttHI90/110 = 
Homogeneity Index. §WBDE = Whole body dose equivalent. 
IMR T has been shown to reduce the dose to the contralateral parotid, brain, and 
spinal cord [24,27]. In our series, IMRT decreased the mean dose to the contralateral 
parotid by 27% on average when compared to the 3D-CRT plan (Table 5-3). The use of 
EMET-CRT further reduced the dose to the contralateral parotid dose by an addition al 
58%. The amount of normal brain tissue treated with a given technique is also an 
important issue when comparing different treatment techniques. The mean dose to the 
brain was 27% lower on average with the EMET-CRT plan as compared to the IMRT 
plan. The maximum dose to the spinal cord was 22% lower on average with the EMET-
CRT plan when compared to the IMRT plan. 
The estimate of WBDE (in mSv) is shown in Table 5-4. The WBDE was lowest 
for the EMET-CRT plans and the highest for the IMRT plans for aIl cases. The use of 
EMET-CRT resulted in a 69% decrease in the whole body dose on average compared to 
the IMR T plan. 
5.3.2 Left breast cancer post-mastectomy case 
Table 5-3 summarizes the quantitative comparison between different plans for the 
target volume and OARs. The minimum, maximum, and mean doses to the target, 
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ipsilateral lung, heart, skin overlying the treated breast, and ribs are given for each of the 
treatment plans. COIN95, SPIN50/1O, HI90/11O, and the WBDE are given for each plan 
in Table 5-4. Figure 5-4 (c) compares the isodose distributions for each of the treatment 
plans. 
The me an doses to the target were similar with each of the plans. However when 
using the conformity index, the EMET-IMRT plan had the highest conformity followed 
by the IMRT plan, EMET-CRT plan, and the 3D-CRT plan the lowest. EMET-CRT gave 
the most homogeneous dose distribution to the target as shown by the HI90/11 0 seen in 
Table 5-4. The SPIN50/1O showed that the 3D-CRT plan had highest value due to the 
poor conformity, shown in COIN95, that increased the volume of normal tissues 
irradiated with high isodose lines while lessening the volume covered by low isodose 
lines. The sparing of the 3D-CRT plan is followed by the EMET-CRT plan, EMET-
IMRT plan, and the IMRT plan. 
An important concern with left-sided breast cancer patients treated with 
radiotherapy is the dose to the heart. Table 5-3 gives the doses to the he art according to 
the different techniques. The 3D-CRT technique gave the lowest me an heart dose 
followed by the EMET-CRT plan, EMET-IMRT plan, and the IMRT plan. The use of 
EMET -CRT in this case gave a similar conformity as IMRT, but with a decrease in the 
dose to the heart. The EMET-CRT plan gave a 47% lower mean heart dose and a 41% 
lower maximum heart dose as compared to the IMRT plan. 
The ipsilaterallung often receives significant dose with conventional radiotherapy 
using tangential fields. Table 5-3 shows the doses to the ipsilateral lung by the different 
techniques. The EMET-IMRT technique gave the lowest mean dose to the lung, which 
resulted in a 10% decrease in the mean lung dose compared to the IMR T plan. The dose 
to the contralateral lung was negligible since it was not in the path of any irradiation 
field. In addition, the skin and rib doses were analyzed, and the IMR T plan gave the 
lowest mean doses to each. The higher mean dose to the skin seen with the EMET -CR T 
plan is likely due to the location of the CTV 3 - 4 mm below the surface so that the skin 
is in the build-up region. However, the maximum skin dose was the highest with IMRT 
and the lowest with EMET-CRT. The increased dose to the skin seen with IMRT is 
likely due to the fact that the skin is in the buildup region for photons, and IMR T uses 
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multiple tangential beams to deliver a homogenous dose to the target. This effect has 
been seen with patients treated with lMR T for head & neck cancers [28]. The EMET-
CRT plan had an 8% lower maximum skin dose when compared to the lMRT plan. 
WBDE is shown in Table 5-4. It was lowest for the EMET-CRT plan followed by 
the 3D-CRT plan, EMET-lMRT plan, and the lMRT plan. The EMET-CRT plan was 
72% lower than the lMRT plan with respect to the estimated whole body radiation dose. 
5.4 Discussion 
ln this study, we introduce a novel EMET technique using a FLEC as a modality 
for use in conjunction with 3D-CRT and/or lMRT in the context of mixed beam 
treatment planning and delivery. The automated FLEC circumvents the challenge of 
remotely shaping the electron fields required for the clinical application of EMET. This 
technique was applied to two parotid cases and a breast case for which comparisons with 
Monte Carlo-recalculated conventional3D-CRT and lMRT plans were performed. 
Although the FLEC involves the use of limited beam ports and large fieldlets compared 
to the fine MLC beamlets used in lMRT, the results show a significant overall 
improvement in several parameters used to analyze treatment plans. 
5.4.1 3D-CRT vs. EMET -CRT 
Conformity is significantly enhanced when EMET was added to the 3D-CRT 
plan. The conformity effect was more pronounced with the breast case where the high 
isodose lines ex tend to the Iung covering sorne portion of it with the prescribed dose 
while with EMET-CRT plan, as shown in Fig. 5-4, the 45 Gy isodose line conforms to 
the breast tissues, sparing the lung from irradiation by high doses. The volume of lung 
that receives the prescribed dose as seen from the DVH was reduced by 50% using 
EMET. Sparing was also significantly improved with the use ofEMET-CRT in both he ad 
& neck cases, leading to considerable reduction of the mean dose to all OARs including 
the contraiateral parotid. Sparing could also be achieved by replacing the lateral photon 
field with a lateral conventional cutout-shaped electron field. However, this would lead to 
extremely unfavorable heterogeneities in the dose distribution appearing as an extended 
tail in the DVH of the PTV. Target dose uniformity was affected by the addition of 
EMET to the 3D-CRT in the head & neck cases, but the reduction to the H190/110 caused 
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by EMET remained modest. Homogeneity could possibly be enhanced by assigning more 
penalty to it in the optimization procedure but this will cause competing goals in the 
objective function that might sacrifice conformity and/or reduce sparing of the other 
organs. In the breast case, however, the homogeneity of the dose distribution was 
improved with the use of EMET. The addition of a relatively large number of electron 
MUs did not increase the WBDE; EMET-CRT showed systematic reduction of the 
WBDE by reducing the photon MUs which are the dominant source of radiation outside 
the beam and replacing them with electron MUs which make a minimal contribution to 
the whole body dose. 
5.4.2 IMRT vs. IMRT -EMET 
Optimizing the EMET fieldlets with the IMRT whole fields that are added to form 
the IMRT-EMET plan does not represent the best possible optimization as only the 
weight of the entire IMR T field is varied and not the weight of the individual beamlets 
since the CUITent technology has not yet been clinically implemented for Monte-Carlo 
based optimization of photon beams. Using EMET-IMRT for the head & neck cases 
showed reduced conformity relative to IMRT alone. This is not the case for the breast 
case where conformity was enhanced with the EMET -IMR T plan. This is attributed to the 
relative large size of the fieldlets compared to the projection of the small PTV. In the 
parotid cases, due to the small size of the PTV, the effect of the edges of the fieldlets 
appeared to be significant while this effect diminished in the breast case where a large 
target is irradiated. Overall, homogeneity is preserved with the addition of EMET. 
Sparing, however, systematically improves with EMET due to the lower exit dose of 
electrons compared to photons. Improvement of sparing was seen as the SPIN50/l0 as 
well as the mean dose and the maximum dose to the OARs, aIl of which were 
consistently reduced when EMET fields were optimized with IMRT. EMET-IMRT has 
the advantage of lowering the WB DE because of the reduction of the photon bearn-on 
time. 
5.4.3 IMRT vs. EMET -CRT 
Although the conformity achieved by IMRT cannot be challenged with the 
EMET-CRT due to the use ofrather large fieldlets, the sparing attained by EMET-CRT is 
superior even with such limited fieldlets. The significant reduction of dose to the 
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contralateral parotid suggests that EMET -CR T has the potential to improve the quality of 
life, while the reduction of dose to the spinal cord is important sin ce it allows the patient 
to receive further radiation treatment if needed. Target dose homogeneity was modestly 
improved with the breast case where the hot spots caused by the tangential effect of the 
IMR T fields could be avoided. The maximum dose to the skin in the breast case was 
reduced by 8% with EMET-CRT compared to IMRT. ln the second parotid case, the hot 
spots in the IMRT plan were in the soft tissues while they were in the air cavities in the 
EMET-CRT plan. This effect cannot be differentiated when comparisons are made 
through DVHs only but it might have clinical implications. This study also underlies the 
concem of the inclusion of the air cavities in the PTV especially when true Monte Carlo 
optimization is implemented [29]. For the WBDE, EMET-CRT shows major reduction of 
the estimate ofWBDE (in the order of 70%). 
5.5 Conclusion 
In summary, we investigated the use of energy modulated electron beam 
treatment planning and delivery using a few-leaf electron collimator in a context of 
mixed beam treatment planning with conventional radiation therapy and IMR T. We used 
Monte Carlo techniques to calculate treatment plans for convention al 3D-CRT planning 
and IMRT alone or combined with EMET. We have shown that EMET delivered with the 
FLEC could be a valuable addition to CUITent treatment techniques especially when 
applied to superficially located tumors that are inherently difficult to plan using IMR T. 
Since the FLEC can be readily automated and remotely controlled, the complexity of 
EMET delivery will not exceed what is deemed acceptable in IMR T. The characteristics 
of quality assurance procedures are expected to be similar to those for IMRT treatments. 
For two head & neck cases and for one breast case we showed that target conformity and 
homogeneity are preserved while drastically improving normal tissue sparing. As a result 
ofreducing the number of photon MUs for delivery, the addition of EMET systematically 
leads to a reduction in whole body dose, especially when compared to IMRT. The 
application of EMET to other treatment sites is cUITently being investigated. 
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Chapter 6 
Construction and Validation of an Automated Few Leaf 
Electron Collimator 
Subsequent to the verified clinical significance of the Monte Carlo-based inverse 
planning for energy modulated electron therapy (EMET), we proceeded with constructing 
the collimation device in order to provide a full solution that integrates treatment 
planning with delivery. In this chapter we present a paper submitted to Medical Physics 
which explains the details of the hardware and software structure of the proposed 
automated few leaf electron collimator (FLEC). It also shows the comprehensive sets of 
measurements that were used to validate the Monte Carlo ca1culations. Compared to 
previous methods of electron beam collimation, this represents the first automated 
delivery unit that is incorporated with a flexible optimization algorithm. 
Title: Construction and dosimetry of a new automated collimator for delivery of Monte 
Carlo-based energy-intensity modulated electron therapy. 
Authors: Khalid Al-Yahya, Frank Verhaegen, and Jan Seuntjens 
Submitted: Il November 2005 
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Abstract 
Energy modulated electron therapy (EMET) with conventional clinical 
accelerators is lagging behind photon intensity modulated therapy (IMR T). Despite the 
capability of EMET to achieve highly conformaI dose distributions in superficial targets, 
it has not been widely implemented due to problems inherent to electron beam 
radiotherapy such as planning dosimetry accuracy and verification as weIl as a lack of 
systems for automated delivery. In previous work, we proposed a novel technique to 
deliver EMET using an automated "few leaf electron collimator" (FLEC) that consists of 
four motor-driven leaves fit in a standard clinical electron beam applicator. Integrated 
with a Monte Carlo-based optimization algorithm fed with patient-specific dose kemels, a 
treatment delivery was incorporated within the linear accelerator operation. Based on 
Monte Carlo simulations, the FLEC was envisioned to work as an accessory tool added to 
the clinical accelerator. In this paper, we present the design and construction of the FLEC 
prototype that match our compact design goals. It is controlled using an in-house 
developed EMET controller. The structure of the software and the hardware 
characteristics of the EMET controller are demonstrated. Using a parallei plate ionization 
chamber, output measurements were obtained to validate the Monte Carlo calculations 
for a range of fields with different energies and sizes. Further verifications were also 
performed for comparing I-D and 2-D dose distributions using energy independent 
radiochromic films. Comparisons between Monte Carlo calculations and measurements 
of complex intensity map deliveries show an overall agreement to within ± 3%. 
6.1 Introduction 
Energy modulated electron therapy (EMET) is a promising treatment modality 
that offers the fundamental capability to achieve highly conformaI electron dose 
distributions tailored to superficial targets [1]. However, due to the absence of an 
automated collimation system that allows electron beam modulation and due to the lack 
of dosimetric accuracy of clinical electron pencil beam algorithms in the presence of 
beam modifiers, the EMET has lagged behind photon IMRT. 
Considerable efforts were made to investigate the potential of delivering the 
EMET using bolus electron conformaI therapy [2-5]. However, using custom-made bolus 
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remams time consummg and expenSlVe especially there is a need to restore dose 
homogeneity in the target using further beam modulations [5]. An attractive alternative 
approach was to use a separate add-on electron collimator that could offer a simple 
upgradeable solution to complement the existing radiation technology. Different designs 
of electron multileaf collimators (eMLC) that are attachable to radiotherapy accelerators 
were introduced to demonstrate potential capabilities of delivering EMET [6-9]. 
Nevertheless, the weight of a bulky eMLC raised concerns not only in terms of lack of 
practicality of installing and removing such a heavy device, but also in terms of its use 
with gantry angles that might cause sagging of the eMLC and even of the gantry [9]. 
Moreover, the automation of eMLC has so far not adequately been addressed. 
We have recently studied the feasibility of an automated "few-Ieaf electron 
collimator" (FLEC) for delivering the EMET using a sequence of rectangular fieldlets 
[10]. The FLEC is essentially composed of two pairs of trimmer bars that allow electron 
shaping using a combination of arbitrary rectangles. In our study, the FLEC was 
envisioned ta serve as an add-on accessory too1. The collimation of the FLEC is backed 
up by the photon jaws and a sequence of apertures can form a series of fieldlets to 
compose a desired irregular electron field. 
The delivery of complex electron fields is performed in a step-and-shoot 
approach. In addition to its compactness, the foremost characteristic of the prototype 
FLEC lies in its capability to deliver a full EMET plan in an automated fashion. The 
feasibility of this approach was supported by a Monte Carlo dose calculation engine and 
an inverse planning system was developed for this purpose. Patient-specific dose 
deposition kemels extracted from Monte Carlo calculations were fed into an in-house 
optimization algorithm that was used to select fieldlet energies and their associated 
intensities corresponding to the optimal plan [10]. 
In another study, we have shown that EMET delivered with FLEC in the context 
of mixed beam treatment planning could be a valuable addition to the currently available 
treatment techniques especially when applied to superficial tumors that are inherently 
difficult to plan using the IMRT [11]. Compared to the IMRT, the EMET preserves target 
conformity and homogeneity while significantly improving normal tissue sparing. Also, 
as a result of reducing the number of photon beam monitor units (MUs) for complete 
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dose delivery, the addition of the EMET systematically leads to a reduction in the whole 
body dose equivalent [11]. 
The photon jaw position affects the output of electron beams much more than it 
affects the photon beam output [12-14]. The dose delivered by electron beams, unlike 
with photon beams, cannot be divided into primary and secondary components. Rather, it 
is mainly due to the multiple scattered electrons that show their highest contribution at 
the depth of maximum dose (zmax). This creates a critical dependence on the photon jaw 
collimation and, thus, emphasizes the need for accurate characterization of the 
energy/shape-dependent fieldlets. Although Monte Carlo techniques were previously 
proven to predict successfully the beam output in conventional electron beams [15-18], 
there has been no quantitative study to investigate the accuracy of Monte Carlo 
simulations in the setups that involve back-up photon jaw collimation. Therefore, further 
validation studies were required to evaluate the accuracy of the Monte Carlo model of the 
FLEC system for measurements of output, central axis dose distributions, and off-axis 
dose profiles as weIl as for measurements in regions where the presence of leakage dose 
is suspected. For modulated electron beams, the spatial validation can be achieved with 
the use of radiochromic films with their favorable energy independence characteristics 
[19]. 
In this study we present design, construction and validation of the novel 
automated FLEC. We also demonstrate the structure of a control unit that was built and 
integrated to deliver EMET plans. The accuracy of the calculated electron beam output 
factors has been tested against measurements performed with parallel plate ionization 
chamber for a range of fieldlets. AIso, we have validated the Monte Carlo-calculated 1-D 
and 2-D dose distributions of energy modulated electron beams by comparing the 
distributions with results of film measurements using energy-independent HS 
GafChromic film. 
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6.2 Materials and Methods 
6.2.1 Construction and automation of the few leaf electron collimator (FLEC) 
6.2.1.a Design considerations 
The design and materials of the FLEC prototype were guided by a series of Monte 
Carlo studies to optimize materiallthickness/width of the FLEC and to achieve the 
optimal photon jaw opening associated with each desired FLEC opening (fieldlet). An 
optimal photon jaw opening is needed to preserve typical c1inical electron beam 
characteristics with a narrow penumbra region and a minimized peripheral leakage dose 
from in-air scattering through peripheral field areas that are not covered by the FLEC 
leaves. To simplify the characterization of the square fieldlets, each fieldlet is designated 
by three parameters: the electron beam nominal energy (in MeV), photon jaw opening 
(represented by a number following 1), and the FLEC opening collimator (represented by 
a number following C). For example, "1818C7" represents a fieldlet with an energy of 18 
MeV, jaw opening of 8x8 cm2, and collimator opening of 7x7 cm2• This notation applies 
for square fieldlets only. For the rectangular fieldlets, the exact opening for the four jaws 
and four FLEC collimators are required. 
The collimator thickness ideally should be sufficient to stop the direct passage of 
aIl electrons as weIl as the produced bremsstrahlung photons of the highest energy used 
in the EMET optimization procedure, e.g., 18 MeV. Different material types were 
investigated, inc1uding tungsten, lead, and copper. A copper leaf, with a thickness of 1.2 
cm, offers a good compromise among the three materials, since it is suitable to attenuate 
high energy electrons and also has a relatively lower yield of bremsstrahlung photons. 
Since we are striving to develop a light-weight collimation device and for reasons of cost 
and machinability, copper was selected as the leafmaterial for our prototype FLEC. 
In the initial prototype, a leaf width of 3 cm was chosen to limit the effect of the 
lateral electron leakage. Despite the use of the photon jaws as backup collimation, the 
increased multiple Coulomb scattering exhibited by lower-energy electrons could lead to 
an unacceptable lateral electron leakage for the lowest energy (9 MeV) through are as that 
are not covered by the FLEC. Further studies were performed to minimize the lateral 
leakage by optimizing the margin of jaws openings (the shi el ding margin). Monte Carlo-
calculated profiles for 18 MeV and 9 MeV electron beams were obtained for a fixed 
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FLEC opening projecting to a 6x6 cm2 field while varying the shielding margin by 
modifying the jaw settings to have openings of 6x6 cm2, 7x7 cm2, and 8x8 cm2 . This is 
represented in our notation convention as (1 816C6, 18J7C6, and 1818C6) for the 18 MeV 
field1ets and as (9J6C6, 9J7C6, and 918C6) for the 9 MeV fieldlets. 
The dosimetric characteristics of a fieldlet can be optimized by maximizing the 
output, minimizing the width of the dose penumbra and reducing the percentage dose 
beyond the outer edge of the leaf. Maximizing the output is favored in order to increase 
the efficiency of the fieldlet delivery. 
The dose penumbra 90/10 was quantified by the lateral distance between 90% and 
10% points along the in-plane profile and the peripheral leakage was represented by the 
point of maximum leakage along the major axes (maximum X-Leakage for cross-plane 
axis and maximum Y-leakage for in-plane axis). These parameters were obtained from 
profiles calculated in Solid Water® at a depth of 2.8 cm for the 18 MeV fieldlets and at a 
depth of 1.5 cm for the 9 Me V fieldlets. The calculated profiles were subsequently 
verified by comparing them with measured profiles obtained by irradiating radiochromic 
HS films under the same conditions and following the protocol described below. 
6.2.1.b FLEe electronics 
The primary difference between the FLEC and previously reported means of 
electron collimation for delivering EMET is that we have opted to have a design that is 
completely automated without compromising compactness and practicality. To serve this 
purpose, each leaf is connected to a miniature stepper motor, micro-limit switch and 
micro-encoder taking into account the proximity of delicate electrical connections. A 
two-phase stepper motor with a 4-wire configuration (ARSAPE, Switzerland) was chosen 
to drive each leaf. lts miniature physical dimensions (a weight of 3.3 g and a front shaft 
length of 1.4 cm) combined with its powerful torque of 1 mN·m that is adequate to lift the 
copper leaf against gravit y were the two main characteristics that dictated our choice. 
Optimal control of the FLEC requires the leaf positions to be independently verifiable. 
Hence, micro-encoders were incorporated to provide a feedback about the leaf 
movements in a "c1osed-Ioop" application. Switches were also added to simplify the 
automation procedure and to report further information of any electronic/mechanical 
failures. AlI the wires emerging from the FLEC were incorporated into two connectors 
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Figure 6-1: (a) Flow chart of the software structure of the EMET controller, 
(b)Schematic diagram of the integrated EMET hardware that communicates with the 
Monte Carlo-based optimization station, the FLEe, and the linear accelerator, 
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that communicate with an external controller using twisted pair cables. These cables were 
shielded for reduced noise susceptibility and enhanced signal integrity to avoid lost 
counts or reduced accuracy due to erroneous operations. 
6.2.1.c EMET controller 
The EMET controller is a delivery unit that was programmed to communicate 
with the optimization station and was locally assembled to accomplish the task of 
comprehensive delivery automation. It is a portable computer system accompanied with 
customized software to acquire the plan details from the optimization station and deliver 
the beam configuration of the optimal plan to the FLEC and the linac console. 
EMET controller software 
Figure 6-1(a) shows a flow chart of the structure of the EMET controller software 
that is programmed in C++ and operates in Windows® environment. At the end of the 
planning optimization process, a file is produced containing the prescribed fieldlets along 
with their associated energies and intensities (in terms of MUs). Four parameters are 
required for each prescribed fieldlet: (1) the positions of the FLEC leaves, (2) the photon 
jaw settings, (3) the beam nominal energy, and (4) the MU settings. The EMET controller 
software manages the translations of the text file containing the fieldlet prescriptions into 
binary commands that are sent to the FLEC as weIl as to the accelerator. A full treatment 
system has been integrated and a delivery can be performed entirely in a remotely 
controlled fashion. This includes initialization of the devices, sending binary signaIs to 
both the accelerator and the FLEC, reading the feedback of the positions of leaves/jaws, 
setting up the energies and MUs, and, finally, detecting the errors and limitations. The 
software was written to communicate with V ARIAN accelerators operated in Service 
Mode. 
EMET controller hardware 
In terms of hardware, the EMET controller consists ofthree components (1) a PIn 
CPU equipped with a PCI -7334 board (National Instruments, Austin, TX), RS-232 port, 
and a Microsoft Visual Basic package; (2) MID-7604 Integrated axis stepper drive with 
power amplifier (National Instruments, Austin, TX); and (3) KVM switch (short for 
Keyboard, Video monitor, and Mouse). Built and assembled in-house, the EMET 
controller serves as a complete power supply and system interface that simultaneously 
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controls the stepper motors, analyzes the feedback from the encoders, detects the signaIs 
from switches, and, also offers a full control over the linac options. 
The communication between the EMET Controller and the FLEC is carried 
through the shielded cables that are attached to the connectors, as previously described. 
On the other hand, the communication with the linac console is mediated through a KVM 
switch that is connected to the EMET controller through an RS-232 port from one end 
and to the console' s keyboard from the other end. The use of the KVM switch allows a 
simplified "external" access for controlling the linac by emulating keyboard strokes, thus 
avoiding any modifications in the accelerator controller. Combining the portability of the 
EMET controller with the compactness of the FLEC adds to the efficiency of the system 
and enables the use of the FLEC with any available c1inical accelerator. 
6.2.2 Monte Carlo simulations 
In an our Monte Carlo studies presented in this paper, the electron beams were 
modeled using the BEAMnrc [20,21] accelerator mode1 to calculate phase space files for 
each fieldlet. The phase space files were used as source inputs that were transported 
through a simulated solid water phantom, with a voxe1 size dimension of 0.2 cm, using 
the XVMC [22] fast Monte Carlo code. The geometry of the FLEC was fully simulated 
and incorporated in our previously validated Monte Carlo model of McGill Varian 
CL2300 [10]. The BEAMnrc simulation parameters were set to ECUT=0.700 MeV, 
AE=0.521 MeV, PCUT=0.010 MeV and PRESTA II electron step algorithm. The 
number of initial histories ranged from 120x 106 for 9 MeV electron beams to 80x 106 for 
18 MeV electron beams. The number of histories was chosen to ensure a statistical 
uncertainty (la) of 0.5% or less in the absorbed dose calcu1ations surrounding regions 
with more than 80% of the maximum dose. 
6.2.3 Ionization cham ber measurements of output factors 
Output factors for the electron fieldlets formed by the FLEC are defined in this 
work as follows: 
OF = Dmax (E,fieldlet) 
Dmax (EJ9C8) , (6-1) 
which represents the ratio of the absorbed dose to water at the depth of maximum dose 
for a square fieldlet with a certain energy E to the absorbed dose to water at the depth of 
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maximum dose of the maximum opened fieldlet (J9C8) of the same energy at source-
surface distance (SSD)= 1 00 cm. The measured and calculated output factors were 
normalized to the output of the 19C8 fieldlet in order to be consistent within the same 
applicator/FLEC settings. Normalization in this fashion, in contrast to normalization to 
the standard 1 Ox 10 cm2 field configuration without the FLEC, avoids manual 
replacement of the applicator which causes unnecessary delays and limits the automation 
of the QA procedure. However, this procedure does require establishment of reference 
dosimetry at the depth of maximum dose in the 19C8 fieldlet and therefore requires an 
adaptation of the TG-51 protocol [23] factors to this irradiation geometry. 
Using the PPC-40 plane-parallel ionization chamber, measurements of output 
factors were performed at 9, 12, 15, and 18 MeV for various fieldlets. The PPC-40 
chamber was cross-calibrated to the Exradin A12 Farmer chamber (Standard Imaging, 
Middleton) following the procedures described in the TG-51 protocol. After obtaining the 
parameter kecaIN~o~o valid for the TG-51 reference depth, the PPC-40 was positioned with 
its effective point of measurement at Zmax in a water phantom of 50x50x40 cm3 for each 
fieldlet. This depth was determined by measuring percentage depth doses (PDDs) using 
the same chamber after correcting for Monte Carlo calculated stopping power ratios 
water-to-air. At the reference depth corrected charge for influence quantities was 
determined. Thus, Dmax (EJ9C8) is obtained as: 
D (EJ9C8)=Mk'k N"J(~ rLe, Yw""pfl)",e! 
max R50 ecal D,w (( ]Waler J (p p) , L wall fi 1 Ox 10 
P . 
Qlr IOxlO 
(6-2) 
where Mis the collected charge at Zmax corrected for influence quantities, polarity, and 
60 e ion recombination. The parameter kecalN D W 0 is determined from the cross calibration and 
k~ is obtained from the TG-51 formula for the Roos ionization chamber. It is reasonable 
50 
to assume that the ratios of P correction factors can be neglected. The depth-dependent 
stopping power ratios, water to air, were obtained from Monte Carlo calculation using the 
EGSnrc/SPRZnrc code. The stopping power ratio was calculated for each fieldlet at the 
Zmax and the correction was applied to determine the output as shown above. 
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6.2.4 Film measurements 
6.2.4.a Film analysis 
Construction and automation ofthe FLEC 
Calibration and dose measurement of HS films were performed following the 
protocol proposed by Devic et al. [24]. Multiple film pieces were exposed to a range of 
electron beam dose irradiations. A calibration curve, fitted with a 6th order polynomial, 
was determined in order to convert optical density change to dose. This calibration curve 
was examined for multiple electron energies so as to confirm its energy independence. 
The film sheets were consistently placed at the same position in the center of an Agfa 
Arcus II desktop flat-bed document scanner and were scanned using the AGF A FotoLook 
3.5 software with a scanning resolution of 0.2 mm/pixel in the 48-bit RGB transparent 
mode. The scanned images were transferred into an in-hou se developed MA TLAB 
routine (Version 6.5.0 The Math Works, Natick, MA), where they were processed to 
ob tain net optical densities of the exposed films and from there the corresponding dose 
values. The response of the scanner was analyzed to eliminate faulty pixels and to correct 
the readings of the pixels that are dependent on both the position and the optical intensity. 
It has been reported that applying this protocol for HS GafChromic® films results in an 
improved dose uncertainty ranging from 3% for doses above 5 Gy to 2% for doses above 
10 Gy [24]. 
6.2.4.b I-D measurements 
HS GafChromic film was used for companson between calculation and 
measurements of central axis depth doses and profiles. Radiochromic films have been 
shown to be nearly energy independent [19], hence, they can be used for PDD 
measurements with the electron beam axis parallel to the film. Reporting the dose in 
absolute terms, using radiochromic films for central axis depth dose and profile 
measurements served also as a verification of output measurement to confirm our 
previously described reference dose measurements. In addition, the HS films show 
relative output differences for different beam energies with the same FLEC settings. The 
drawback of using films to measure PDDs, however, is the film's inaccurate dose 
measurement in regions at depths less than 1 cm, as discussed by Shiu et al. [25] and 
partly attributed to edge effects of radiochromic films [24,26]. 
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PDD curves were measured at 100 cm SSD for four fieldlets: J9C8, J7C6, J5C4, 
and BC2 for energies of 9, 12, 15, and 18 MeV. A sheet of HS film with dimensions of 
2.5x 12 cm2 was inserted between two slabs of Solid Water® with dimensions of 
(30x30x 1 0 cm3). A special device was constructed to press the slabs together to 
minimize airgaps. The linac output was measured before and after the irradiation using a 
cylindrical ionization chamber to determine the dose delivered to the film. To obtain the 
absorbed dose, the Monte Carlo calculated dose, which is reported in terms of dose per 
partic1e, is converted to dose in Gy/MU by assigning the dose/MU measured by the 
ionization chamber for the J9C8 fieldlet to the calculation dose under the same settings. 
This normalization procedure is applied only once per energy and aIl the subsequent 
calculations for the other fieldlets are reported with respect to this calibration. 
6.2.4.c 2-D measurements 
2-D isodose curve distributions were measured by HS films for various fieldlets 
as weIl as for an intensity map based on the sum of these fieldlets at different depths. 
Standard HS film sheets (12.7 xI2.7 cm2) were irradiated with 2000 MUs after being 
sandwiched between layers of Solid Water® at a depth of 2.8 cm for fieldlets 12J9C8 and 
9J5C4. To examine the behavior of the off-axis fieldlets, two additional sheets were 
irradiated at the same depth under fieldlets having energies of 15 MeV and 18 MeV with 
asymmetric jaws/FLEC configurations that partially blocked the electron beams. 
Following the irradiation of these individu al field1ets, two sheets, placed at depths 
of 3 cm and 5 cm, were exposed to a combination of the four fieldlets with a prescription 
of750 MUs given to each ofthem. The 2-D isodose lines were obtained and compared to 
the calculation. 
6.3 Results 
6.3.1. FLEe prototype 
Based on the results of the Monte Carlo simulations, a prototype of the FLEC was 
designed and machined using CAD technology. The FLEC is comprised of two 
perpendicular sets of 2 leaves where each copper leaf has a thickness of 1.2 cm and a 
width of 3.0 cm. Figure 6-2 shows the computer design of the FLEC. It consists, in 
verification of the position of the leaves independently from the motor driving software. 
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Figure 6-2: Design drawing showing a side view of the FLEe prototype. 
Each leaf moves on a linear baU-bearing in order to minimize friction. With aU these 
considerations, the FLEe maximum fieldlet opening is 8x8 cm2 . Using the same 
electronic parts, a field size of 13 x 13 cm2 is achievable with a FLEe designed to fit in a 
20x 20 cm2 applicator and a field size of 18 x 18 cm2 is also feasible with the FLEe 
mounted in the 25 x 25 cm2 applicator. 
Figure 6-3 shows the compact prototype of the FLEe compatible with Varian's 
clinical 15 x 15 cm2 electron applicator. The downstream edge of the lower part of the 
FLEe is 5 cm above the isocenter. Although in the CUITent prototype the leaf ends have 
straight edges, the FLEe design allows replacement of these leaves by leaves with 
rounded ends but this is a topic requiring further investigations. The manufacturing 
foUowed a design where aU the parts could be replaced easily in case of mechanical 
and/or electrical failure. The total FLEe weight is less than 2.5 kg. 
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Figure 6-3: The FLEC prototype, including the necessary wiring, shows ils compact 
design to fit in a clinical applicator. 
Powered and controlled through two extemal connectors, the FLEC was 
automated and the controlling software was integrated in the EMET controller runnmg 
under Windows®. 
6.3.2 Leaf and backup jaw optimization 
Figure 6-4(a) shows measured and calculated off-axis dose distributions of 18 
MeV electron beams for multiple settings of jaw collimation, while maintaining the 
opening of the FLEC to project a field of 6x6 cm2 at SSD= 1 00 cm. Both the profile shape 
and output change by varying the shielding margin. When normalized to the maximum 
dose (Fig. 6-4(b)) at the centre of the profile, the dependence of the relative fall-off in the 
penumbra region on the jaw settings becomes clear. Figure 6-4(b) also shows the 
shielding margin effects on the relative peripheral leakage dose in the are as not covered 
by the leaves. At lower energies, the output dependence on the jaw settings is more 
pronounced and the leakage dose effects are magnified due to the in-air increased 
multiple Coulomb scattering. As shown in Figures 6-5(a) and (b), measurements and 
calculations for 9 Me V verify the manifestation of the leakage dose with the use of lower 
energles. 
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Figure 6-4: (a) Calculated (symbols) and measured (fulllines) offaxis profiles for three 
18 MeV fieldlets with a fixed FLEC opening (at C6) and varying jaw openings (J8(O), 
J7( Ji..), and J6(.)) based on a delivery of 1500 MUs. (b) The calculated normalized 
profiles of the three fieldlets . 
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Figure 6-5: (a) Calculated (symbols) and measured (full lines) off-axis profiles for three 
9 MeV fieldlets with a fixed FLEC opening (at C6) and varying jaw openings (J8(O), 
J7( Jt..), and J6(_)) based on a delivery of 1500 MUs. (b) The calculated normalized 
profiles of the three fieldlets . 
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Three parameters (namely: the Dose penumbra 90/10, maximum Y-Leakage, and 
output factor) that quantify the relative differences between different jaw settings were 
used to evaluate the dosimetric characteristics of the fieldlets. Table 6-l(a) shows the 
effect of the shielding margin on these characteristics. The fieldlets that have jaw settings 
that project a shielding margin of 2 cm (18J8C6 and 9J8C6) provide the highest output 
and lowest penumbra but they also provide the highest undesirable maximum Y-Leakage. 
ln contrast, jaw openings that have no margin (18J6C6 and 9J6C6) show the lowest 
leakage but the output and the penumbra width are deteriorated for both 18 MeV and 9 
MeV. 
Jaw opemngs that project to the same opemng of the FLEC with an added 
projected margin of 1 cm (18J7C6 and 9J7C6) showed to be the configuration that 
optimizes the dosimetric quality of the fieldlet. The profiles that are measured along the 
in-plane axis (denoted as Y-axis) would follow the projection of the upper jaws and, 
therefore, would cause more significant leakage dose than the profiles measured along 
the cross-plane axis (denoted as X-axis) under the lower jaws that are closer to SSD=100 
cm. Thus, the profiles shown in Figures 6-4 and 6-5 and their consecutive parameters 
represent the extreme case while the profiles that are calculated along the cross-plane 
would exhibit a reduced leakage dose. 
Table 6-1 (b) shows the Dose penumbra 90/10, maximum Y-leakage, and 
maximum X-Ieakage for different fieldlets following the optimum configuration of jaw 
settings. Although the leakage dose should be minimized to improve the efficacy of the 
inverse planning optimization procedure, our Monte Carlo-based optimization algorithm 
takes the "actual" leakage dose into account during optimization and in the final dose 
distribution. The optimizer has the complete dose information that allows it to evaluate 
the role of the leakage doses in the objective function. Based on their contribution (or 
their violation) to the optimal plan, the fieldlets that exhibit high leakage dose are 
accepted for modulation (or rejected). 
6.3.3 Comparison of calculated and measured dose from FLEC-defined fields 
6.3.3.a Output measurements at the reference point 
A comparison between measured and calculated output factors for a selection of 
square fieldlets is shown in Table 6-2 for 9-18 MeV electron beams. The output was 
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(a) 
Fieldlet Dose penumbra Y-Leakage Output 90/10 (mm) Peak(%) 
18J8 C6 13.5 6.6 0.987 
18]7 C6 15 3.6 0.964 
18J6 C6 17.5 2.4 0.925 
9J8 C6 18 11.4 0.94 
9]7 C6 20 8.0 0.837 
9J6 C6 22 5.8 0.741 
(b) 
Fieldlet Dose penumbra Y-Leakage X-Leakage 90/10 (mm) Peak(%) Peak (%) 
18J9 C8 16 2.1 1.4 
18]7 C6 15 3.6 1.9 
1SJ5 C4 14.5 2.9 1.8 
1SJ3 C2 10 2.5 1.3 
9J9 CS 21.5 3.1 2.2 
9J7 C6 20 8.0 3.4 
9J5 C4 15.5 8.5 3.6 
9J3C2 11 8.6 3.7 
Table 6-1: (a) Numeratedfactors obtainedfrom the ojJ-axis profiles of9 and 18 MeV of 
difJerent jaw openings corresponding to a certain FLEC opening (C6). (b) Dose 
penumbra 90/10, Y-Leakage Peak, and X-Leakage Peak for difJerent fieldlets following 
the optimum jaw opening. 
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Nominal Fieldlet Measured Calculated % diff Energy Zmax Output Output 
9 MeV 9J9C8 2.2 1.000 1.000 
9J7C6 2.2 0.835 0.837 0.3 
9J5C4 2.2 0.541 0.535 0.9 
9J3 C2 1.3 0.221 0.224 -1.1 
12 MeV 12 J9 C8 2.8 1.000 1.000 
12 J7 C6 2.7 0.906 0.900 0.6 
12 J5 C4 1.9 0.717 0.696 2.9 
12 J3 C2 1.3 0.356 0.363 -1.9 
15 MeV 15 J9 C8 3.2 1.000 1.000 
15 J7 C6 2.2 0.972 0.950 2.2 
15 J5 C4 1.7 0.829 0.799 3.6 
15 J3 C2 1.3 0.469 0.476 -1.4 
18 MeV 18 J9 C8 2.8 1.000 1.000 
18 J7 C6 2.8 0.973 0.964 0.9 
18 J5 C4 2.1 0.878 0.855 2.5 
18 J3 C2 1.5 0.558 0.572 -2.4 
Table 6-2: Measured and calculated output factors for the 9, 12, 15, and 18 MeV 
electron beams for difJerent fieldlets. Measurements were performed with a PPC40 
paraUel plate cham ber in water and the localization of Zmax was determined from 
ionization measurements about Zmax. The output for each energy is normalized to the 
measured dose at the largestfieldlet (J9 C8). 
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Figure 6-6: Calculated (symbols) and measured (full fines) output factors for the 9, 12, 
15, and 18 Me V electron beams for difJerent fieldlet sizes. The output for each energy is 
normalized to the measured dose at the largest fieldlet (J9 C8). 
measured at Zmax and normalized to the open fieldlet formed by the FLEC (J9C8). 
Similarly, the calculated value at the corresponding depth, which is reported in dose per 
partic1e, was also normalized to the dose per particle value calculated for J9C8. For 
consistency, the measured Zmax was chosen as the reference in case of differences 
occurring in defining Zmax between measurements and calculations (the position of Zmax 
agreed within ±2 mm). As shown in Table 6-2, the predicted Monte Carlo output is 
generaUy in good agreement with measurements with only one case showing a difference 
that exceeds 3%. We have no explanation for the latter disagreement. 
For aU energies, the measured output is higher than the calculation except at the 
lowest opening with a (BC2) configuration where the measured output becomes lower. 
This could be attributed to the contribution of backscattered electrons from the jaws into 
the monitor ionization chamber, hence reducing the measured dose as demonstrated in a 
study by Verhaegen et al. [27]. 
Figure 6-6 shows the measured and the calculated output and their dependence on 
both energy and field size. Although, the output demonstrates a similar sharp faU-off with 
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decreasing field size for aIl energies, the field size dependence for lower energies is more 
significant. 
6.3.3.b Central axis depth dose 
Figure 6-7(a) shows measured and calculated depth dose distributions in Solid 
Water® for 18 MeV electron beams for fieldlets 18J9C8, 18J5C4, and 18J3C2. The 
calculated depth dose was normalized to the integrated dose under the curves in the 
region between 0.5 cm and the depth corresponding to 80% of the maximum dose. This 
procedure was necessary to avoid the propagation of statistical uncertainties that could 
result from normalizing to a Monte Carlo point dose calculation. Figure 6-7(b) shows the 
difference between calculation and measurement in terms of percentage dose for the three 
fieldlets. GeneraIly, a good agreement is found with a maximum deviation of less than 
3%. Most of the significant deviations appear at depths associated with the 
bremsstrahlung tail where the Monte Carlo statistical uncertainty is usually higher (up to 
1.5%, one sigma). The difference between the measured and calculated depth doses in 
the high dose gradient region was within 1.5 mm. 
Expressed in absolute dose, the comparison of measurement vs. calculation in 
central axis dose distribution is shown in Fig. 6-8 for 18 MeV and 9 MeV for the fieldlets 
J9C8, J7C6, and J5C4. Calculation and measurements agree weIl for both the output 
factors and the depth dose behavior. For the six fieldlets shown, the discrepancy in output 
is weIl within 1 % around Zmax and the differences for other depths are never worse than 1 
mm except for the lower part of the 18J5C4 fie1dlet where the difference was within 2 
mm. The calculation was corraborated by the consistency of the output factor 
measurements obtained by both film and ionization chamber. 
Figure 6-9 shows the validation of the normalized Monte Carlo calculated PDDs 
when compared to film measurements for two fieldlets (J9C8 and J5C4) for the energies 
9, 12, 15, and 18 MeV. R90, Rso, Rso, and Zmax were predicted weIl by the calculation. 
Figure 6-9 also shows the ability of the calculation to account for the effect of the field 
size on the PDD behavior that appears most c1early with the highest energy. The 
differences vanish for the lowest energy. 
The good agreement between Monte Carlo calculations and measurements that 
was shown for multiple profiles in the previous section is considered as another form of 
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the 1-D validation where it proved the ability of the model to predict precisely the shape 
of the measured profile distribution including the leakage effect. 
6.3.3.c 2-D dose distributions 
Figures 6-1O( a) and 6-1O(b) compare the resulting calculated and film-measured 
dose distributions for the fieldlets 9J7C6 and 12J9C8 based on an irradiation with 2000 
MUs. With a same amount of delivered MUs, the comparison of dose distributions of 
partially blocked fields for 15 MeV and 18 MeV are shown in Figures 6-10(c) and 6-
1 O( d). The summation of four fieldlets of different energies and with different jaws/FLEC 
configurations produces dose distributions that are shown in Figures 6-1O(e) and 6-10(f) 
at depths of 3 cm and 5 cm, respectively. The isodose lines obtained from Monte Carlo 
calculations and measurements, reported in absorbed dose in Gy, are in excellent 
agreement. The similarity in the intensity maps includes the effect of the beam output, the 
isodose lines representing the high dose region, and the low-isodose lines. The leakage 
dose is weIl predicted except at the edges of the film where artifacts are present. 
6.4 Conclusions and Future Work 
The results of this work confirm our design objectives and support the potential of 
usmg the prototype FLEC for automated EMET. The FLEC was designed and 
constructed based on Monte Carlo simulations and was incorporated within the clinical 
accelerator operation so as to be easily controlled using the in-house developed EMET 
controller. 
Monte Carlo simulations, which represent the dose calculation engine for our 
proposed EMET, generally showed good agreement with measurements for different 
experimental setups including output factors, PDDs, off-axis profiles, and 2-D dose 
distributions. For aIl energies studied, the dosimetric properties observed with 
measurements for the electron beams collimated using the FLEC were weIl predicted by 
Monte Carlo simulations. 
With its current design, the FLEC is able to deliver treatment plans in step-and-
shoot for SSD settings. Based on a previous study, a full EMET delivery is feasible 
within a 15 minutes time slot [10]. Since the FLEC is automated, we plan to investigate 
its use in dynamic deliveries, such as arc therapy and also in an operation mode 
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Monte Carlo calculation (dotted fines) based on 2000 MUs irradiations at depth of 2_B cm for (a) 9 MeV 
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Absorbed dose distribution comparison at depths of 3 cm (e) and 5 cm (j) for an intensity map formed by 
sum of the above four fieldlets with 750 MUs given to each of them_ The Monte Carlo calculation 
accurately predicts the dose distribution of the mixed energy beam delivery at different depths. 
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synonymous to a dynamic wedge in photon beam therapy. This would require developing 
a new component module for BEAMnrc that efficiently simulates the movement with 
high accuracy in similar fashion to the dynamic wedge module [28] and the DYNMLC 
module [29] that was previously developed in our department. AIso, we plan to design a 
new retractable applicator that allows isocentric deliveries, including arc therapy. 
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Chapter 7 
Summary and Future Work 
7.1 Summary 
Energy modulated electron therapy (EMET) has been proposed to deliver highly 
conformaI treatments to superficial targets that are less suitable for conventional x-ray 
intensity modulated radiation therapy (lMRT). However, EMET has not yet been used to 
its full potential due to the absence of a practical automated collimating device that is 
able to provide a series of different field openings (beamlets) during the treatment and the 
difficulties arising from limited dosimetric accuracy when using pencil beam algorithms 
in conjunction with beam modifiers. The main objective of this work was to develop, 
implement, and validate a practical technique of delivering EMET. This technique (1) 
allows for flexible, Monte Carlo-based inverse planning of modulated electron treatment 
and (2) employs the use of a custom-made automated electron collimator as a delivery 
method. Designed and constructed in-house, the few leaf electron collimator (FLEC) 
serves as an accessory to the cUITent-day accelerator equipment. More importantly, the 
operation of the FLEC is comprehensively integrated into the planning process. The work 
in this thesis is summarized as follows. 
7.1.1 Construction and automation of the few leaf electron collimator (FLEC) 
Guided by a series of Monte Carlo studies, a prototype of the FLEC was designed 
and machined so that it is suitable to be attached to a clinical electron applicator. Figure 
7-1 shows the final computer design and the realization of the compact and light-
weighted FLEC. It fits in the electron applicator and is readily automated with controlling 
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Figure 7-1: The design of the FLEC prototype, including the necessary wiring, shows ils 
compact design to fit in a clinical applicator. 
software that has been developed to run in the Windows® environment. The controlling 
software has been customized to acquire plan details and deliver the beam configuration 
while monitoring the performance of the delivery. A portable control unit (shown in Fig. 
7-2) was assembled and integrated with the operation ofVARIAN accelerators. 
7.1.2 Monte Carlo dose calculation engine 
We implemented the EGSnrc/BEAM and XVMC Monte Carlo codes for radiation 
therapy dose calculations. The accelerator specifications were modeled for aIl energies, 
including the FLEC, according to the information supplied by the manufacturer/designer. 
The beam model is used to obtain phase space representations which are then transported 
through the patient model derived from the computed tomography (CT) images. 
7.1.3 Incorporating a Monte Carlo-based optimization algorithm 
The optimizer was developed to acquire Monte Carlo-calculated and patient-
specific dose kemels in order to provide an optimal plan that satisfies user-specified 
dose-volume constraints. In the optimization procedure, because of the nature of Monte 
Carlo, the effects of the tissue heterogeneities are included while also taking into account 
the leakage and the bremsstrahlung produced by the FLEe. The use of deliverable beam 
ports eliminates the need for leaf sequencing and any additional steps that require further 
optimizations. 
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Figure 7-2: The EMET controller is portable and can easily be linked to the FLEC and 
the linear accelerator through connectors. 
7.1.4 Integrated software for planning and delivery of EMET 
Figure 7-3 shows the overall structure of the EMET planning and delivery 
software. Many routines were introduced to efficiently interface the different components 
of the EMET procedure. The software involves the management of more than 20000 lines 
of programming. Its structure was outlined to proceed with developing a graphical user 
interface. 
7.1.5 Investigation of the clinical significance of EMET 
We investigated the application of EMET treatment planning and delivery using 
the FLEC in the context of mixed beam treatment planning with conventional radiation 
therapy and IMRT. When applied as a sole treatment modality, the use of modulated 
electron beams exhibits undesirable dose heterogeneity within the target. Therefore, the 
combination of EMET with conventional photon beams, used in 3-dimensional 
conformaI therapy (3D-CRT), is more of interest because it achieves better clinical 
outcome. Extensive comparisons between EMET and IMRT were provided to show the 
clinical advantages gained by the addition of EMET. The dosimetric evaluations showed 
that EMET preserves target conformity and dose homogeneity and improves sparing of 
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the normal tissues. It also significantly reduces the estimated whole body dose. We 
showed that EMET could be a valuable added modality to the CUITent treatment 
techniques especially wh en applied to superficially located tumors that are inherently 
difficult to plan using IMRT. 
7.1.6 Validation of Monte Carlo calculations 
The accuracy of the dose distributions obtained by our Monte Carlo system was 
verified. We started the validation by comparing the measured standard dosimetric data 
against the calculations of the simulated CL2300 CD linear accelerator for the electron 
energies 9, 12, 15, and 18 MeV. The confirmation of the accurate model was followed by 
a series of measurements to validate the FLEC configuration which involves the 
unconventional jaw collimation in the electron beam delivery. We compared the absorbed 
dose at a reference point by delivering different fieldlet distributions/energies to a 
standard phantom with the measured dose values obtained by an ionization chamber in 
the same geometry. Also, I-D and 2-D dose distributions obtained from calculation and 
measurements were compared using the energy-independent tissue-equivalent 
radiochromic films. Complex intensity maps delivered with different energies/intensities 
were also compared to the calculation where they showed excellent agreement. Using 
radiochromic films for the validation of 2-D dose distributions that were obtained from 
energy modulated electron beams has never been reported before. 
7.2 Future Work 
Further improvements and development are still required in order to enhance the 
functionality of the FLEC performance and to exp and its clinical applications. First, the 
use of EMET planning will have wider applications if it is integrated with Monte Carlo-
based IMR T planning. The practice of radiation therapy will experience a significant shift 
if both the photon beamlets and the electron fieldlets are modulated with the same level 
of accuracy in the calculation and flexibility in the delivery. Second, we propose 
introducing dynamic movement of the leaves while the beam is under operation. We 
believe that the dynamic delivery increases the delivery efficiency compared to the 
present use of the step-and-shoot approach. The dynamic delivery also has the potential 
to feather the dose distribution by avoiding junctioning of the fieldlets. Third, we propose 
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to construct a new FLEe-specifie applicator. Initially, the FLEe was developed to fit 
inside the clinical applicator provided by the manufacturer. This was necessary to show 
that the FLEe has the ability to complement the existing technology. However, we 
believe that another applicator will be more practical in order to avoid possible conflicts 
with the operation of the linear accelerator's electronics. The newly designed applicator 
can have more features that widen the area of application of the FLEe. For example, 
having a retractable applicator opens the possibility to use the FLEe for arc therapy and 
isocentric setups. Finally, technical modifications in the software structure and the 
management of the multiple routines are recommended. Moreover, the EMET planning 
will be facilitated with graphical user interface. 
It is hoped that the results of this thesis and the future work based on it will 
improve the treatment planning process and ultimately provide better tumor control and 
avoid complications that affect the quality of life of cancer patients. 
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Appendix A 
McGill Monte Carlo Treatment Planning (MMCTP) 
McGill Monte Carlo treatment planning (MMCTP) system is an in-house 
developed software environment that integrates the research-aimed Monte Carlo codes 
with current and new treatment modalities and deliveries. Until the year 2000, Monte 
Carlo code packages remained mainly for research and development and were 
disconnected from the treatment planning clinical applications. At Mcgill University, we 
initiated a long term project dedicated to merge the theoretical knowledge of Monte Carlo 
with the applications of treatment planning procedure in the clinical environment. 
MMCTP system started with the development of simple programs that interface different 
Monte Carlo packages with the commercial treatment planning systems. It evolved to 
become a full research environment that uses multi modality and multi instance imaging 
in order to provide analysis tools for patient specific treatment planning. 
This section discusses the clinical implementation of a Monte Carlo treatment 
planning system at McGill University. The steps involve determining the particle phase-
space of the radiation source, defining the patient geometry including the inhomogeneity 
data, ca1culating the dose distributions, and developing the tools that display/analyze 
these dose distributions. 
Modeling the beam 
The EGSnrc/BEAMnrc [1] code system is used to simulate alllinear accelerators 
that are available at our clinic. The code runs under the UNIX operating system and is 
designed to simulate the radiation beams for any radiation therapy source by defining its 
geometry through a series of individual component modules positioned perpendicularly 
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to the beam aXIS. The BEAM code produces data output in many forms for each 
simulation. The most useful output form, however, is the full phase space data that 
contains the energy, charge, position, direction, and the particles' history for aIl the 
particles in a certain scoring plane. 
AI-Yahya [2] modeled the x-ray beams of Varian CL-2300 including modeling 
the 52-leaf Multi-Leaf Collimator (MLC). Interface routines that extract the beam 
parameters Uaws, MLC, isocenter) from the CadPlan system and present them to the 
BEAM code were inroduced. Heath [3] developed an advanced component module that 
simulates the 120 leaves MLC in Varian CL-2100EX for both static and dynamic 
deliveries obtained from CORVUS IMRT treatment planning system. Dai [4] 
incorporated the simulation of the wedges for aIl x-ray beams. Electron beams were 
modeled for Varian CL-1800 by Doucet [5], Varian CL-2300 by Albaret [6], and Varian 
CL-2100 by Garry [7]. Albaret [6] developed a user code for transport of particles 
through irregularly shaped cutouts. AlI these models were extensively validated and their 
accuracies were verified to match the results of detailed measurements. 
Modeling the patient 
The phase space representations generated from the BEAM code are transported 
through the patient using the XVMC code [8]. The patient dose calculation is performed 
after converting the computed tomography (CT) images into mass densities to define the 
patient geometry. A C routine was written to combine the CT slices to create the density 
matrix required as an input for the XVMC code. Since the CT couch is not present at the 
time of the treatment, still incorporated in the CT data, it was necessary to remove the 
couch from the the CT images by setting CT numbers to air in the regions outside the 
body contour. The patient models consist of two-dimensional (2D) arrays of materials 
containing 128x 128 voxels in the xy plane and n slices (depending on the patient) in the z 
direction. All slices have thicknesses that vary between 0.2 - 0.5 cm. The voxel 
dimensions vary between 0.2 - 0.4 cm depending on the resolution of the CT images that 
differs according to the current and time that are applied during the CT acquisition. 
After reading the phase space file, the charged particles and the scattered radiation 
are traced through the patient geometry as defined by the patient-specific CT images, and 
finally produces a three dimensional dose distribution matrix. 
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N ormalization 
To generate a Monte Carlo ca1culated dose distribution for a conventional 
treatment plan, it is necessary to ensure that the same monitor units (MU) are applied to 
both conventional and Monte Carlo plans. The output data of a Monte Carlo simulation 
are reported as dose in each ca1culation voxel per particle incident from the source; 
however, measurements are reported in dose per MU. Calibration factors relating the 
Monte Carlo output to the dose per MU were established by performing Monte Carlo 
simulations under accelerator calibration conditions (1 Ox 10 cm2 , Zmax , SSD = 100 cm). lt 
is important to note that the Monte Carlo calibration factors are energy dependent, unlike 
the clinical calibration value in terms of the dose to tissue which is fixed to 1 cGy/MU 
regardless of the energy used. For example: in x-ray beams, as the energy of the incident 
electron increases, the bremsstrahlung yield in the target, due to the dependence of the 
radiative stopping power on the energy, increases as we11. Thus, the dose per incident 
particle reported by Monte Carlo is expected to have a higher value for an 18 MY beam 
in contrast to 6 MY beam. The linac, on the other hand, has been tuned to provide 1 
cGy/MU at the point of maximum tissue dose for both energies. For this reason, a routine 
was introduced to add dose distributions resulting from applying different beam energies 
by assigning appropriate weights to each one. This ensures that the ca1culated dose 
distributions are consistent with the clinical specifications. 
MMCTP environment 
MMCTP system, built by Alexander [9], was designed to be compatible with the 
file structure implemented in the clinical environment. It has the flexibility to import 
from broad base data sources such as RTOG, DICOM, and CadPlan CART formats. 
Using a graphical user interface (GUI) that runs on a simple workstation, the commands 
to perform Monte Carlo calculations are sent through a standard secure-she11 connection 
protocol to a computer cluster dedicated for lengthy computations. After the completion 
of the ca1culation, only the final dose distribution (in order of 3 Mbytes) is received at the 
local station where it is displayed on the GUI. The GUI was built using REAL Basic and 
it off ers a11 the tools required for treatment planning procedures including external beam 
editing, image visualization options, contour editing, and dose analysis tools. Figure A-1 
shows the MMCTP display with its various windows. 
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Figure A-l: The display of the main MMCTP window showing, in addition to the beam 
parameters list box, three canvas for axial, sagittal, and coronal views. 
MMCTP converts the imported files into a new file structure that uncouples the 
private data from the parameters that are sent to the remote dose ca1culation engines. This 
design enables the use of an off-site cluster with a minimum amount of data transferred 
while maintaining the anonymity of the patient information. Alexander [9] tested 
MMCTP for its consistency of dealing with different Monte Carlo packages and 
treatment planning systems. AlI the consistency features were verified including 
coordinate transformation, beam and patient orientations, and dose ca1culations. 
Conclusion 
An in-house developed Monte Carlo treatment planning system was implemented, 
teste d, and debugged. The development of this system involved programming different 
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routines in order to interface the different components to the existing treatment planning 
software. Figure A-2 shows a block diagram of the components of our system and 
summarizes the work that has been performed. The software is accessible from any 
computer regardless of its operating system. The MMCTP system enables us to proceed 
with detailed studies to evaluate the accuracy of the dose calculation algorithms 
implemented in CUITent treatment planning systems. 
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Abstract 
Energy modulated electron beam therapy with conventional clinical 
accelerators has lagged behind photon IMRT despite its potential to achieve 
highly confonnal dose distributions in superficial targets. One of the reasons 
for this is the absence of an automated collimating device that allows for 
the flexible delivery of a series of variable field openings. Electron-specific 
multileaf collimators attached to the bottom of the applicator require the use of 
a large number of motors and suffer from being reIatively bulky and impractical 
for head and neck sites. In this work, we investigate the treatment planning 
aspects of a proposed 'few-Ieaf' electron collimator (FLEC) that consists of 
four motor-driven trimmer bars at the end of the applicator. The device is 
designed to serve as an accessory to standard equipment and allows for the 
shaping of any irregular field by combination of rectangular fieldlets. Using 
a Monte Carlo model of the FLEC, dose distributions are optimized using a 
simulated annealing (SA) inverse planning algorithm based on a Iimited number 
of Monte Carlo pre-generated, realistic phantom-specific dose kemels and user-
specified dose-volume constraints. Using a phantom setup with an artificial 
target enclosed by organs at risk (OAR) as weil as using a realistic patient 
case, we demonstrate that highly confonnal distributions can be generated. 
Estimates of delivery times are made and show that a full treatment fraction 
can be kept to 15 min or less. 
(Some figures in this article are in colour only in the electronic version) 
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1. Introduction 
Energy modulated electron therapy (EMET) has the ability to provide conformaI dose 
distributions to superficial tumours for which it could compete with intensity modulated 
radiation therapy (lMRT). The high surface dose followed by a steep fall-off makes the 
electron beams weil suited for treating shallow targets. However, EMET has not yet been 
clinically used to its full potential, in contrast to photon IMRT. The main reasons for this 
lag in clinical implementation are: (1) the lack of dosimetric accuracy of electron pencil 
beam algorithms in the presence of heterogeneities and beam modifiers and (2) the absence 
of a practical automated collimation device that allows the delivery of a series of different 
field openings (fieJdlets) during one treatment. Although a high degree of accuracy of the 
dose calculation could be achieved if Monte Carlo techniques are used (Bielajew et al 1987, 
Kawrakow et al 1996, Ma et al 1997), the development of a beam shaping device that is able 
to preserve the electron beam characteristics and yet allow for flexible use of multiple fieldlets 
remains challenging. 
In recent years, significant efforts have addressed the feasibility, implementation and 
clinical utility of EMET which employs a thin-leaf multileaf collimator attached onto a frame 
at the bottom of an existing electron applicator (Lee et al 2000, Ma et al 2000, Lee et al200l, 
Ravindran et al 2002, Ma et al 2003, Hogstrom et al 2(04). To automate such a collimator 
in a clinical setting, this approach requires the presence of a large number of motors at the 
bottom of the electron applicator and suffers from being relatively bulky and impractical to 
handle. 
The use of inverse techniques for treatment planning of EMET is more complex than 
in photon beam IMRT since collimation has a profound effect on electron scattering and the 
dose gradients in a specific sub-field. In addition, accurate dose calculations in and near 
patient heterogeneities are essential for a successful application of EMET. Having detailed 
information about the effect of both the collimation devices and the complex patient geometry 
on the dose provided to the optimization algorithm would lead to a truly optimal treatment 
plan. Hence, the output and the dose distribution realized through the combination of multiple 
sub-fields require the electron transport to be faithfully modelled through the collimating 
system and inside the patient. Any optimization algorithm that does not make use of realistic 
dose deposition kemel data will inevitably produce segment weights that lead to suboptimal 
and/or undeliverable dose distributions. 
In this work, we introduce an approach to deliver EMET plans using a simplified model for 
an automated collimation device. This feasibility study is based on Monte Carlo calculations 
where the fundamentals of electron transport and scattering through collimating devices and 
in the heterogeneous patient are ail taken into account. 
2. Materials and method 
2.1. Design of few-leaf electron collimator 
To facilitate the formation of irregular electron fields and to allow the flexible combination 
of different energies and intensities, a few-Ieaf electron collimator (FLEC) is proposed as an 
add-on accessory that could fit on a light-weight frame at the bottom of an electron applicator. 
In its most basic appearance (as shown in figure 1), this collimator consists of four blades 
(or trimmer bars) driven by motors so as to form arbitrary square or rectangular fields with 
an area between zero and nominally 9 x 9 cm2 (for the 15 x 15 cm2 electron applicator) 
and between zero and 14 x 14 cm 2 (for the 20 x 20 cm2 electron applicator). Any irregular 
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Figure 1. (a) Position of few-leaf electron collimator (FLEC) relative to other components in the 
accelerator (not to scale). (b) Schematic drawing of beam's eye view of FLEe. 
irradiation field can be made up by a combination of rectangular and square fields which 
possibly could involve the use of collimator rotation in a more evolved stage, The function 
of the FLEC is an automated final re-collimation of e1ectron fields, previously collimated by 
jaws and/or the photon MLC that will be used as backup collimation devices. Hence, the 
blades, made of copper, can be relatively thin. In our study, their thickness was 1.5 cm and 
their width was 3 cm. To first order, the delivery of complex dynamic electron fields will be 
performed in a step-and-shoot approach, whereby every sub-field is formed by simultaneous 
collimation of the electron beam by the jaws and the FLEe. We verified the ability of our 
clinical accelerators to dynamically control jaws wh en run in electron mode. 
2.2. Monte Carlo calculations 
In this study, the BEAM/EGSnrc (Rogers et al 1995) Monte Carlo code was used to simulate 
a CL2300 CD linear accelerator for the electron energies 6, 9, 12, 15, 18 and 22 MeV as weil 
as for the photon energies of 6 and 18 MV. The transport parameters used in EGS accelerator 
simulations were ECUT = AE = 700 ke V cutoff for electron transport, PCUT = AP = 
10 keV for photon transport, and the electron step is 1 % (i.e. ESTEPE = 0.01). After 
validation of the simulated beams against standard dosimetric data that include the validation 
of the model in the presence of the beam modifiers, the Monte Carlo model was used to 
generate a master phase space file above the jaws for ail energies. The procedure for the 
selection and calculation of fieldlet arrangement is conducted as follows: 
(l) A user-specified number of fieldlets is geometrically selected and positioned to conform 
the shape of the projected target. The fieldlets are chosen such that they are matched at 
the edges of the projected 3D volume of the PTV. An algorithm for optimizing the best 
fieldlet configuration based on the 3D PTV contour is being developed. For the purpose 
of this feasibility study, the fieldlets were selected manually. 
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(2) Using the master phase space file, we proceeded with the simulation of the fieldlet-specific 
jaw openings as weil as with the lower part of the accelerator including the FLEe. For 
each fieldlet setting of FLEC, the secondary jaws are set so as to project an opening equal 
to the one projected by the FLEC plus a margin of 0.5 cm on ail sides. The phase space 
file of a fully simulated fieldlet, for ail energies, is scored at an SSD of 95 cm. 
(3) The final phase space file of the fieldlet is then transported through the patient geometry 
using the XVMC code (Fippel 1999, Kawrakow et al 2000). The patient is modelled 
by converting the CT data into a density matrix with a size of 128 x 128 x (number of 
slices) with the dimensions of the voxel size varying from 0.25 to 0.35 cm. 
(4) Once the dose distribution of each fieIdlet is generated, a Monte Carlo dose distribution 
given in absorbed dose to tissue per particIe is converted to absorbed dose to 
tissue per monitor unit. This is obtained using energy-dependent calibration factors 
obtained from simulations that are performed under accelerator calibration conditions 
(10 x 10 cm 2, dmaJ. The Monte Carlo calculated dose distribution provided by each 
fieldlet-after it is 'properly' normalized-represents the dose deposition kemel whose 
weight is modulated by the optimization algorithm. The number of simulated particIe 
histories was chosen to achieve a statistical uncertainty on the dose calculation of 1 % or 
less per fieldlet. 
2.3. Treatment plan optimization 
Figure 2 shows a schematic diagram of the inverse treatment planning system. The 
optimization is performed using the simulated annealing (SA) algorithm proposed by Sait 
and Youssef (1999). The optimizer selects the fieldlets, their energies, and their associated 
intensities that correspond to the optimal plan while the rejected fieldlets receive the weight 
of zero. 
The dose-volume objective function, FOV (w), is represented by 
F OV (w) = Ffv(w) + F6AR(W) 
where w stands for the array of fieldlet weights, F.g,,(w) represents the (dose-based) target 
objective term and F6AR (w) represents the (volume-based) organs at risk (OAR) objective 
term. The objective functions are calculated as follows: 
F O (w) = JTmax ~ e(D (w) _ Dmax) TV.p W - TV [ D () D
maX ]2 
TV TV ~ TV.p TV D max 
pETV TV 
[
D min _ D (W)]2 
+JT min ~ e(Dmin _ D (w)) TV TV.p TV ~ TV TV.p Dmm 
pETV TV 
and 
v ~ [LPEOARI e(DOARI.P(W) - D3'~'k,) dV - V3'~~I]2 
FOAR(w) = ~ JTOAR, , 
1 VOARJ 
where JT-r~x and JT-r~n refer to the penalty parameters ofthe target maximum and minimum dose 
constraints, respectively, e defines the Heaviside or step function, and DTV.p(w) is the dose 
deposited to point p of the target (denoted by TV) which contains a total of NTV dose points. 
The dose to the target volume is constrained by the user-specified maximum and minimum 
dose D!{!~X and D!ftn and relevant dose-volume relations for critical organs are specified by 
the dose-volume constraints of (D3'~~" V3'~~J, where 1 labels ail the organ constraints. Each 
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Figure 2. A schematic diagram of the CUITent EMET procedure. 
constraint in the OAR is assigned a penalty value JTOAR that weighs the individual penalty 
contribution to the overall objective function. 
The optimization algorithm was developed in an in-house built inverse treatment planning 
system that is developed within a visual software environment (AVS 5.4, Advanced Visual 
Systems, MA), running under SUSE LINUX. Software has been developed to interface the 
optimizer with the Monte Carlo caJculated kemels so that the dosimetric data as weil as the 
contour data required for the optimization algorithm could be extracted. The software also 
extracts the dose deposition coefficients (DDCs) which define the relative dose contribution 
from each fieldlet to each voxel contained in a specifie contour. Moreover, the optimal 
ftuence data obtained by the optimization algorithm are interfaced again with the kemels 
and then fed back to the c1inical planning system (CadPlan 6.2.7) to display the final 
dose distribution. Another optimization algorithm, based on the deterministic steep DVH 
minimization (Hristov et al 2002), has been developed within the same environment and 
objective function. It will be used for future studies for comparison with the simulated 
annealing algorithm to check the ability of both the algorithms to achieve the optimum 
optimization goals. That would include the study of the effect of the dependence of the 
generated fieldlet weights on the initial condition that might result in entrapment in a local 
minimum of the objective function if the deterministic approach is used. 
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Table 1. Target dose and organ dose-volume levels in EMET optimization for the phan tom case. 
Structure Dose (Gy) Volume (%) Penalty value 
Target 50 100 
Target 60 0 
Organ 1 40 2 0.3 
Organ 1 30 10 0.3 
Organ 2 40 2 0.3 
Organ 2 30 10 0.3 
Note that, since we work a priori with realistic and deliverable beam port dose 
distributions, there are no additional steps involved (analogous to an MLC leaf sequence 
caIculator in IMRT) in determining the delivery of the distribution. The combined dose 
distribution is also truly optimized since the effects of both the presence of the heterogeneities 
as weil as the bremsstrahlung produced by the collimation device are taken into account 
without the need to correct the final dose distribution for the leakage and transmission. As 
shown in figure 2, in the event that no convergence can be achieved in the optimization process 
with the existing fieldlets, new beams have to be added and the optimization process repeated. 
An example of such a case cou Id be the need to reduce skin dose through the use of one or 
more conventionally shaped photon beams. As only a limited number of additional fieldlets 
would be required, the incremental time needed for this process is Iimited. 
2.4. Treatment planning details 
2.4.1. Simple water phantom. We have planned for EMET on a 3D homogeneous solid 
water phan tom geometry as weil as for a realistic head and neck case. For the homogeneous 
phan tom case, contours and CT data were acquired from the CART files, the file format used 
by CadPlan treatment planning system. We used a phantom scanned through CT to emulate 
the planning procedure where our caIculations will be performed. The target was drawn to be 
surrounded by critical structures shown in figure 3. The lateral extent of the target was 8 cm 
and the inferior-superior extent was 6 cm while the depth varies laterally. The isocentre was 
placed at the surface so that the phantom is at an SSD 100 cm. With each electron energy, 
five fieldlets were simulated: two ofthem were adjacent to coyer the PTV laterally (along the 
x-axis) with a size of 4.5 x 7 cm2 each; two were chosen to coyer the PTV widely (along the 
z-axis) with a size of9 x 3.5 cm2, and one fieldlet that was of the size of9 x 7 cm 2 to properly 
cover the PTV. Table 1 summarizes the dose and dose-volume constraints prescribed for this 
case. 
2.4.2. Head and neck case. For the head and neck case, we generated two plans: 
(1) the convention al tangential wedged photon beams with cutout-shaped e1ectron boost and 
(2) EMET with four electron fields in addition to the wedged photon beams. In plan l, the 
dose distribution was caIculated after the simulation of the MLC-shaped wedged beams using 
our in-house Monte Carlo based treatment planning system. We acquired the beam modifiers 
as weil as the monitor unit settings to perform the simulation for each beam and add the 
individual normalized dose distributions to be displayed in the c1inical treatment planning 
system. In plan 2, the four electron fields were 9, 12, 15 and 18 MeV with six fieldlets each 
such that the PTV is fully covered. In addition, we considered each photon field as a fieldlet 
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Figure 3. (a) Dose distribution of an optimized EMET plan and (b) DVHs for a hypothetical target 
and two organs at risk surrounding the PTV in a homogeneous solid water phantom scanned by 
CT (PTV is outlined in yellow). 
and allowed the optimization algorithm to decide whether or not to use its contribution in the 
final plan. 
3. Results and discussion 
3.1. Homogeneous phantom 
Using our automated EMET system, we calculated the dose distribution for an imaginary PTV 
outlined in a homogeneous solid water phantom that has been scanned by CT. Figure 3(a) 
shows the conformity of the isodose distribution obtained by EMET at the isocentre slice 
based on a 50 Gy prescription. The corresponding DVHs are shown in figure 3(b) for the 
PTV and the GARs. The DVH confirms the coverage of the PTV with the prescribed dose 
but it shows also the presence of hot spots due to the use of a limited number of fieldlets 
where the bulging effect that occurs at the edge of the fieldlets causes the appearance of dose 
heterogeneity wherever the fieIdlets are junctioned. For this particular case, the effect cou Id 
be reduced by the use of a photon field that covers the PTV to create more uniformity within 
the targe!. The hot spots could be eliminated by feathering the field edges using dynamic 
delivery of the fieldlets. Although it has not been implemented yet, it is a potential topic of 
future study. 
3.2. Head and neck case 
To demonstrate the ability of EMET to deal with more realistic scenarios, a plan was 
generated for a head and neck case and compared with the conventional treatment technique. 
Figure 4(a) shows the comparison between the Monte Carlo calculated isodose distribution 
for a conventional plan using two wedged and MLC-shaped photon beams boosted by a lateral 
12 MeV eIectron beam with an optimized plan provided by EMET. It is shown that the 
EMET plan provides better conformity of the prescribed 50 Gy to the PTV as opposed to the 
conventional plan where the 50 Gy isodose line extends to coyer more volume of the healthy 
tissues. Il is also shown that the low-dose isodose line (20 Gy), obtained by EMET, covers 
a small volume compared to the conventional plan. If we consider any tissue outside the 
PTV as an GAR, th en EMET would show superior behaviour in saving such an GAR. The 
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Figure 4. Comparison of (a) isodose distributions and (b) DYH for an outlined target using 
conventional two AP-PA wedged, MLC-shaped 6 MY beams mixed with one lateral 12 MeY 
electron beam and EMET technique using four fields of 9, 12, 15 and 18 MeY, 
Figure 5. Dose distribution obtained by EMET shows tha! the algorithm takes the effect of the 
heterogeneity into account at the cost of the conformity, 
DVHs, shown in figure 4(b), ofboth plans show that they both converge to the same maximum 
dose with more uniformity within the PTV if the conventional plan is used. Hot spots were 
observed to be spread along the PTV for the EMET plan due to the junctioning effect, while in 
the conventional plan the hotspots are localized in the soft tissue. Figure 5 shows the dose 
distribution obtained by EMET for a slice that contains part of the target located in bone 
tissues. It shows that the PTV is fully covered with the prescription dose of 50 Gy even 
though the slice shows a high level of heterogeneity. With the use of realistic Monte Carlo 
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Figure 6. XY scatter plot for the weighted ftuence obtained by the oplimizer for each energy. 
Table 2. The total number of the prescribed monitor units obtained by the oplimizer over the whole 
treatment. The bearn-on lime required to deliver one fraction remains within a 5 min interval. 
Fieldlet 9 MeV 12MeV 15 MeV 18MeV 6MV 
1 23\0 450 3000 0 ANT 0 
2 7425 0 400 76 POS 1240 
3 315 1408 1590 \372 
4 360 736 60 1892 
5 4750 36 0 0 
6 855 1536 120 252 
7 1980 0 270 1036 
8 495 0 0 0 
simulated fieIdlets kemels a priori, where the patient heterogeneities have been accounted for 
in the optimization algorithm, the EMET plan is truly optimized with its initial requirements. 
However, due to the competing goals in the objective function between covering the PTV 
adequately and conforming the prescribed dose to it, the final outcome depends on which goal 
has higher priority. In this case, the coverage of the heterogeneous tissue came at the cost of 
the conformity. 
The intensity maps for each energy field, obtained by weighing the Monte Carlo simulated 
fieldIets to their contribution provided by the optimizer, are shown in figure 6. The map shows 
the dominance of the 9 MeV electron field. Such dominance is due to the shallow depth of 
the tumour. There is also a significant fraction of the high energy electron fieldlets at the 
positions, which is attributed to the presence of bone tumour heterogeneity along the path of 
those specific fieldlets. Table 2 shows the final output provided by the optimizer converted to 
monitor unit settings. Note that these numbers represent the setting of the complete delivery 
and need to be fractionated based on the number of fractions prescribed by the physician. 
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The minimum output to be given by the optimizer was set to be one monitor unit, yet several 
fieldlets were given a zero weight incIuding the anterior photon beam. The posterior photon 
beam, however, was given a relatively high weight which improved the homogeneity of the 
distribution as specified by the constraints. 
The calculation time required to obtain phase files of 24 fieldlets used in this EMET plan 
was a total of 24 h with a 10 Pentium III CPUs cluster. Calculating ail dose distributions 
based on the generated phase space files is estimated to be 30 min in the same c1uster. The 
optimization process produces its results within 2 h. Most of the time consumed in the process 
is due to the production of the phase space files that could be significantly reduced by the use 
of the beam models or by building up a library of selected phase space files. 
4. Conclusions 
In this work, we studied the feasibility of a simplified collimation device to deliver conformai 
electron beam dose distributions. Our results show that EMET offers advantages over the 
conventional treatments and leads to a significant reduction of the dose delivered to the healthy 
tissues. In the case studied, the bearn-on time for one fraction would be within 5 min if the 
accelerator was set to run 500 MU per minute. The transition time for the six fieldlets for each 
of the four energies used is estimated to be around 8 min based on the basic characteristics of 
standard motors and the pitch of typical driving screws. Given the fact that we used a limited 
number of fieldlets, the optimization algorithm cou Id provide weights that conform to the 
target within reasonable delivery time. More work is needed in the selection of fieldlets and 
in investigating the use of beam models. A prototype of FLEC is under construction in our 
department. Comparisons between EMET and IMRT are being investigated and the feasibility 
of using a practical combined plan is underway. 
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Energy modulated eJectron therapy (EMET) based on Monte Carlo dose calculation is a promising 
technique that enhances the treatment planning and delivcry of superficially locatcd tumors. This 
study investigated the application of EMET using a novel few-Ieaf electron collimator (FLEC) in 
head and neck and breast sites in comparison with three-dimensional conventional radiation therapy 
(3D-CRT) and intensity modulated radiation therapy (IMRT) techniques. Treatment planning was 
performed for two parotid cases and one breast case. Four plans were compared for each case: 
3D-CRT, IMRT. 3D-CRT in conjunction with EMET (EMET-CRT), and IMRT in conjunction with 
EMET (EMET-IMRT), ail of which were performcd and caJculated with Monte Carlo techniques. 
For ail patients. dose volume histograms (DVHs) were obtained for ail organs of interest and the 
DVHs \vere used as a means of comparing the plans. Homogeneity and conformity of dose distri-
butions were calculated. as weil as a sparing index that compares the effect of the low isodose lines. 
In addition. the whole-body dose equivalent (WBDE) was estimated for each plan. Adding EMET 
delivered with the FLEC to 3D-CRT improves sparing of normal tissues. For the two head and neck 
cases. the mean dose to the contralateral parotid and brain stem was reduced relative to IMRT by 
43% and 84%. and by 57% and 7 J c,:'c, respectivcly. Improved normal tissue sparing was quantified 
as an increase in sparing index of 47% and 30% for the head and neck and the breast cases, 
respectiveJy. Adding EMET to eithcr 3D-CRT or IMRT results in preservation of target conformity 
and close homogeneity. When adding EMET to the treatment plan, the WB DE was reducecJ by 
between 6% and J 9% for 3D-CRT and by between 21% and 33% for IMRT. while WBDE for 
EMET-CRT was reduced by up to 72% when cornparecJ with IMRT FLEC offers a practical means 
of delivering modulated electron therapy. Although adding EMET delivered usillg the FLEC results 
in perturbation of target conformity when compared to IMRT it significantly improves normal 
tissue sparing while offering enhanced target confonnity to the 3D-CRT planning. The addition 
of EMET systematically leads to a reduction in WBDE especially when compared with 
IMRT. © 2005 American Association of Physicists ill Medicine. [DOl: 10. 1118/1.2011089] 
Key words: Monte Carlo dosimetry, energy modulated eJectron therapy, intensity modulated radia-
tion therapy, whole body dose 
1. INTRODUCTION 
Electron beams offer signilkant advantages over megavolt-
age photon beams in tenns of deJivery of high dose at shal-
low depths, rapid fall-off of the dose distribution beyond the 
treatment volume, and Jow exit dose. Nevertheless, the use 
of modulated eJectron heams still lags behind that of photon 
intensity mocJulatecJ radiation therapy (IMRT). Compared 
with IMRT. energy modulated electron therapy (EMET) has 
not been widely implemented due to problems Inherent 10 
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lectron beams such as dosimetric accuracy and verification 
s weil as a lack of systems for automatic delivery. Studies 
lave shown the fundamental capabîlity of modulated elec-
ron heams for the deliverv of tailored dose distribution and 
lifferent delîvery approaches have hcen proposed. 1 An auto-
nated system of bolus modulation was proposed to design 
nd producc patient specific bolus.:2-~ But such system is 
xpensive and planning and treatment with holus-modulated 
Iectron heams remain time consuming and cumbersome. 
Electron multileaf collimators (eMLCs)6-8 haw hcen de-
igned for use in their own support frame and have the po-
wtial to serve for modulated dectron radiation therapy 
pplications.8 Aside from being relatively bulky. due to the 
.resenee of a large number of motors in close proximity to 
he patient. automation of such a complex system has not 
.een satisfactorily addressed. 
We have recently proposed and studicd the fcasihility of a 
implified ''few-Ieaf eIectron collimator" (FLEC)9 for deliv-
ring EMET The FLEC is designed as an added accessory 
Dol able to automatically form a sequence of rectangular 
.penings (field lets) to compose any irregular electron field. li 
onsists of four copper bars driven by stepper motors that are 
lectronically coupled to the motors controlling the photon 
aws so that both of them simultaneously project the same 
.pening at source to surface distance (SSD) of 100 cm. Be-
ng backed up by the jaws, the e-collimator blades have a 
hickness of only 1.1 cm and a width of 3 cm. These limitcd 
ateral dimensions ensure that the collimator fits within a 
cgular dinical dcctron applieator. 
The use of invcrsc planning techniques for EMET is more 
omplex than for photon beam IMRT sincc collimation has a 
.rofound effect on electron scattering and the dose gradients 
n a specific fieldIct. In addition. aceurate dose calculations 
n and near patient heterogeneities are essential to ensure that 
he optimizer has the dose information required for calcula-
ion of fieldlet weights that lead to an optimal treatment plan. 
-lence, the output and the dose distribution realized through 
he combination of multiple subfields requires faithful mod-
ling of electron transport through the collimation system 
Ind inside the patient. 
The total body dose resulting, mainly, from scatter and 
eakage in photon beams is considered to be a significant 
lisadvantage to IMRT IO- 12 To deliver an equivalent target 
lose, IMRT techniques require a considerable increase in 
leam-on time compared to conventional techniques (be-
ween 2 and 5 times longer).n.14 The increased number of 
nonitor units (MUs) leads to a greater whole-body dose to 
he patient due to the leakage and scattering of x-rays. 
herehy increasing the risk of radiation induccd 
nalignancies.l~ In contrast, eJectron beams are not associ-
lted with the hazard of the increased total body dose due to 
he absence of the target and the tlattening tiller that produce 
Ind tlatten photon beams and cause Jeaking and scaltering 
lway from the beam direction. 
In this work, we investigated the clinical significance of a 
Cw-leaf collimator with an associated inverse Monte Carlo-
.ased planning algorithm for electron beams. As the use of a 
imited number of eIectron fieldlets may result in undesirable 
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TABl E 1. Objecti\'e function parameters used in treatment planning and op-
tirniLation. 
['!lw/id cuses 
Goal (Gy) Vol below goal ('l,) Min (Gy) Max (Gy) 
Target 60 2 575 6R 
Lirnit (Gy) Vol above limit(\7,·) Max (Gy) 
Tissue 50 20 68 
Eye(L) 40 2 45 
Eye(R) 40 2 45 
Lens(L) 8 fi 
Lens(R) 8 R 
Spinal cord 40 4 45 
Brain 50 33 53 
Brain stern 50 33 53 
Larynx 50 50 50 
Breils! case 
Goal (Gy) Vol below goal ('1r) Min (Gy) Max (Gy) 
Target 50 3 48 55 
Limit (Gy) Vol above Iimit('7<) Max (Gy) 
Tissue 50 1 50 
Heart 20 10 45 
Lung 20 10 50 
dose heterogeneity within the target when applied as a sole 
treatment modality, the combination of EMET with either 
traditional photon beams or IMRT beams is of greater inter-
est because it achieves the conformity and target uniformity 
desired in an optimal plan with better sparing of normal tis-
sues. EMET planning was thus performed either in conjunc-
tion with photon beams used in three-dimensional conformaI 
therapy (EMET-CRT) or in conjunction with IMRT (EMET-
IMRT). We studied thrce clinical cases: two parotid gland 
cases and a breast case. We estimated the whole body dose 
equivalent (WBDE) of the conventional 3D-CRT, IMRT, 
EMET-CRT, and EMET-IMRT plans using measured dose 
data at various distances from the isoccnter. This work rep-
resents the results of a feasibility study and the full applica-
tion of the technique awaits the implementation and valida-
tion of a QA program that verifies the accuracy of the 
delivery using similar techniques as those used in IMRT 
Il. METHODS AND MATERIALS 
A. Patient selection, volume definition, dose 
prescription 
Two parotid cancer patients post-surgical resection previ-
ously treated with adjuvant radiation were selected. Each pa-
tient had been immobilized with a thermoplastic mask, and 
had had a planning computed tomography (CT) scan of the 
head and neck with 5 mm slices. The clinical target volume 
(CTV). planning target volume (PTV). and organs at risk 
(OARs) (brain. brain stem, spinal cord. eyes, lenses, larynx, 
and contralateral parotid) had been contoured for each pa-
tient. The CTV included the post-surgical bed and areas at 
risk for microscopic disease. The PTV included the CTV and 
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13 mm margin. The dose prescribed 10 Ihe PTV was 60 Gy. 
lt 2 Gy per fraclion. For inverse planning, dose conslrainls 
o Ihe OARs are seen in Table 1. 
One patient with left-sided hreast cancer post-mastectomy 
Jreviously treated with adjuvant radiation was sclected. The 
Jalient had bccn immobilized with a breast board, and had 
lad a planning CT scan of the thoraeie cavily with 5 mm 
;lices. The c1inical larget volume (CTV) and organs at risk 
:lungs, heart, contralateral hreast, skin. and ribs) had been 
:onloun.:d. The skin was outlined for a deplh of 2-3 mm. 
fhe CTV inc1uded the Idl chest wall as dcfined on the plan-
ling CT scan. The dose prescribed to the CTV was 50 Gy. at 
2 Gy per fraction. For inverse planning. dose constraints 10 
.he OARs are seen in Table 1. The IMRT plan dose con-
;traints clicl nol inc1ucle the skin or ribs as we dicl not wanl to 
:ompromise the target eoverage. 
For ail cases, the normal lissues exclucling the OARs and 
.arget volumes were clefinecl. 
B. Treatment planning 
1. Treatment planning system 
To ensure consistency of the comparison belwcen differ-
~nt plans, a11 plans computecl in this work were Monte Carlo 
'Ccalculated using the dose engine embedded in the McGill 
\1ontc Carlo Treatmcnt Planning (MMCTP) system. This 
Jlanning interface was developecl with Ihe capability of im-
Jorting Ireatment plans l'rom different planning systems l'rom 
.vhich it reads Ihe CT clata, beam arrangements ancl the MU 
xescription. After acquiring the plan infonnation. the 
Jatient-specific beam arrangements are simulated using the 
\1onle Carlo EGSIBEAMnrc package l6 to obtain the phase 
;pace dala (PSD) representing the beam energy and particle 
Jroperties. For each energy, the MU calibration of the system 
is obtained based on a dose calculation in reference calibra-
:ion conditions. The PSD of each bcam is stored in a tîle 
from whieh each partic1e is transported through the patient 
Jensity matrix [256 X 256 X (number of slices)] derived 
from CT data (voxel size varying from 0.15 to 0.2 cm) using 
:he fast Monte Carlo code XVMe. 17 The beams are added 
Jased on their MU weights to obtain a final dose distribution 
Jisplayed in MMCTP. 
Simulation of the photon beams of aIl plans included im-
?orting the MLC flle l'rom the clinical treatment planning 
;ystem (CadPlan®) and converting them to an input file 
"eadable by the DYNVMLC module l8 in BEAMIEGSnrc. 
fhe DYNVMLC has thc ability to fully mode! the details of 
,he leaves used in the Millennium 120 leaf collimator includ-
ing the difference on the thickness of the inner and the outer 
leaves. leaf holes. tips, air gaps. For dynamic delivery in 
[MRT plans, the leaf sequence files were extracted from the 
lMRT system station and converted to a format suitable for 
the BEAMnrc DYNVMLC component module in which the 
?hysical openings at the MLC plane are caIculated and the 
\1LC segments are sampled bas cd on the MU settings. 
MMCTP is equipped to process the IMRT plan and provide a 
Monte Carlo-recalculated dose distribution for each ap-
proved plan. The wedges were simulated using the WEDGE 
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module developed by van der Zee and Welleweerd 19 and 
modified to work within the BEAMnrc environ ment. While 
the validation of the simulations of DYNVMLC has been 
reported in another study.IS the simulations of the WEDGE 
module have been extcnsive!y stlldied over a wide set of 
experimental setups and the differences between measure-
ments and calculations were less than 3')(. 
2. Energy modulated electron therapy planning 
EMET was planned and the delivery was calculated as 
described in a previous study.9 Brietly. it involves the use of 
the automated FLEC in conjunction with Monte Carlo-
calculation of patient-specific dose deposition coefficients 
(DDCs). Keeping the outer dimensions of the FLEC not 
larger than the currently existing standard electron applica-
tors has the consequence that geometrical restrictions associ-
ated with the electron treatment of head and neck patients 
can be overcome. Thc weight of the FLEC is estimated to be 
around 3-4 kg in addition to the weight of a clinical electron 
treatment applicator. In the first order, the delivery of com-
plex dynamic electron fields will he performed in a step-and-
shoot approach, whcreby every subfield is formed by simul-
taneous collimation of the e1ectron bcam by the jaws and 
FLEe. A complete fraction from a typieal treatmcnt plan 
consisting of a combination of 25 subfields of four energies 
can be deIivered within a 15 min lime framc 9 The DDCs are 
obtained by manual selection of suitabIe fielclIets that geo-
metrically conform to the target followed by full Monte 
Carlo simulation of each fieldlet for ail energies using the 
BEAMnrc code 10 obtain a phase space representation of the 
fieldlets. Particles from this phase space are then transported 
through the patient model using the XV MC code. The dose 
distribution of each simulated fieldlet is considered a kernel 
that is fed into an optimization algorithm. Each fieldlet's 
phase space flle contains 2-6 million particles depending on 
its dimensions which results in a negligible latent uncer-
tainty. In a previous stlldy, the accuraey of the Monte Carlo 
engine for clinical electron beams has been commissioned 
and compared 10 measurements in hetcrogeneous phantoms 
and the overaJ] accuracy was Iess than 3% near maximum 
dose?O The number of simulated histories was sclected so as 
to achieve a statistical uncertainty within 2% or less per 
fieldlet in the voxels receiving 10% or more of maximum 
dose. Ma et al. illustrated that such sm ail statistical uncer-
lainties in moclulated electron beams \vill not affect the final 
results represented in close volume histogram (DVHs).21 
The in-hou se developed optimizalion software operates 
under a graphical programming system (Application Visual-
ization System, AVS Inc.) and uses the deterministic steep 
DVH minimization algorithm22 as an optimization technique. 
The software manages the extraction of the dosimetric infor-
mation l'rom the Monte Carlo calculated kernels which in-
cludes the contour data and the DDCs that characterize the 
relative dose contribution from each kcrnel 10 each point 
confined in an individual contour. Obtaining both contour 
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fAIlLL Il. The total !vl\Js to deliver the plans (lI' the conventipnal 3D·CRT.' FMFT-CRT." IMRT.' and EMET·IMRT." The addition of EMET reduces the photon 
)eam contrihutions of the 3D·CRT and IMRT plans by transferring ,ome weight to the electwn beams. The electron MUs and the photon MUs are not additive 
iince they contributc differently to the whole body dose. 
Case 1 , ['am'id) 
lD·CRT EMET·CRT IMRT EMET·IMRT 
Energy Angle MU Encrgy Angle MU Energy Angle MU Energy Angle MU 
6 MV Wi 142 6 MV 345 R6 6 MV 240 259 6 MV 240 297 
6 ]'vIV 200 141 6 MV 200 199 6 MV 280 199 6MV 280 89 
6 MV no 97 li MV 270 39 6 l'vI V 310 226 6 MV JIO 67 
6 MeV no 4g 6 MV J50 160 6 MV 350 131 
9 MeV 270 53 6 MV 30 216 6 MV 030 219 
12 MeV no 251 6 MeV 270 50 
9 MeV 270 60 
12 MeV 270 279 
Case 2 (Pam,id) 
3D·CRT E1'vIET·CRT IMRT EMET·IMRT 
Energy Angle MU Energy Angle MU Energy Angle MU Energy Angle MU 
6 MV 10 165 6 MV 10 211 6 MV 330 209 6MV 330 158 
6 MV 190 155 6 MV 190 76 6MV 100 209 6MV 100 102 
6 MV 90 134 6 MY 90 11 6MV 130 207 6 MV no 171 
9 MeV 90 159 6 MY 170 212 6 MV 170 III 
12 MeY 90 135 6MV 30 198 6 MY 30 146 
15 MeV 90 320 6l\IV 60 247 6 MV 60 206 
9 MeV 90 43 
12 MeV 90 74 
15 MeV 90 219 
Case 3 (Breas!) 
3D·CRT EMET·CRT IMRT EMET·IMRT 
Encrgy Angle MU Energy Angle MU Energy Angle MU Energy Angle MU 
6 MY 302 205 6 MV 302 156 6MV 302 207 6 MV 302 137 
6 MV 127 205 6MV 127 156 6 MY 312 184 6MV 312 120 
6 MeV 46 370 6 MV 322 196 6 MV 322 lOI 
9 MeV 46 414 6 MY 127 185 6 MV 127 130 
6 MY 117 228 6 MV 117 144 
6 MY 107 243 6 MV 107 150 
6 MeY 46 570 
9 MeV 46 805 
'The number of MUs is prescribed by the CadPlan treatment planning system. 
'The number of MUs is prescribcd by the EMET optimizer. 
The number of MUs is prescribed by the CORVUS treatment planning system. 
1bbreFiario/ls: MU= Monitor Unit: 3D·CRT=three·dirnensional confonnal radiation therapy: EMET·CRT =energy modulatcd electron thcrapy in conjunction 
/Vith three·dimensional conformai radiation therapy: IMRT =intensity modulated radiation therapy; EMET·IMRT=energy 1l10dulated elcctron therapy in 
:onjunction with intensity modulated radiation therapy. 
:lata and DDCs for the PTV and OARs is followed by as-
,igning the prescription, the dose-volume constraints. and 
heir related penalties. The EMET optimizer evaluates the 
'ole of each fieldlet in the overall dose distribution and as-
,igns a relative weight to it. After an optimum plan is 
lchieved, the EMET optimizer returns the energies of the 
~ontributing fieldlets along with their associated relative in-
:ensities in the form of number of MUs. Fieldlets that receive 
1 weight of zero by the optimizer are considered rejected. In 
:his work, the Monte Carlo simulated photon beams are 
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considered as fieldlets in both EMET-CRT and EMET-IMRT 
plans. The EMET optimizer determines the weight of the 
entire field in the same fashion it deals with an electron field-
let. Thus, the optimizer reweighs the overall delivered IMRT 
treatment but does not change the leaf sequence of each of 
the individu al IMRT fields. 
3. Treatment techniques 
For each patient, we have used four planning techniques 
that are summarized in Table II. 
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FI(;. 1. The intensity map of two energy fJclds bascd on the relative weights assigned by the EMET optimizcr. The intensity map is normalized to the fieldlet 
with the highest MUs. 
Technique 1: 3D conformaI radiotherapy (3D-CRT) tech-
ll1que 
For each of the two parotid cases. three wedged 6 MV 
photon heams From a Varian Clinac 2100EX aceelerator 
(Varian Medical Systems. Palo Alto, CA) were used. The 
perpendicular heams (the 270° heam for the first case and the 
90° he am for the second case) were given a reduccd weight 
to ohtain a more homogeneous dose distrihution. The lields 
were shaped hy means of the heam's eye view (BEV) feature 
in ACQSIM (Philips, Andover. MA) and a 120 multileaf col-
limator (MLC) was used with a 6 mm consistent margin 
around the PTV to reduce the dose to the OARs. For the 
breast case, two tangential rectangular 6 MV photon tîelds 
were chosen based on the BEV feature to entirely co ver the 
CTY. A wedge angle of 30° was selected to provide a uni-
fOfm dose distribution within the CTY. 
Technique 2: IMRT 
The commercial inverse planning system (CORVUS 5.0. 
NOMOS Inc., Cranberry Township. PA) was used to gener-
ate the IMRT plans. The IMRT technique used five step-and-
shoot 6 MV beam orientations for the first parotid case and 
six gantry angles for the second parotid case and the hreast 
case. The optimization procedure was performed without 
considering the effect of tissue inhomogeneities. Although 
the CORVUS treatment planning system allows one to use 
heterogeneity corrections in the optimization procedure, 
Yang et al. showed that this leads to only a negligible differ-
enee when compared to the CORVUS plan obtained without 
the heterogeneity correction for copI anar plans.23 The effect 
of this approximation is manifested as discrepancies between 
the predicted DVH by the optimization algorithm and the 
"actual" DVH obtained after calculating the dose distribution 
with Monte Carlo simulations which rigorously accounts for 
the effect of tissue inhomogeneities. 
Once the IMRT plans are approved. leaf sequence files 
were produced for each beam orientation derived from the 
intensity maps required to achieve the f1uence proposed by 
the optimization algorithm and the dose distribution is then 
recalculated by Monte Carlo methods. 
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Techniques 3 and 4: EMET-CRI' and EMET-IMRT 
For case 1, 10 fieldlets of 6. 9, and 12 MeV in addition to 
the newly weighted three heams of the conventional plan 
were selected for the EMET-CRI' and the same electron 
fieldlets (with different intensities) were also sclected in con-
junction with the five IMRT fieldlets for the EMET-IMRT. 
Case 2 employed 12 lieldlets with energies of 9, 12, and 
15 MeV. The intensity maps of the 9 and 12 MeV electron 
fields are shown in Fig. 1. The hreast case used eight field lets 
of 6 and 9 MeV. Table Il shows the MU settings for the four 
techniques where the settings of the EMET plans were pro-
vicled by the EMET optimizer. 
C. Plan evaluation parameters 
For each case studied, the mean dose, minimum dose, and 
maximum dose to the target were caJculated for each of the 
four plans. As per Nutting et al.?~ the minimum dose is 
defined as the dose received hy ?99% of the target volume 
and the maximum dose is defined as the dose received by 
~ 1 % of the targel. DVHs were oblained for each of the four 
treatment plans for Ihe target and OARs delineated. Only the 
mean dose and the maximum dose were reported for the 
OARs. 
Conformity was compared by caJculating the conformity 
index (COIN95) defined hy Baltas et al?5 for each plan. 
COIN95 is deflned as the product of the fraction of the targel 
covered by higher than 95Cff (PTV9S / PTV) of the preseribed 
dose and the ratio of the volume of the target receiving at 
least 95% of the prescribed dose to the total volume of tissue 
receiving al least 95% of the prescribed dose (PTV95 / V9S ) 
COIN95 = P7V95 P7V9S . 
PTV V95 
(1) 
However. although COIN95 provides reasonable evalua-
tion of the conformity surrounding the target for the high 
dose values, il does not consider the volume that lies in the 
low dose region. As shown in Fig. 2, having two plans 
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30"/0 
30% 
95% 95% 
FIl<. 2. Schematic diagram of Iwo plans that have the same coverage of the 
95Si isodose line to the PTV volume but with different conformity of the 
low isodose lines. The confonnity index (COIN95) will be equivalent for 
both plans despitc their differences. The sparing index (SPIN501I 0) could be 
used 10 differentiate between them. 
ddivering the same 9Yk coverage will not be differentiated 
by the COIN95 factor if one plan extends the :i0% line to 
cover larger volume which is undesirable if it could he 
avoided. We therefore propose the use of a new term, the 
sparing index (SPIN50/l 0), to quantify the volume that re-
ccives between 50% and 10% of the prescribecl close. We 
have clefinecl this as 
SPIN50/l 0 = 1 - v~g. (2) 
where v~g is the ratio of the volume of tissue that receives 
between 10% and 50% of the prescribecl close to the irradi-
atecl volume. The irradiated volume was clcfined as the vol-
ume of tissue that receives at least 0.5% of the prescribecl 
dose. SPIN50/l0 cannot stand alone without being evaluated 
in conjunction with COIN95 where both values. ideally, 
should approach 1. 
We also used the homogeneity inclex HI90/ll0 to com-
pare plans in terms of the ability to deliver homogeneous 
close clistribution to the target. HI901I lOis clefined as the 
percentage of the target volume with a close higher than 90% 
ancl lower th an 110% of the prescribed close. These param-
eters assist in evaluating plans that have comparable irradi-
ated volumes since there is a central dependence of these 
parameters on the planning volume in relation to normal tis-
sue. 
D. Assessment of whole body dose-equivalent 
(WBDE) 
The dose was measurecl using a cylinclrical Farmer ion-
ization cham ber placecl at a clepth of 2 cm in a solid water 
phantom and positioned at 35. 55, 75 and 95 cm away from 
the edge of the field. To resemble the patient geometry, a 
semispherical solid water phantom that mimics a head was 
placecl at the isocenter while the other parts of the bocly were 
mimicked using bolus bags to account for the effect of the 
internaI scatter. Dose per MU was obtained for a 7 X 7 cm2 
fielcl (a typical fielcl collimated with jaws and FLEC used in 
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FI(;. 3. Off axis dose at depth of 2 cm in a sol id water phantolll based on the 
number of MUs given by four techniques j()r the breast case. 
EMET) at ail energies (6, 9,12, 15 MeV). as weil as the dose 
per MU for 10 X 10 cm2 of the 6 MV photon field which 
agreecl with the results obtainecl by other authors?6 Using the 
total number of MUs acquired from the CaclPlan treatment 
planning system for the conventional plan, from the 
CORVUS treatment planning system for the IMRT plan, and 
from the EMET system for both the EMET-CRT and EMET-
IMRT plan, WBDE was estimatecl by multiplying the total 
MUs of each fiel cl by the close value per MU measured at 
40 cm from the Îsocenter. This value was used as a reason-
able approximation to determine WBDE resulting from the 
60 Gy prescribecl dose for heacl and neck cases and the 
50 Gy prescribecl dose for the breast case. Figure :i illustrates 
the comparison of the hehavior of the peripheral close caused 
by the four techniques based on the total MUs prescribed for 
the breast case. 11 is important to note that this estimate of the 
total body dose assessment serves only as a first orcler ap-
proximation due to the vital dependence of the WBDE on the 
treatment technique of each plan. In this work. we have used 
WBDE only to relatively compare differcnt planning tech-
niques. 
III. RESULTS 
A. Parotid cancer cases 
The isodose distributions of the four clifferent plans with 
the DVHs of the outlined organs for the two cases are shown 
in Figs. 4(a) and 4(b). Table III shows the summary of the 
DVH analysis of the four treatment plans for each case 
where the minimum, maximum, ancl mean doses to the target 
are reportecl. COIN95, SPIN501I 0, HI901I 10, and the esti-
mate for the WBDE are shown in Table IV. 
The target was weil covered by ail four plans. However. 
the IMRT plan gave the highest conformity lO the target, 
followecl by the EMET-IMRT plan. The use of IMRT and 
EMET-CRT produced hot spots. but these were within the 
target volume and were consiclered acceptable. For case 2, 
the hot spots obtainecl with the EMET-CRT plan were within 
the air-filled cavities of the temporal bone in the mastoid air 
cells. Since the dose distribution was ca\culated by Monte 
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Carlo. the dose that is reported is the actual dose that is 
deposited in the air cavities. The hot spots with the IMRT 
plan were in the soft tissues due to the heterogeneities that 
were not taken into account in the optimization. As expectcd. 
the high isodose curves were very conformaI \vith both the 
IMRT and El\·1ET-CRT plans. hut the low isodose curves for 
the IMRT plan contained a much larger volume of normal 
tissue compared with the EMET-CRT plan as seen in Fig. 4. 
This corresponds to the EMET-CRI' plan having a much 
higher SPIN50/1 0 value lhan the IMRT plan (Table IV). If 
the SPIN50/l0 is accepled as a measurc of the ability of a 
given plan to spare the normal tissues in the low dose re-
gions. then the EMET-CRI' plan had a 47(k higher sparing 
on average compared to the IMRT plan. 
IMRT has been shown to reduce the dose to the contralat-
eral parotid. brain. and spinal cord?4.27 In our series. IMRT 
decreased the mean dose to the contralateral parotid by 27% 
on average when compared to the 3D-CRI' plan (1àble III). 
The use of EMET-CRT further reduced the dose to the con-
tralateral parotid dose by an additional 58(!{. The amount of 
normal brain tissue treated with a given technique is also an 
important issue when comparing different treatment tech-
niques. The mean dose to the brain was 27% lower on aver-
age with the EMET-CRI' plan as compared to the IMRT 
plan. The maximum dose to the spinal cord was 22(71; lower 
on average with the EMET-CRI' plan when compared to the 
IMRT plan. 
The estimate of WBDE (in mSv) is shown in Table IV. 
The WB DE was lowest for the EMET-CRI' plans and the 
highest for the IMRT plans for ail cases. The use of 
EMET-CRI' resulted in a 69lk decrease in the whole body 
dose on average compared to the IMRT plan. 
B. Left breast cancer post-mastectomy case 
làble III summarizes the quantitative comparison be-
tween different plans for the target volume and OARs. The 
minimum. maximum. and mean doses to the target. ipsilat-
eral lung, heart, skin overlying the treated breast, and ribs are 
given for each of the treatment plans. COIN95. SPIN50/10, 
HI90/11O, and the WBDE are given for each plan in Table 
IV. Figure 4(c) compares the isodose distributions for each 
of the treatment plans. The mean doses to the target were 
similar with each of the plans. However, when using the 
eonformity index, the EMET-IMRT plan had the highest eon-
forrnity followed by the IMRT plan, EMET-CRI' plan. and 
the 3D-CRI' plan the lowest. EMET-CRI' gave the most ho-
mogeneous dose distribution to the target as shown by the 
HI90/110 seen in Table IV. The SPIN50/10 showed that the 
3D-CRI' plan had highest value due to the poor conforrnity, 
shown in COIN95, that increased the volume of normal tis-
sues irradiated with high isodose Iines while lessening the 
volume covered by low isodose lines. The sparing of the 
3D-CRT plan is followed by the EMET-CRI' plan. 
EMET-IMRT plan, and the IMRT plan. 
An important concern with left-sided breast cancer pa-
tients treated with radiotherapy is the dose to the heart. Table 
III gives the doses to the heart according to the different 
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techniques. The 3D-CRI' technique gave the lowest mean 
heart dose followed by the EMET-CRI' plan, EMET-IMRT 
plan, and the IMRT plan. The use of EMET~CRT in this case 
gave a similar conformity as lM RI', but with a decrease in 
the dose to the heart. The EMET-CRI' plan gave a 47% lower 
me an heart dose and a 41 (;{ lower maximum heart dose as 
eompared to the IMRT plan. 
The ipsilateral lung often receives signi11cant dose with 
conventional radiotherapy using tangential fields. Table III 
shows the doses to the ipsilateral lung by the different tech-
niques. The EMET-IMRT technique gave the lowest mean 
dose to the lung. which resulted in a 100/( decreasc in the 
mean lung dose compared to the IMRT plan. The dose to the 
contralateral lung was negligible since it was not in the path 
of any irradiation tield. In addition. the skin and rib doses 
were analyzed, and the IMRT plan gave the lowest mean 
doses to each. The higher mean dose to the skin seen with 
the EMET-CRI' plan is likely due to the location of the CTV 
3-4 mm below the surface so that the skin is in the buildup 
region. However, the maximum skin dose was the highest 
with IMRT and the 100vest with EMET-CRT. The increased 
dose to the skin seen with IMRT is likely duc to the fact that 
the skin is in the buildup rcgion for photons, and IMRT uses 
multiple tangential beams to deliver a homogenous dose to 
the targe!. This effect has been seen with patients treated 
with IMRT for head and neck cancers?8 The EMET-CRI' 
plan had an 8% lower maximum skin dose when compared 
to the IMRT plan. 
WBDE is shown in Table IV. It was lowest for the 
EMET-CRI' plan followed by the 3D-CRI' plan, EMET-
IMRT plan, and the IMRT plan. The EMET-CRI' plan was 
72% lower than the IMRT plan with respect to the estimated 
whole body radiation dose. 
IV. DISCUSSION 
In this study, we introduce a novel EMET technique using 
a FLEC as a modality for use in conjunction with 3D-CRI' 
and/or IMRT in the contexl of mixed beam treatment plan-
ning and delivery. The automated FLEC circumvents the 
challenge of remotely shaping the electron fields required for 
the clinical application of EMET. This technique was applied 
to two parotid cases and a breast case for which comparisons 
with Monte Carlo-recalculated conventional 3D-CRI' and 
IMRT plans were performed. Although the FLEC involves 
the use of limited beam ports and large fieldlets compared to 
the tine MLC beamlets used in IMRT. the results show a 
significant overall improvement in sever al parameters used 
to analyze treatment plans. 
A. 3D-CRT vs EMET-CRT 
Conformity is significantly enhanced when EMET was 
added to the 3D-CRI' plan. The conformity effect was more 
pronounced with the breast case where the high isodose lines 
extend to the lung covering some portion of it with the pre-
scribed dose while with EMET-CRT plan, as shown in Fig. 4, 
the 45 Gy isodose line confomlS to the breast tissues, sparing 
the Jung from irradiation by high doses. The volume of lung 
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FIG. 4. A compatison of the Monte Carlo calculated dose distributions and DVHs for ail outlined organs produced by four plans: (1) 3D-CRT, (II) EMET-CRT, 
(Ill) IMRT. and (IV) EMET-IMRT; (a) and (b) are for the two parolid cases and (c) is for the breast case. 
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rAIlU' ilL Comparison of dose for PTV and OARs using four planning techniques. The overall statistical uncertainties of ail plans were less than 2%. 
Contralateral 
PTV Brain Brain stern Cord parotid 
Plan A1ean Min Max ,,,"Jean Max Mean Max Mean l'vIax Mean Max 
~'ase 1 (PaFOTid) 
3D-CRT 59.1 49.6 62.2 3.60 24.5 16.0 19.9 7.5 31.6 12.7 14.7 
Il\-IRT 59.7 55.9 64.7 4.82 29.2 17.2 25.1 9.9 32.2 9.9 163 
EMET-CRT 59.5 50.7 63.6 2.79 23.9 7.4 11.3 3.8 18.2 5.7 6.7 
EMET-IMRT 59.9 54.7 65.4 2.9 23.5 9.1 14.5 7.2 24.2 7.5 14.3 
~ase 2 (l'amTid) 
3D-CRT 59.9 56.9 63.1 9.01 59.3 18.4 29.3 8.1 43.2 13.7 15.7 
IMRT 60.3 55.1 68.9 6.64 52.2 17.8 38.4 8.6 39.9 9.5 15.1 
EMET-CRT 59.6 52.2 65.9 5.94 55.4 5.3 18.7 4.6 40.7 2.5 3.1 
EMET-IMRT 59.3 53.2 66.1 6.15 51.8 14.0 34.5 7.8 37.3 6.5 Il.! 
Plan Brea,t Lung Heart Skin Ribs 
Ml'tllT Min lv/ax Mean Max Mean Max Mean Min A1ean Ma, 
~'(/se J (Brel/st) 
3D-CRT 52.4 47.3 55.5 14.3 48.7 2.1 6.2 41.7 51.9 12.2 52.2 
IMRT 51.7 48.1 56.3 11.2 42.8 43 17.2 40.7 55.6 9.5 49.4 
EMET-CRT 52.5 48.5 55.4 12.4 45.1 2.3 10.1 42.6 51.4 11.8 49.9 
EMET-IMRT 52.4 48.7 56.2 JO. 1 41.3 3.8 ln 41.7 53.7 10.3 49.5 
Ihbre\'iaTi()lJs: min=minimum dose: max=maximum dose: mean=mean dose; 3D-CRT = three-dimensional conformai radiation therapy; EMET-CRT 
=energy modulatcd electron therapy in conjunction with three-dimensional conformai radiation therapy: IMRT=intensity modulated radiation therapy; 
:MET-IMRT=energy modulated electron therapy in conjunction with intensity modulated radiation therapy. 
hat rcccivcs the prescribed dose as seen from the DVH was 
'(;duccd by 50% using EMET. Sparing was also significantly 
mproved with the use of EMET-CRT in both head and neck 
:ases, Jeading to considerable reduction of the mean dose to 
111 OARs including the contralateral parotid. Sparing could 
11so be achieved by replacing the lateral photon field with a 
ateral convention al cutout-shaped electron field. However, 
his would 1ead to extremely unfavorable heterogeneities in 
he dose distribution appearing as an extended tail in the 
)VH of the PTY. Target dose uniformity was affected by the 
lddition of EMET to the 3D-CRT in the head and neck cases. 
mt the reduction to the HI90/l1O caused by EMET remained 
11odest. Homogeneity could possibly be enhanced by assign-
ng more penalty to it in the optimization procedure but this 
.viII cause competing goals in the objective function that 
11ight sacrifice conformity and/or reduce sparing of the other 
)fgans. In the breast case, however, the homogeneity of the 
Jose distribution was improved with the use of EMET. The 
lddition of a relatively large number of electron MUs did not 
ncrease the WBDE; EMET-CRT showcd systcmatic reduc-
.ion of the WBDE by reducing the photon MUs which are 
. he dominant source of radiation outside the beam and re-
)Iacing them with electron MUs which make a minimal con-
ribution to the whole body dose. 
B. IMRT vs IMRT-EMET 
Optimizing the EMET fieldlets with the IMRT whole 
fields that are added to foml the IMRT-EMET plan does not 
~eprcsent the best possible optimization as only the weight of 
Inedical Physics, Vol. 32, No. 9, September 2005 
the entire IMRT field is varied and not the weight of the 
individual beamlets since the CUITent technology has not yet 
been c1inically implemented for Monte Carlo based optimi-
zation of photon beams. Using EMET-IMRT for the he ad and 
neck cases showed reduced conformity relative to IMRT 
al one. This is not the case for the breast case where confor-
mit y was enhanced with the EMET-IMRT plan. This is at-
tributed to the relative large size of the fieldlets compared to 
the projection of the small PTY. In the parotid cases, due to 
the small size of the PTV, the effect of the edges of the 
fieldlets appeared to be significant while this effect dimin-
ished in the breast case where a large target is iITadiated. 
Overall, homogeneity is preserved with the addition of 
EMET. Sparing, however, systematically improves with 
EMET due to the lower exit dose of electrons compared to 
photons. Improvement of sparing was seen as the SPIN50/l 0 
as weil as the mean dose and the maximum dose 10 the 
OARs, ail of which were consistently reduced when EMET 
fields were optimized with IMRT. EMET-IMRT has the ad-
vantage of lowering the WBDE because of the reduction of 
the photon bearn-on time . 
C. IMRT vs EMET-CRT 
Although the conformity achieved by IMRT cannot be 
challenged with the EMET-CRT due to the use of rather large 
fieldlets, the sparing attained by EMET-CRT is superior even 
with such Iimited fieldlets. The significant reduction of dose 
to the contralateral parotid suggests that EMET-CRT has the 
potential to improve the quaIity of life. while the reduction of 
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TAilLI. IV. Comparison of treatrnent planning evaluation parameters of the 
four planning techniques. 
Plan COIN95a SPIN5011 0" 
C<lse / 
(Parotid) 30-CRT 0.56 
IMRT O.6ll 
EMET-CRT 0.59 
EME1~IMRT 0.62 
Case 2 
(Pamtid) 3D-CRT 0.54 
IMRT 0.69 
EMET-CRT 0.62 
EMET-IMRT 0.64 
Case 3 
(Breust) 30-CRT 0.30 
IMRT 0.54 
EMET-CRT 0.43 
EMET-IMRT 0.57 
'COIN95=Conforrnitv index. 
hSPIN50/1 0= Sparing index. 
cHI90/110=Homogeneity index. 
dWBOE=Whole body dose equivalent 
0.49 
0.52 
0.77 
0.59 
0.69 
0.61 
0.88 
0.60 
0.93 
0.67 
0.88 
0.71 
HI9011 10c WBOE" (mSv) 
0.957 9.4 
0.997 26.3 
0.956 8.9 
0985 20.8 
0.987 113 
0.935 11.8 
0.957 9.4 
0.973 23.4 
0.949 8.5 
0.956 25.7 
0.980 7.2 
0.960 17.4 
Abbrel'iatirJlls: 30-CRT =three-dirnensional conformaI radiation therapy: 
EMET-CRT=energy rnodulated electron therapy in conjunction with three-
dimensional conformaI radiation therapy: IMRT=intensity modulated radia-
tion thcrapy: EMET-IMRT=cncrgy modulated c1cctron therapy in conjunc-
tion with intensity modulated radiation therapy. 
dose to the spinal cord is important since it allows the patient 
to receive further radiation treatment if needed. Target dose 
homogeneity was modestly improved with the breast case 
where the hot spots caused by the tangential effect of the 
IMRT fields could be avoided. 1l1e maximum dose to the 
skin in the hreast case was reduced by 8% with EMET-CRT 
compared to IMRT. In the second parotid case, the hot spots 
in the IMRT plan were in the soft tissues while they were in 
the air cavities in the EMET-CRT plan. This effect cannot be 
differentiated when comparisons are made through DVHs 
only but it might have c1inical implications. This study also 
underlies the concern of the inclusion of the air cavities in 
the PTV especially when true Monte Carlo optimization is 
implemented.29 For the WBDE, EMET-CRT shows major 
rcduction of the estimate of WB DE (in the order of 70%). 
V. CONCLUSION 
In summary, we investigated the use of energy modulated 
eJectron beam treatment planning and delivery using a few-
leaf electron eollimator in a context of mixed beam treatment 
planning with conventional radiation therapy and IMRT. We 
used Monte Carlo techniques to caleulate treatment plans for 
convention al 3D-CRT planning and IMRT alone or com-
bined with EMET. We have shown that EMET delivered 
with the FLEC could be a valuable addition to current treat-
ment techniques especially when applied to superficially 10-
cated tumors that are inherently difficult to plan using IMRT. 
Since the FLEC can be readily automated and remotely con-
trolled, the complexity of EMET delivery will not exceed 
\\- hat is deemed acceptable in IMRT. The characteristics of 
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quality assurance procedures are expected to be similar to 
those for IMRT treatments. For two head and neck cases and 
for one breast case we showed that target conformity and 
homogeneity are preserved whilc drastically improving nor-
mal tissue sparing. As a result of reducing the number of 
photon MUs for delivery, the addition of EMET systemati-
cally leads 10 a reduction in whole body dose, especially 
when compared to IMRT. The application of EMET to other 
Ircatment sites is currently being investigated. 
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